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SUMMARY 
Carrier surface roughness is an important physical characteristic which critically 
influences the aerosolization of micronized drug particles in carrier-based dry powder 
inhaler (DPI) formulations. This research work attempted to address several important 
aspects in the development of improved DPI formulations by surface roughening of 
lactose carrier particles. In the first part of the work, reliable criteria for roughness 
measurement were defined, particularly the filtering wavelength in image processing, 
image size and sample size. Digital filtering of the raw surface profiles obtained by 
optical profilometry was found to be an important image processing step for obtaining 
comparative measures of surface roughness. In the second part of the work, roughened 
carrier particles were prepared using both fluid-bed coating and roller compaction. In 
fluid-bed coating, the attachment of micronized lactose particles to the surfaces of coarse 
lactose carriers resulted in changes to the micro-scale surface roughness. The surface 
roughening effect was investigated using feed powders of different starting particle size 
and surface area as well as carrier particles in different size fractions. In roller 
compaction, extensive fragmentation and bonding of particle fragments resulted in much 
rougher carrier particles of granular nature. The relationships of composition of the 
powder blend with variability of compaction parameters and carrier surface roughness 
were studied. The roughened carrier particles produced using both methods, when 
incorporated into DPI formulations containing a micronized drug, showed significant 
improvement in the fine particle fractions. Further studies using Raman spectral mapping 
showed that the surface distribution of drug particles and/or agglomerates was influenced 
by the degree of carrier surface roughness. Overall, the findings of this research work 
can aid formulation scientists in refining the selection criteria for carriers in DPI 
formulations, especially in terms of their surface characteristics. 
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1 INTRODUCTION 
Pulmonary drug delivery systems are effective therapeutic options available in the 
clinical setting for delivering drugs for the treatment of lung diseases as well as for 
systemic applications. The pulmonary route is optimal for administering drugs to treat 
asthma and chronic obstructive pulmonary disease (1). The main physiological 
advantages of the lung as the site for drug delivery include a very large absorptive 
surface area and the relatively low enzymatic activity present. These physiological 
conditions in the lung allow substances, which cannot be delivered orally, to be absorbed 
rapidly into the bloodstream and to avoid first pass metabolism (2). Recent interest in the 
systemic delivery of medications by the pulmonary route has emerged after studies 
revealed that the lung epithelium is far more permeable to both small molecules and 
macromolecules compared to the gastrointestinal tract or skin (3). Coupled with the non-
invasive nature of drug delivery, the pulmonary route has emerged as an especially 
attractive route for delivering therapeutic peptides and proteins and even as an effective 
alternative route for clinically-approved oral medications.  
A pulmonary drug delivery system typically comprises an inhalation device which aids 
in the generation of an aerosol containing very fine droplets/particles of drug suspended 
in the gas phase. Inhalation devices may be classified into three types; (a) pressurized 
metered-dose inhaler (MDI), (b) dry powder inhaler (DPI) and (c) nebulizer. Pressurized 
MDIs and nebulizers contain drugs present in a liquid formulation while DPIs are 
formulated as dry powders. Compared to nebulizers, MDIs and DPIs are generally more 
compact, portable and convenient to use. They are therefore more commonly 
encountered in the outpatient setting, in particular the MDIs. Nebulizers, on the other 
hand, are usually reserved for patients unable to use the MDIs or DPIs effectively, such 
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as very young children or adults with severely compromised lung function (4). This is 
because nebulizers are generally bulkier due to the requirement of an additional source 
of compressed air to generate the aerosol in a confined breathing space and are more 
costly to operate. Regardless of the type of inhalation device, the efficacy of aerosol 
delivery to the lung is largely determined by four factors: the formulation, metering 
system, inhalation device design and inhalation technique of the patient (5). 
The aerodynamic particle size distribution of the aerosol leaving the inhalation device is 
arguably the most important pharmaceutical characteristic of inhalers as it is directly 
related to the extent of drug delivery to the lung (6). Aerosolized drug particles that meet 
the critical size requirements for deposition at the therapeutically-relevant sites of the 
respiratory tract are known as respirable particles. An upper particle size limit of 4 – 6 
µm is optimal for central airway deposition while that for peripheral airway deposition is 
2 – 4 µm (7, 8). Particles below 0.5 µm can enter the deep alveolar lung regions but they 
may remain airborne and be exhaled with the expiratory airstream (9, 10). Particles 
larger than 10 µm are unlikely to be conveyed to the lower respiratory tract and are 
mainly deposited in the oral, pharyngeal and trachea-bronchial regions instead (10-12). 
The aerodynamic size distribution of aerosols can be assessed in vitro using cascade 
impactors, such as the Andersen cascade impactor and the Next Generation Impactor 
(NGI), or the multi-stage liquid impinger. An impactor or a liquid impinger is normally 
used to measure the performance of an inhalation product by means of its fine particle 
fraction (FPF). The FPF is defined as the mass fraction of respirable particles, which fall 
in the 1 – 5 µm size range, relative to the nominal dose contained in the device before 
aerosolization. In general, research efforts into the formulation and inhalation device 
design are aimed at improving the aerodynamic performance of the aerosol to ensure 
high FPF and reproducible drug deposition in the lung. 
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1.1 Dry powder inhalers 
DPIs have been available since 1967 when the Spinhaler™, which was the first product 
for the delivery of sodium cromoglycate, was launched (13). Scientific and commercial 
interest in the development of DPIs were further stimulated after the implementation of 
the 1987 Montreal Protocol, which called for nations to phase out the manufacture and 
use of ozone-depleting chlorofluorocarbons (CFCs) (5). This posed major restrictions to 
the widespread use of the MDIs as CFCs were the main dispersive energy source of 
MDIs before alternative propellants were introduced in the later years. In comparison to 
other inhalation devices, DPIs have the capacity to deliver high doses of drug to the 
airways (14). The drug dose per actuation is in the order of tens or hundreds of 
micrograms (15). Stability of the drug substance in dry form and the reduced need for 
coordination of device actuation and inhalation are some other advantages of DPIs (5).  
In order to overcome the natural barriers of the respiratory system to large foreign 
particles in the environment, drugs in a DPI have to be delivered as very fine particles 
(typically in micronized form) in the inhaled airstream. As a result of its small particle 
size and high surface energy, these fine drug particles tend to be highly agglomerative 
and poorly dispersible (16). Cohesion between fine particles is predominantly due to the 
van der Waals, capillary and electrostatic forces (17). These forces have to be overcome 
for the efficient dispersion of fine drug powders into discrete primary particles when 
inhaled. Researchers developing DPI formulations generally adopt a two-pronged 
approach to overcome the technical challenges associated with fine agglomerative 
particles. These two approaches are best examined by broadly dividing DPI formulations 
into two categories: (a) carrier-free formulations which usually, but not always, contain 
only drug particles of a suitable morphological form for effective lung delivery and (b) 
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carrier-based formulations which contain coarse carrier particles (typically lactose), in 
the size range of 40 – 200 µm, blended with the micronized drug. 
1.1.1 Carrier-free formulations 
Carrier-free formulations have been developed using a wide variety of sophisticated 
particle engineering techniques, which are aimed at reducing the intrinsic cohesion 
between very fine particles (18). There is no defined approach to the formulation of 
carrier-free particles because the methods adopted are highly dependent on the chemical 
and physical nature of the active ingredient. Hence, almost all successful commercial 
products utilizing these technologies generally fall under specific patent protection. An 
important distinction must be made between carrier-free formulations and excipient-free 
formulations. Conventionally, carriers in DPIs should fulfill two main criteria: (a) they 
are of a much larger physical size compared to the drug particles and (b) drug particles 
are distributed on the surfaces of carrier particles after blending. Therefore, the function 
of a carrier is dependent on its formation of an interactive mixture with the fine drug 
particles (Figure 1). Formulations may contain excipients which do not strictly fulfill the 
‘carrier’ criteria but may occasionally be classified as carrier-free formulations in 
literature. 
A number of carrier-free formulations have been produced by coating lipid materials 
(19), L-leucine (20, 21) and magnesium stearate (22) on drug particles to reduce their 
cohesiveness. Mannitol (23), trileucine (24) and other excipients (25) have also been 
used to reduce the cohesiveness of spray-dried particulates which contain drug. Some 
carrier-free formulations contain drug particles with large geometric mean diameters (5 – 
20 µm) but low density (less than 0.4 g/cm3) as a result of their porous structures (26). 
The aerodynamic performance of these large and porous particles has been shown to be 
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equivalent to that of smaller micronized particles but they exhibit improved flow and 
reduced bulk cohesiveness. Spray-dried drug particles in the 1 – 5 µm size range and 
with wrinkled surfaces or spherical shapes have also been successfully developed as 
inhalation products. They have been shown to exhibit lower dispersion energies during 
aerosolization (18). In order to complement the carrier-free formulations, inhaler devices 
may be specially designed to improve drug dispersion in these formulations. Some 
examples include the Intal Spincaps™ (27), Bricanyl® Turbohaler and Pulmicort® 
Turbohaler (28, 29), which create turbulent airflow for more efficient drug deaggregation.  
 
Figure 1. The differences in the orientation of particles, relative to each other, in random 
and interactive mixtures. The different-coloured spheres represent two 
different materials, or particles of the same material but with different sizes. 
1.1.2 Carrier-based formulations 
Carrier-based DPI formulations contain coarse carrier particles which are physically 
blended with micronized drug particles. Lactose monohydrate is the most commonly 
used carrier in commercially-available carrier-based DPIs and the typical carrier to drug 
mass ratio is 67.5:1 (10, 30-32). Alternative carrier materials that have been reported in 
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literature include mannitol, trehalose, erythritol and sorbitol (33, 34). In carrier-based 
formulations, drug particles adhere to the surfaces of carrier particles via different forms 
of particle interaction, resulting in a certain degree of ordered/interactive mixing (35, 36). 
This reduces the amount of free drug agglomerates, improves bulk flow and thereby 
enables more precise dose metering (37). The ‘carrier’ function of these excipients is 
best understood by examining the mechanisms of drug dispersion during inhalation. 
Compared to the agglomerates of fine drug particles, carrier particles are more 
susceptible to the aerodynamic forces in the turbulent airflow generated upon an 
inspiratory effort (38). After the carrier particles are entrained in the air, a combination 
of three groups of forces aid in the dislodgement of drug particles from the carrier 
surfaces. These forces may be broadly categorized as the (a) drag and lift, (b) shear and 
friction and (c) inertial forces, as shown in Figure 2. The detachment processes must 
occur within a relatively short time span, after the release of the powder from the inhaler 
into the oral cavity and the respiratory system. Due to their large particle size, carrier 
particles are mainly deposited in the oro-pharyngeal region where they are eventually 
swallowed. Hence, carrier particles do not increase the burden of lung clearance of 
foreign matter even though the percentages by mass of carriers are typically greater than 
95 % of the DPI formulation. 
Lactose monohydrate remains as the excipient of choice for carrier-based DPI 
formulations. There is an abundance of published literature about the preparation, 
characterization and performance of lactose carriers in DPIs. Several comprehensive 
review articles have been dedicated to the discussion of the physicochemical 
characteristics of lactose carriers, mechanistic aspects of drug dispersion in DPI 
formulations containing lactose and its interaction with inhaler design (5, 39-43). The 
size, size distribution, surface roughness, moisture content and crystal habit of lactose 
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carriers have been found to interact in complex relationships and influence one or more 
of the many performance attributes of DPIs (5). In addition to carrier properties, DPI 
performance may also be influenced by the type of drug, the physicochemical properties 
of the drug and the inhaler design. 
 
Figure 2. The mechanisms of drug detachment from the carrier surface. 
Surface roughness (or rugosity) is an apparently simple inherent property of carrier 
particles. However, it is also a primary influence of the physical interactions between the 
drug and carrier in contact. Hence, it can affect the formulation and performance of a 
DPI in several ways. Surface roughness has an impact on mixing (44, 45) and the 
stability of interactive mixtures (46, 47). Interactive mixing of a DPI formulation is a 
two-step process involving the breaking up of drug particle agglomerates and dispersion 
of these fine particles on the surfaces of carrier particles. The surface asperities on 
rougher particles may restrict the opportunities for close contact between two 
approaching surfaces and hinder the adhesion of drug onto carrier surfaces during 
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blending. Drug agglomerates trapped in the recesses between the large asperities are also 
sheltered from the blending forces, which are essential for the continual breakage of drug 
agglomerates and the redistribution of drug particles to other carrier surfaces. This may 
adversely affect blend homogeneity during mixing. Rougher carrier surfaces, on the 
other hand, can promote blend stability by reducing the ease of removal of the drug 
particles by low shear abrasive forces. This decreases the likelihood of drug particles 
rolling off the surfaces during capsule or blister filling. However, the performance of 
DPI formulations containing rougher carrier particles was poorer as the drug particles 
were more firmly attached to the carrier surfaces and remained largely immobile (48-50). 
Surface roughness can dictate the adhesion potential of drug particles onto carriers, an 
attribute which also determines the ability of drug particles to detach from the carrier 
surfaces in the airstream when subjected to higher shear forces. A strong negative 
correlation between the carrier roughness and the FPF of a binary mixture composed of 
terbutaline and lactose has been observed (51). Lactose carriers that exhibit larger 
variability in adhesion force measurements also tended to result in greater standard 
deviations of FPF when in vitro studies were conducted (52). Hence, the reduction of 
carrier roughness can be a foremost strategy to reduce drug-carrier adhesion, although 
some researchers have suggested otherwise (41, 45, 53). It has been noted that an 
increase in carrier roughness does not necessarily affect the FPF adversely when the 
predominant mechanism for drug dispersion is by inertial impaction (45, 54). Despite 
considerable studies conducted in this area, it still remains a major challenge to relate the 
surface roughness to the functional characteristics of the carrier (55). This is partly due 
to the difficulties in developing methodologies with clearly defined parameters for 
surface characterization and in the definition of surface roughness. The following 
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sections in this chapter are dedicated to an in-depth review of surface roughness of 
particulate matter, with an emphasis on their impact on DPI performance. 
1.2 Surface roughness of particulates 
1.2.1 Fundamental concepts in surface roughness analysis 
A surface can be visualised as a horizontal plane with surface irregularities (i.e., peaks 
and valleys) projecting from the plane. It can be represented in two dimensions (2D) by a 
cross-sectional line profile or in three dimensions (3D) by the surface topography. 
Depending on the scale of observation (or otherwise the degree of magnification at 
which a surface is viewed), the ‘smoothness’ or ‘roughness’ of the surface can vary 
significantly. A flat and shiny surface visually appears as smooth. However, as surface 
details are magnified under a microscope and observed over a shorter length scales, the 
surface may appear much rougher due to the presence of many surface irregularities. 
Hence, roughness is a scale-dependent property of a surface and any qualitative or 
quantitative measurement of roughness should be accompanied by the magnification and 
resolution of the surface profile.    
As an alternative to the image magnification, the scale of observation of a surface can be 
more precisely defined by mathematical means. This involves an analysis of the 
spectrum of spatial frequency components present on the surface. In mathematics, a 
curve of any shape can be broken down (i.e., decomposed) into its constituent sine 
functions using Fourier analysis. Each sine function is defined by its amplitude and 
frequency of oscillation and the summation of all the sine functions results in the original 
curve. Fourier analysis can similarly be applied to surface profiles, regardless of whether 
they are in 2D or 3D. The term ‘spatial frequency’ is used to describe the number of 
times the surface features repeat per unit lateral distance while the amplitude refers to the 
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deviation of surface heights in the vertical direction. It is generally accepted that the low- 
and medium-frequency (i.e., widely-spaced) components constitute the shape and 
waviness of the surface, while high-frequency (i.e., closely-spaced) components 
constitute the surface roughness (Figure 3). A measured surface profile can be filtered 
into a series of sub-images, each containing only the surface features within well-defined 
spatial frequency (also known as cut-off frequency) ranges (56, 57). This facilitates the 
numerical characterization of the surface, based on their roughness attributes, waviness 
and shape profiles. A variety of filtering techniques for separating roughness from 
waviness and shape are proposed in the International Organization for Standardization 
(ISO), American Society of Mechanical Engineers (ASME) and German Institute of 
Standardization (DIN) standards (57). Selection of cut-off frequencies for the roughness 
profile is dependent on the lateral resolution of the stylus or optical instrument used in 
surface mapping. Hence, surface roughness measurements are only meaningful when 
accompanied by appropriate measurement and image processing criteria (58, 59). 
 
Figure 3. Surface information at different length scales can be extracted from the raw 
surface profile. 
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The study of surface metrology has historically been essential in many engineering 
disciplines especially where the surface finish of machine parts determines their 
performance. For such engineered surfaces, it has been widely accepted that surface 
features of different spatial frequencies affect their functions in different ways (57). For 
carrier particles in a DPI formulation, the spatial frequencies of surface features that 
most critically affect drug adhesion and detachment have not been clearly defined yet in 
literature. However, carrier surface models in pictorial form have been proposed to 
describe the roughness of carriers at the different length scales and its effect on drug 
dispersion, most often in relation to the particle size of the drug (9, 60, 61). Figure 4 
illustrates how drug particles may interact with the carrier surface features presented at 
different length scales. Generally, crevices and protuberances on carrier surfaces that are 
wider than the diameters of the micronized drug particles and in which the particles can 
be entrapped within constitute the macro-roughness of the surface (62). It has been 
suggested in literature that the entrapment of drug particles usually adversely affects 
drug-carrier separation as a greater inspiratory effort would be required to dislodge the 
entrapped drug particles. On the other hand, nano-roughness refers to the nano-scale 
surface asperities which are much smaller in size than the drug particles. Nano-scale 
surface asperities establish a controlled number of contact points between adhering drug 
particles and carrier surfaces, and determine both the true area of contact and their 
distance of separation (63). The increase in nano-scale roughness is usually associated 
with a positive effect on drug dispersion.  
Often, surface roughness is quantitatively represented by surface height parameters that 
are based only on the magnitude of asperity heights but provide no additional 
information on the length scale of the asperities. The roughness of particulate matter in 
different literature reports ranges from a few tens to hundreds or even a thousand nm. 
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The wide reported range could be attributed to the marked variability in length scale 
from which the surface information was obtained. Roughness values are almost always 
significantly smaller in magnitude than drug particles (1 – 5 μm). There is no consensus 
on the extent of roughening or smoothening of carrier particles required to result in 
significant changes to DPI performance. No optimal roughness value for carriers has 
been defined because the differences in other particle properties such as size, size 
distribution, shape, crystallinity, flow and packing properties may also alter carrier 
performance (9, 31, 48). Nevertheless, these surface models still provide useful modes 
for the classification of carrier surfaces to account for the differences in DPI 
performance with respect to carrier surface roughness. 
 
 
Figure 4. The interaction of micronized drug particles with carrier surface features at 
different length scales. 
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1.2.2 Factors affecting the measurement of surface roughness 
1.2.2.1 Particle size 
A major challenge in determining the surface roughness of carrier particles is their 
relatively small particle sizes, which typically fall between 40 – 200 μm. Due to the 
random orientation of particles on the measurement stage and variability in their shapes, 
it is laborious to locate sufficiently large number of suitable planar surfaces for 
roughness measurements and to obtain statistically acceptable mean values. Tilted or 
curved surfaces that are very rough often contain surface features that exceed the range 
of vertical distance from the measurement stage (in the order of a few μm) which very 
precise stylus-based instruments can measure. The size of sampling areas is thus 
markedly limited and this hampers accurate quantification of surface heights at larger 
length scales. Conventionally, determination of the roughness of irregular particles 
smaller than 20 μm was considered neither useful nor reliable (64), as they existed 
largely as fragments with a large number of fracture planes and abrupt variations in 
particle shape. Another challenge encountered during surface profiling of small particles 
is the inadequate resolution of surface details. Hence, very few studies have investigated 
the surface roughness of micronized particles in DPI research, with the exception of two 
studies on spherical bovine serum albumin particles (54, 65). The use of precise 
instruments, such as the atomic force microscope (AFM) and the confocal laser scanning 
microscope, is necessary for resolving the nano-scale surface features on micronized 
particles (17, 54, 66). The geometry of the stylus tip, and any wear sustained during the 
measurement process, has a significant influence on the accuracy of the measured 
roughness value (67). 
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1.2.2.2 Measurement conditions 
Three major considerations in image capture and analysis to validate roughness 
parameters are the scan area (68, 69), image processing technique (68) and probe tip 
geometry for stylus-based instruments (67, 70). As the tilt on a surface should not exceed 
7° for high precision roughness measurements (53), scans are generally limited to very 
small areas. Thus, a very large number of images are required to accurately represent the 
surfaces of particles in a sample (71). In 2D line profiling, a characteristic length, given 
by the minimum length that allows for representative roughness measurements, exists for 
any given surface (68). A minimum sampling length should be at least four to five times 
the characteristic length for representative measurements to be obtained. As it increases 
further, confidence in a scale-independent roughness measurement also increases. For a 
given surface, the magnitude of roughness increases with the sampling length or area due 
to the inclusion of more prominent surface features (72). In one study, the mean root 
mean square roughness of a lactose tablet surface using 1 μm2 scan areas was 7.7 nm 
compared to 53.7 nm when the scan area was 2500 μm2 (69). In another study, smaller 
scan areas increased the standard deviation of the arithmetic mean roughness and root 
mean square roughness by almost 50 % of their respective mean values (53). Prior 
optimisation of the sampling length and measurement variables, such as the depth and 
rate of image scans, was shown to be important for accurate roughness measurement 
using the scanning probe microscope (60). For the highest resolution of surface details 
using stylus-based instruments, probe–surface interaction should take place when the 
surface is perpendicular to the axis of the probe tip (73). This condition is not always met 
when the geometry of the probe tip is not as sharp as the peaks and valleys on highly 
irregular surfaces (68). Any surface asperity that is sharper than the probe tip cannot be 
accurately reproduced on the surface topography and a mirrored shape of the tip is 
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produced instead (69). Lateral forces experienced by the probe tip contribute to the 
distortion of surface features (74). Issues of probe tip wear and tear or breakage are 
commonly encountered if the probe comes into contact with the surface during scanning 
(75). In order for accurate representation of the surface, the sample needs to be relatively 
smooth on a scale comparable to the radius of the curvature at the apex of the tip (67). 
1.2.2.3 Image processing techniques 
The application of algorithms to remove sample tilt and surface curvature is required for 
surface images since the particle surfaces are rarely perfectly flat planes. Subsequently, 
filtering of the surface profile is required before surface texture parameters can be 
derived (76). Filtering involves the suppression of surface components of selected spatial 
frequencies so that the surface profile at the desired length scale is obtained. The use of 
standard roughness parameters alone does not always allow meaningful comparison of 
data obtained from different measuring instruments unless surface profiles of identical 
spatial frequencies are extracted (57). Until a functional correlation between particular 
surface components and carrier performance can be established, neither the shape, 
waviness nor roughness of particles should be omitted when undertaking surface analysis 
(56). The lack of a proper definition of surface roughness of carrier particles may have 
contributed to the reported conflicting trends in surface roughness and DPI performance. 
While the standardisation of filtering techniques is necessary, there are also concerns that 
post-processed images may be a misrepresentation of the actual average surfaces (68). 
Hence, a variety of filtering techniques are still being developed for surfaces with 
different characteristics and for increasingly complex applications in surface roughness 
analysis (57). 
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1.2.2.4 Selection of roughness parameters 
Surface topography contains a series of data points with each being defined by its x-, y-
and z-coordinates relative to a mean surface. Line profiles are defined by points along 
the x- (or y-) and z-axis. Before the advent of 3D surface profiling instruments, such as 
white light interferometers, surface analysis was largely based on 2D line profilometry. 
Many repeatedly-spaced line scans were required to produce 3D surface topographies. 
Two-dimensional surface parameters are denoted by different prefixes that reflect the 
surface components described (76-80). For example, Pa, Wa and Ra represent the 
arithmetic mean surface height in the shape, waviness and roughness profiles, 
respectively. At present, it is recognised that the spatial distribution of surface features 
from 3D measurements may allow more comprehensive surface analysis. In addition to 
height parameters, many spatial and hybrid parameters relevant only to 3D surfaces have 
been derived (81). All 3D parameters start with the prefix S and are distinguished by the 
filtering process for the derivation of the parameter (78). However, due to their simple 
physical interpretation and long history of use, Ra and Rq remain as the most widely-used 
roughness parameters in pharmaceutical research (56, 80). Fractal descriptors, which are 
derived from 2D pixel measurements of particles in images from light microscopes, have 
also been used when surface profilometers are not available. However, they can be 
unreliable for accurate characterisation of surface roughness due to the insufficient 
image resolution (64). The use of single height parameters to represent surface roughness 
imparts simplicity for making statistical comparisons but they do not contain any actual 
spatial information about the surface (68, 82). The ratios of the distances between carrier 
surface features to drug particle size may account for the likelihood of drug entrapment 
(61). Without specifying the length scale of roughness, numerically large height 
parameters could be describing surfaces of vastly different qualities. For higher 
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roughness measurement values at the greater length scales, surfaces may contain wide 
and deep surface crevices. On the other hand, tall but closely-spaced asperities may also 
result in comparable roughness values. Hence, a combination of height and spatial 
parameters is usually necessary to provide reflective information about the specific 
qualities of a surface (53, 77). 
1.2.3 Methods to measure surface roughness 
1.2.3.1 Surface profiling by atomic force microscopy 
The AFM is capable of recording the surface topography down to sub-nanometre 
resolution besides determining the adhesion force between the probe tip and the surface 
(58, 68, 83). This allows the direct estimation of the strength of drug particle adhesion to 
the shape of individual asperities (69). Surface roughness on length scales with many 
orders of magnitude can be measured by the AFM. A sharp probe mounted on a 
cantilever spring traverses the surface during a scan. The force required to lift the probe 
off the surface can also be measured (69, 83, 84). Deflection of the probe corresponding 
to the height of each scan point is monitored by a laser beam reflected onto a position-
sensitive photodiode detector. The AFM is often used as a reference method for 
roughness measurement as it involves physical mapping by a probe of the surface and 
produces images with superior resolution (85). The ability of the AFM to resolve nano-
scale surface features is achieved by positioning the probe tip at very close distances 
from the surface asperities while the scans are conducted over very small areas of the 
surface (85). The duration required to scan a 5 × 5 μm2 area of a surface was reported to 
be 15 min when using the AFM, but only 30 s for a 45 × 59 μm2 area using an optical 
method (86). The AFM also exhibits a limited vertical range of the probe deflection and 
tall asperities or deep crevices often cannot be measured at all (39, 51). In one study, the 
surface roughness of relatively smooth anhydrous lactose particles with Rq of 300 – 600 
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nm was successfully characterised using the AFM (87). In contrast, accurate 
measurements of similarly-sized fractions of rough, fluid-bed granulated lactose particles 
could not be obtained. In another study, the roughness of several inhalable grades of 
lactose particles also could not be accurately measured due to the restricted movement of 
the probe, particularly at very rough sections of the surfaces (88). Hence, the AFM 
appears to be ideal for smooth to moderately rough surfaces and is not suited for very 
rough surfaces especially when the scan area is large. 
1.2.3.2 Non-contact surface profiling by optical methods 
Optical profilers make use of white light interferometry to measure very rough surfaces 
(Ra in the order of μm), especially those which the AFM cannot measure due to the 
restricted probe vertical deflection range (88, 89). However, most optical profilers also 
exhibit a limited lateral resolution of about 0.5 μm (80) and are more effective at 
evaluating the macro-roughness of a surface. An interferometer is present together with 
the objective lens in the optical profiler (80). Light from an optical source is split into 
two coherent beams; the reference beam follows a fixed optical path in the 
interferometer, while the sample beam is directed to and reflected from the sample (89). 
When the objective lens is positioned at the plane of precise focus, maximal constructive 
interference, resulting from the combination of the two beams, is detected by the charge-
coupled device camera. The plane of focus of every point on the surface is detected 
through vertical scanning of the objective lens. The suitability of using the optical 
profiler for determining the roughness of both micron-sized protein particles and coarse 
lactose carrier particles has been evaluated (86). Particles were imaged using three 
different instruments: scanning electron microscope (SEM), optical profiler and AFM. 
Visual observations of all surface profiles suggested that there was good agreement 
among the three methods. The root mean square roughness values determined by the 
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optical profiler were slightly higher but correlated well with measurements using the 
AFM. However, it has been reported elsewhere that the optical profiler is unable to 
image regions of spherical surfaces if the surface slope exceeds 30º (80). Sub-micron 
surface details are likely to be smoothened out due to the limited image resolution (85). 
Optical artefacts can also contribute to significant deviations in roughness values 
determined when surface features have extreme gradients. The extreme sensitivity of the 
optical profiler to vibration may also lead to high variability in roughness measurements 
(86). This, however, can be overcome by placing optical profilers on vibration-
dampening tables.  
Confocal laser scanning microscopy is another optical technique used to produce high 
resolution 3D images of surfaces (89). A spatial pinhole between the photo-detector and 
sample is employed to eliminate out-of-focus light, so that only light from the focal 
plane forms the image. Images are constructed from point-to-point scans across the 
surface. This technique was used to quantify the surface roughness of spherical spray-
dried mannitol particles with mean particle size of 13 – 14 μm (66). The lateral 
resolution was reported to be 120 nm with a minimum detectable roughness of 10 nm. 
Fourier transformation of the data was required to differentiate the small-scale from the 
large-scale roughness, which also included a component of particle shape. As the 
roughness values obtained corresponded well to visual observations of the particles 
under the SEM, this method was proposed as a simple quantitative technique for 
roughness measurement of spherical particles.  
Light scattering techniques have been used to obtain the surface fractal dimension of 
particles as a parameter of surface roughness (65). Particles in suspension are subject to 
an incident light beam that is scattered in various reflected angles due to the presence of 
surface irregularities. The intensity of scattered light and scatter angles are measured by 
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detectors positioned at various angles. The surface fractal dimension is obtained from the 
fractal region of the scattering curve where surface structures can be resolved. In one 
study, a Mastersizer S laser diffractometer (Malvern, Worcs, UK) was used to quantify 
the roughness of 2 μm spray-dried bovine serum albumin particles (65). Due to their 
small particle size, the roughness values obtained were not considered as physically 
correct but were more useful to rank order the samples. The roughness trend obtained 
was consistent with visual observations of the samples under the SEM. 
1.2.3.3 Surface imaging by scanning electron microscopy 
The SEM has been widely used for qualitative roughness analysis due to the possibility 
for high magnification and resolution (80). It is routinely used for investigating particle 
morphology, ordered structures in powder mixtures (89) and for obtaining fractal 
descriptors in quantitative roughness analysis (90). However, only roughness at the 
macro-scale can be reliably evaluated due to limitations in the image resolution in 
comparison with the AFM (90). In a study, lactose particle surfaces were visibly smooth 
in SEM images but were significantly rougher, with peaks and valleys varying over 0.5 
μm, when measured using the AFM (88). Even though SEM images appear to have a 3D 
structure, the extraction of 3D information is of limited use for accurate roughness 
quantification due to the sophistication and errors in the mathematical methods 
employed (91). However, 3D reconstruction software has been used on one occasion to 
create surface line profiles of 80 μm mannitol particles from SEM images (61). The Ra 
values were obtained by averaging several Ra values from different line profiles over the 
analysed surfaces. Similar to the AFM, it is generally time-consuming to obtain a 
representative number of images for accurate roughness quantification (62). In addition 
to qualitative surface analysis, the SEM has been used to investigate agglomerate 
structure and the organisation of drug and carrier particles in DPI mixtures. In one study, 
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images of micronized budesonide powder showed that a high proportion of particles with 
optical diameters of 1 – 5 μm presented as agglomerates (92). Even after prolonged 
mixing with carrier lactose in a Turbula® mixer, drug agglomerates still remained but 
became more predominantly concentrated within the surface crevices of carrier particles. 
This suggests that rougher areas of the surfaces were strong binding sites for the drug 
particles and confirmed the highly cohesive nature of budesonide, which was in 
agreement with findings from the drug–carrier adhesion experiments (17). 
1.2.3.4 Determination of specific surface area 
The specific surface area of particles has been used as an indirect measure of surface 
roughness. The particle size, shape and porosity are additional factors which also 
influence the surface area (53). Several studies have reported positive correlations 
between the surface roughness and specific surface area of particles. Surface area can be 
measured using nitrogen adsorption with the single-point (87) or multiple-point 
Brunauer–Emmett–Teller (BET) methods (90) or by air permeametry (9). Nitrogen 
adsorption method is preferable to air permeametry as it is more accurate, especially 
when large particles are involved (90). Among the different nitrogen adsorption 
techniques, the static volumetric technique was found to be more sensitive to changes in 
carrier roughness and showed better correlation with SEM images and AFM 
measurements. The specific surface area of different commercial grades of recrystallised, 
fluid-bed granulated and spray-dried lactose particles was positively correlated with the 
emitted dose and the FPF in an in vitro study involving the drug, pranlukast hydrate (93). 
This was attributed to the greater drug-carrying capacity of rougher lactose particles. 
However, surface area measurements alone cannot distinguish between roughness at 
different length scales and surface imaging is still necessary for meaningful roughness 
characterisation. 
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1.2.4 Surface roughness modification 
1.2.4.1 Spray drying 
Spray drying has been most commonly investigated for the surface modification of fine 
drug particles since highly spherical particles with homogenous surfaces can be 
produced. Homogenous surfaces offer similar adhesion conditions to adhering particles, 
whereas milling causes particles to have variable surface affinities as mechanical damage 
creates sharp edges and amorphous regions on crystalline surfaces (89). Both smooth and 
corrugated bovine serum albumin particles with Rq of 15 and 67 nm, respectively, have 
been prepared by using different parameters in spray drying (54, 65). A lower feed 
concentration, air atomisation pressure, inlet and outlet temperatures resulted in rougher 
particles without significant changes to their median diameter. Rough surfaces were 
formed due to indentations on the surface when the external crust of protein collapsed 
into the protein-depleted interior as drying progressed. In another study, the roughness of 
spray-dried bovine serum albumin particles was quantified using the surface fractal 
dimension, Ds (65). A Ds value of 2 indicates a perfectly smooth surface while a value of 
3 represents a very rough surface. It was found that a small increase in surface roughness, 
from 2.06 to 2.18, was sufficient to improve the FPF significantly when the formulation 
was tested in a Rotahaler®. It was thought that rougher particles adhered less to the walls 
of the inhaler and were easier to disperse. No improvement in FPF was observed when 
Ds was further increased from 2.18 to 2.41. The rougher surfaces could also have 
contributed to higher drag forces on the particles when they were airborne and this 
accounted for the constant FPF despite further increase in surface roughness. The 
influence of the outlet air temperature on surface roughness was found to vary according 
to the size of the spray dryer used. Mannitol carrier particles were prepared by spray 
drying 15 %, w/w aqueous mannitol solutions. The Ra of approximately 13 μm mannitol 
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particles was about 120 nm when the outlet air temperature was 60 ºC and 240 nm when 
the temperature was increased to 120 ºC in a laboratory-scale spray dryer (66). With a 
lower outlet air temperature, the slower rate of drying led to supersaturated layers of 
mannitol solution on the particle surfaces. Upon drying, tiny surface crystals were 
formed and this led to smoother surfaces. When a similar study was conducted using a 
pilot-scale spray dryer (diameter, 2.7 m; height, 3.7 m), which was significantly larger 
than the laboratory-scale spray dryer, the influence of the outlet air temperature on 
roughness was found to be reversed (61). Mannitol carrier particles with diameters of 
about 80 µm were prepared. Particles with the roughest surfaces (Ra = 140 nm) were 
produced with an outlet air temperature of 67 ºC and the rough surfaces were due to 
approximately 3 μm rod-shaped crystals lining the surface. When the temperature was 
increased to 84 ºC, smoother particles (Ra = 89 nm) were formed due to the presence of 
singular and smaller surface crystals. The exact reason for the differences in the two 
studies is unclear but it appeared to be related to the scale of the spray dryer and the 
post-spray particle residence time in flight. The highest FPF was obtained when rougher 
particles produced by the laboratory-scale spray dryer were used (66), while the lowest 
FPF was obtained when rougher particles produced by the pilot-scale spray dryer were 
used (61). The differing trends were attributed to the differences in the quality of surface 
roughness of the particles produced by the two spray dryers. The laboratory-scale model 
produced particles with long-wave roughness, which promoted the entrapment of drug 
particles and thus decreased the FPF. On the other hand, the pilot-scale model produced 
particles with short-wave roughness which increased the FPF (61).  
The spray drying process has also been used for surface smoothening by polymer coating 
of lactose particles (94). Both ethylcellulose and polyvinylpyrrolidone were investigated 
as coating materials for lactose carriers in the size range of 63 – 90 μm. The feed for 
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spray drying consisted of coarse lactose carriers suspended in a saturated lactose-ethanol 
solution containing the dissolved polymer. Coated lactose appeared visibly smoother 
than the uncoated lactose under the SEM even though there were no significant 
differences in the roughness parameters determined by the AFM. The chemical nature of 
the coated particle surface resembled that of the polymer, indicating successful surface 
coverage. The FPF of DPI formulations containing polyvinylpyrrolidone-coated and 
ethylcellulose-coated lactose carriers were lower and higher than that of the uncoated 
lactose carrier, respectively. It was found that the increase in the drug-carrier adhesion 
was accompanied by a reduction in the FPF. However, the lactose particles were coated 
with polymers with different chemical nature and the differences in adhesion forces 
could no longer be solely ascribed to changes in the carrier surface roughness.  
1.2.4.2 Solution phase processing 
Solution phase processing describes techniques where carrier particles are exposed to a 
liquid medium to bring about partial surface dissolution of adhering fines and asperities 
without any marked change to the mean particle size and overall shape (95). Dry lactose 
carrier particles have been added to a saturated solution of lactose at 25 ºC for the 
initiation of temperature-controlled dissolution. By ramping up the temperature at a 
controlled rate of 0.5 ºC/min to the final set temperature ranging from 30 ºC to 50 ºC, 
particles with different surface roughness were produced. A higher dissolution 
temperature resulted in smoother particle surfaces with less adhering fines when 
visualised under the SEM (95). This method did not result in significant changes to the 
flowability, surface area and crystallinity of lactose. Surface smoothening appeared to 
reduce the number of active sites since the FPF was improved, especially for drug to 
carrier ratios of less than 1:100 (96). Decantation methods have also been explored for 
surface smoothening of carrier particles. In one study, lactose and mannitol particles 
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were repeatedly immersed in absolute ethanol and decanted (with fresh solvent replaced) 
to result in partial dissolution of the adhering fines and surface smoothening (62, 88). In 
another study, decantation was combined with wet sieving. The process was repeated a 
total of eight times to obtain homogenous smooth-surfaced crystalline lactose for 
roughness analysis (86). In all dissolution-related methods, surface smoothening is 
achieved by reducing both the surface fines and surface asperities. An increase in the 
drug adhesion forces occurs, accompanied by the reduction of FPF when smoothened 
particles of this type are used in comparison to the untreated particles (62, 97). 
Surface smoothening of milled lactose particles by the adsorption of moisture and 
subsequent dissolution of adhering micron-sized fines has been validated by surface area 
measurement and SEM imaging (98). Changes to the lactose particle surfaces were 
controlled by three main variables: relative humidity during storage, concentration of 
adhering fines and duration of storage. When lactose was stored at room temperature and 
a low relative humidity of 32 % for 10 days, the specific surface area decreased by 40 % 
without any observable change in surface roughness. This phenomenon was attributed to 
the preferential dissolution of sub-micron surface features according to the Kelvin effect 
(98, 99). Micron-sized (or larger) features remained relatively unaffected by adsorbed 
moisture at low humidity levels. In contrast, smoother surfaces were clearly observable 
in SEM images when the relative humidity was increased to 75 %. In another study, the 
exposure of atomically smooth α-lactose monohydrate crystals (Rq = 0.250 nm) to either 
increasing relative humidity conditions (15 – 75 % RH) or 75 % RH for 12 h had no 
effect on either the appearance or the root mean square roughness of the crystalline 
particles (100). The attractive forces between two dry particles are mainly van der Waals 
and electrostatic forces. However, above a certain relative humidity, capillary forces due 
to adsorbed moisture on the carrier surface become the predominant attractive force (99). 
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The contribution of capillary adhesion to total adhesion force between α-lactose 
monohydrate and two drugs, salbutamol sulphate and budesonide, was investigated 
under increasing relative humidity conditions using the AFM (100). While the adhesion 
forces increased with each incremental rise in humidity for both drugs, the range of 
relative humidity values for which the adhesion forces increased most drastically was 
between 15 % and 60 % for the budesonide/lactose combination but above 60 % for the 
salbutamol/lactose combination. This suggests that the general opinion about the limiting 
role of capillary forces on particle adhesion below the relative humidity of 65 % was not 
always applicable (100). Moisture uptake by carrier particles is commonly responsible 
for particle agglomeration and surface changes but can be prevented by adding 
magnesium stearate (101). It has been shown that formulations containing magnesium 
stearate do not show a decrease in FPF with storage at 30 – 40 % RH for 90 days, 
whereas formulations without magnesium stearate exhibit an 8 % decrease in FPF. 
A smoothening process involving the spraying of a 5:3 ethanol–water mixture onto 
lactose particles in a high shear mixer has been attempted (59). Each spray process was 
followed by vacuum drying and the cycle was repeated 10 times. The whole process was 
also carried out with magnesium stearate dispersed in the solvent mixture (59, 90). The 
shape and size of the particles were retained but the edges were rounded and the surfaces 
smoother. This was confirmed by the measurement of three roughness parameters: grey 
level variation in SEM images, Ra using the AFM and specific surface area. The Ra value 
was significantly reduced, from 110 nm for the untreated lactose to 25 nm for the 
smoothened lactose. The combined effect of the wetting of particle surfaces and the 
rolling motion of particles against each other and the mixer wall resulted in superficial 
dissolution of surface asperities and deposition of dissolved substances into surface 
fissures. Such particles exhibited improved flow and packing properties. 
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1.2.4.3 Crystallization 
A temperature-controlled micro-crystallisation technique was adopted to modify the 
nano-scale roughness of α-lactose monohydrate particles (100). Seed crystals produced 
from a small volume of saturated lactose solution were immersed in a crystallisation 
vessel containing supersaturated lactose solution. Sub-nanometre scale surface roughness 
could be controlled by modifying the temperature and degree of supersaturation of the 
solution. Highly smoothened lactose crystals with Rq of 0.250 nm were produced and 
used as the substrate in the AFM measurement of the adhesion forces to drug probes 
under different relative humidity conditions. In another study, α-lactose monohydrate 
were crystallised from neutralised Carbopol® 934 gels and they exhibited smooth 
surfaces without detectable roughness under the optical microscope (102). When a 
sufficiently high concentration of Carbopol® was used, the growing crystals were held 
within the gel framework and their surface topography was independent of the 
temperature, duration and concentration of lactose in the gel. In addition to surface 
smoothness, the harvested crystallised lactose exhibited desirable attributes of DPI 
carriers such as a narrow size distribution, more uniform shape and better flowability 
(103). When the smoothened carriers were tested with salbutamol, the FPF increased 
from 14.7 % to 21.5 % compared to lactose carriers crystallised from aqueous lactose 
solutions. However, it may also be possible that residual Carbopol® on the surface of the 
carrier particles had affected drug adhesion properties and this factor cannot be 
completely ignored. 
1.2.4.4 Sieving 
Mechanical or air jet sieves are commonly used to produce narrow size fractions of 
carrier particles as well as to remove surface fines. As a result of the strong adhesion of 
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fines to coarse particles, both sieving methods caused some reduction in fines but not 
complete removal as required for effective surface smoothening (50, 95). As the actual 
amount of fines for surface layering is generally very low, particle size analysis using 
laser diffraction is not sufficiently sensitive to assess the level of fines remaining. With 
air-jet sieving, the energy input from the airstream could not efficiently remove surface 
fines smaller than 4.8 μm, while the concentration of fine lactose (smaller than 20 μm) 
could be reduced to constant level after a certain duration of air-jet sieving (104). The 
efficiency of lactose fines removal was shown to be dependent on both the crystal form 
and the initial amount of fines (31). Anhydrous α-lactose crystals are weaker than α-
lactose monohydrate crystals and have a higher tendency to fragment (105).  
1.2.4.5 Fluid-bed coating 
A reduction in carrier surface roughness was achieved when lactose particles were 
sprayed with an aqueous solution of lactose and hydroxypropyl methylcellulose in a 
Wurster coater (50). The surface roughness of lactose was decreased with the increase in 
surface coating time. The highest in vitro FPF of 34.9 % was achieved using particles 
with the optimal Ra of 610 nm, while particles with Ra above or below 610 nm exhibited 
lower FPF. It was thought that surface smoothening had not only reduced drug 
entrapment and adhesion but also decreased the drug-carrying capacity and emitted dose. 
Hence, the FPF decreased further from 34.9 % to 31.7 % when particles with Ra of 480 
nm were tested. However, the presence of hydroxypropyl methylcellulose layer on the 
surfaces of coated lactose particles could have completely altered the drug-carrier 
adhesion properties. These findings may not be directly related to the changes in the 
surface roughness of the lactose particles, which had occurred during the surface coating 
process. In another study, a precision coater that utilised a swirling air flow pattern in the 
coating zone was used for surface roughening of lactose particles (48). Coarse lactose 
30 
 
particles were sprayed, with suspensions containing micronized lactose in different 
isopropyl alcohol/water mixtures. The use of 75 %, w/w of isopropyl alcohol resulted in 
lactose particles with the highest Ra value of 216 nm, compared to the Ra value of 159 
nm for the untreated lactose. In contrast to other studies, the FPF increased linearly with 
carrier roughness but the emitted dose was relatively unchanged. 
1.2.4.6 Dry powder coating 
Fine powders can be used to coat coarse particles with the aim of modifying the surface 
properties of the coarser particles. This can be carried out through either a vigorous 
mixing process or mechanofusion (22). Fine lactose and magnesium stearate have been 
the most commonly used coating excipients, with the latter being most notable for its 
anti-adherent and anti-friction properties. Magnesium stearate has also been reported to 
reduce both the electrostatic charges (46) and capillary forces (59) between lactose 
particles so as to promote greater interaction between the fines and coarse lactose 
carriers (101). Other sugars, such as glucose, mannitol, sorbitol, maltitol, xylitol and 
trehalose, have also been investigated as powder coating excipients (34, 106-108). Fine 
excipients have been produced by micronization using various mills, such as 
ultracentrifuge (106), jet (104, 108, 109) and ball (104) mills. In powder coating by 
physical mixing, sufficient shear forces are required to break down the cohesive 
agglomerates and fill the fine particles into surface depressions of the coarse carriers for 
surface smoothening (49). Various mixing equipment, such as vortex mixers (9, 48, 50, 
106), Turbula® mixers (51, 108, 110), shaker mixers (106) and high shear mixers (111), 
have been used. The identity of the finely-divided excipients (lactose, mannitol or 
sorbitol) had no impact on the FPF when the concentration of fines was greater than 
4.4 %, w/w (108). In one study, the FPF of formoterol fumarate increased linearly with 
the concentration of lactose fines for up to about 5 %, w/w and decreased thereafter 
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(101). The increase of FPF was attributed to the reduction in drug entrapment, as well as 
the formation of mixed agglomerates. In another study, lactose carriers, which were 
mixed with 10 %, w/w of sucrose tristearate in a high-speed elliptical-rotor type mixer, 
produced an increase in FPF of salbutamol sulphate from 17.4 % to 46.8 %. In addition 
to the identity and concentration of fine excipient, mixing process variables, such as the 
type of mixing equipment, mixing speed (44), order (109) and duration (109, 110, 112, 
113), were all found to independently affect the FPF. These variables influenced the 
magnitude of shear forces during mixing and affected the extent of surface layering, the 
drug–carrier adhesion, the agglomerate structures and the final organisation of the blend 
(114). 
Both the coarse and fine particles are subjected to intense shear and compression forces 
in a mechanofusion system (115, 116), where the particles are repeatedly forced through 
small clearances between the vessel wall and an inner rotating element (117). The high-
energy input creates conditions for mechanical fusion of surfaces by solid sintering. The 
effects of mechanofusion on the surface energy of carrier particles depend on their 
particle size and the identity of the fine excipient added (118). Magnesium stearate and 
sucrose stearate had less effect on both the surface properties and inhalation performance 
of a grade of fine lactose (SorboLac® 400, d50 = 10 μm) compared to a coarser lactose 
grade (Pharmatose® 325M, d50 = 60 μm). Coarse lactose carriers that were either 
mechanofused with magnesium stearate or sucrose stearate resulted in higher 
dispersibility of drugs in several DPI formulations. It was postulated that mechanofusion 
had reduced the macro-roughness of the surface, increased the number of microscopic 
asperities (118) but did not affect the particle size (16). Mechanofusion of micronized 
drug with fine excipient particles has also been investigated. The process was postulated 
to (a) overcome strong inter-particulate cohesive forces and reduce the degree of drug 
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agglomeration, (b) increase the speed of powder fluidisation in the airstream and (c) 
increase the extent of drug de-agglomeration during aerosolisation (22, 115). Limited 
size reduction of drug is expected to occur and the most probable physical change is 
some plastic deformation to produce rounder drug particles (117). The deformation, 
smearing and fusion of fine excipient on drug particle surfaces may occur. 
Mechanofusion of 5 %, w/w magnesium stearate with micronized salbutamol sulphate, 
salmeterol xinafoate, triamcinolone acetonide and budesonide particles have been carried 
out separately (22, 115). In all instances, the modified drug particles exhibited higher 
FPF in in vitro studies. When observed under the SEM, unmodified particles appeared 
mainly as agglomerates larger than 10 μm while modified particles formed visibly 
smaller agglomerates. Significant reduction in powder cohesiveness was further 
confirmed using flow measurements in a shear cell apparatus. A high degree of drug 
particle surface modification at the nano-scale was hypothesised to cause the reduction 
in particle cohesion but this could not be confirmed due to the limited resolution using 
the SEM. 
1.3 Research gaps 
Carrier surface roughness has been widely presumed to exert an influence on the fine 
particle fraction in carrier-based DPI formulations. Fundamentally, the study of surface 
roughness is a necessary prerequisite for a better understanding of the physical 
interactions between any two surfaces (drug and carrier) in contact. There have been 
considerable but varied literature reports on the effect of carrier roughness on DPI 
performance. These research efforts have largely been disproportionate to the outcomes 
gained from application of knowledge about carrier surface roughness to the formulation 
of DPI products. The majority of literature findings are in agreement with the general 
principles proposed in various carrier surface models (9, 60, 61). These principles are 
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logically based on the size of drug particles relative to the surface crevices as well as the 
contact area and adhesion strength between the drug and carrier. While they serve as 
useful models to rationalize the experimental observations of the in vitro performance of 
DPI formulations, the measurement and interpretation of carrier particle surface 
roughness itself remains largely as an empirical field of study.  
A comprehensive investigation of carrier surface roughness in DPI usually involves three 
major directions: (a) development of a reliable measurement protocol for particle surface 
roughness, (b) investigation of the processes by which carrier surfaces can be modified 
reliably in predictable ways and (c) assessment and rationalization of the in vitro 
performance of inhaled formulations containing carriers with different degrees of surface 
roughness. The work performed in this thesis will attempt to address the research gaps 
identified in each of these areas. 
1.3.1 Roughness measurement of particulate matter 
Surface roughness can be measured either by contact or non-contact profilometry. As 
discussed in Section 1.2.3, the choice of the measuring equipment will determine the 
length scale of surface information. Where surface profiling is used for roughness 
measurement, the AFM has traditionally been preferred due to its high resolution and 
precision for evaluating nano-scale particle surface features. For carrier particles with 
very rough surfaces, such as those which are granular in nature, the AFM cannot provide 
reliable measures of roughness due to limitations in the vertical range of probe deflection. 
Hence, the AFM might not be a sufficiently versatile tool for the evaluation of a range of 
carrier particles with widely varying roughness (from atomically smooth to granular 
rough). One other important consequence of the widespread use of the AFM for 
roughness evaluation is that most published findings relate more to the nano-roughness 
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of carriers, rather than their macro-roughness. The relationship between nano-scale 
surface roughness of carrier and adhesion strength of drug to the carrier is well-
established. Relatively less research has been conducted on very rough carriers of 
granular nature, partly due to the limitations in the methods for roughness measurement. 
The restricted vertical scanning range may be overcome by the use of non-contact 
profilometers. The rate of data capture is also much higher when non-contact 
profilometers are used, compared to the AFM, but the spatial resolution of scans is 
compromised. Therefore, an in-depth study of carrier macro-roughness may be 
performed by the selection of an appropriate measurement tool. 
There is much subjectivity in the definitions and measurement parameters of particle 
surface roughness. Due to the scale-dependency of roughness, the measured values 
seldom contain direct meaningful information unless they are accompanied by the scale 
of measurement. A review of the literature has shown that DPI carriers normally exist 
within a narrow size range but roughness values in different reports can span several 
orders of magnitude. One common observation in this field of roughness measurement 
research is that roughness values are usually valid only for comparative use when 
measurements are carried out within the same laboratory and using similar measurement 
protocols. Unlike the well-established measures of particle size or surface area, these 
roughness values are often not directly comparable as long as the equipment, 
measurement and data processing conditions differ. Hence, roughness at different length 
scales is most commonly described in a qualitative manner, either as macro-, micro- or 
nano-roughness, rather than in quantitative terms. At the same time, visual information 
from SEM images are often more informative than the actual roughness values presented. 
There is a general lack of awareness that the efforts to standardize roughness 
measurements and calculations are required to confer physical meaning to the values. 
35 
 
Therefore, it is important to investigate the measurement and data processing conditions 
for the calculation of roughness parameters. 
Surface roughness is known to be an intrinsically highly variable characteristic of 
particles in a population. However, surface roughness, like surface area, is often viewed 
as a bulk characteristic of the carrier. Each individual carrier particle interacts with many 
other drug particles and their collective behavior eventually determines the DPI 
performance. This concept may be better understood by drawing a parallel to the 
importance of the size distribution, and not only the median size, of particles in 
determining their bulk properties. Hence, a deeper understanding of surface roughness 
may be gained by examining the distribution of roughness values in the population of 
carrier particles. 
1.3.2 Creation of rough carrier particles 
In order to study the effect of surface roughness on carrier function, different processing 
methods which give rise to surface modification at different length scales should be 
available. This would allow the preparation of carrier particles which exhibit a wide span 
of roughness values, ranging from atomically smooth particles to very rough and 
irregular particles. Good control of carrier roughness can be achieved using each surface 
modification process only if the effects of the process parameters on carrier roughness 
are known. The particle surface modification methods widely reported in literature are 
predominantly used to induce surface smoothening on carrier particles. The typical 
crystalline α-lactose monohydrate particles suitable for DPI possess a characteristic 
tomahawk shape associated with monoclinic crystals. These crystals are regularly-
shaped and are generally flat with relatively smooth surfaces. The commonly reported 
surface smoothening methods involve either the manipulation of the crystallization 
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conditions of lactose or the controlled dissolution of surface asperities. The methods for 
surface roughening, on the other hand, have been limited to spray drying to produce 
spherical particles with wrinkled/dimpled surfaces. There are evidences to suggest that 
carrier particles with roughened surfaces at a macro-scale result in higher FPF (52, 87) 
due to a reduction in the drug adhesion to the carrier particles (52). One possible method 
to induce surface roughening is by the physical aggregation of primary lactose particles 
to form larger, surface-roughened carrier particles. With careful selection of lactose 
particle size and processing techniques, it may be possible to design the surface 
characteristics of carrier particles for use in DPI products.  
1.3.3 Relationship between the surface properties and functional characteristics 
of a carrier 
Rougher carrier surfaces are generally considered to possess counteractive effects on 
drug detachment in a DPI formulation. The concept of cohesive-adhesive force balance 
has been extensively applied to studies in blend uniformity and drug detachment from 
the carrier. Researchers have shown that the adhesion strength of drug particles to 
rougher surfaces was reduced due to reduced contact area. Others have found that 
rougher carriers increased the emitted dose of drug from the inhaler. Despite these 
potential positive contributions to the FPF, researchers have also reported that the FPF 
was decreased when rougher carriers were used. These findings have led some 
researchers to the compelling argument that a greater degree of drug entrapment in the 
carrier surface crevices can negate the positive effects of roughened carrier surfaces to 
reduce drug adhesion. However, this remains inconclusive as there is a lack of clear 
physical evidence to show that more drug particles are truly entrapped on roughened 
surfaces. A logical outcome of this argument is that there exists an optimal carrier 
surface roughness that balances the reduction of adhesion force and the degree of drug 
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entrapment. In order to establish the optimal surface roughness, investigations of the in 
vitro performance of DPI formulations containing very rough carriers will also be 
necessary. Finally, the surface distribution of drug particles on carriers with varying 
surface roughness may be investigated using both visual and chemical imaging methods. 
These imaging tools may be used to ascertain whether the distribution of drug particles 
on carriers is altered by the carrier surface roughness. 
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2 HYPOTHESES AND OBJECTIVES 
The research work carried out in this thesis was aimed at developing strategies to 
quantify and to modify surface roughness of lactose carrier particles for use in DPI 
formulations. Lactose monohydrate was selected as the carrier material for study 
primarily due to its widespread regulatory acceptance as well as the limited choice of 
carrier excipients as suitable alternatives. Much contradicting evidence still exist 
regarding the extent of carrier surface ‘smoothness’ or ‘roughness’ that is most ideal for 
maximizing the FPF. It is not uncommon for commercial lactose carrier-based DPI 
products to exhibit FPF of less than 50 %, with many in the 10 – 20 % range. Surface 
modification of lactose carriers was an attempt to address the pressing concerns of the 
low FPF of commercial lactose carrier-based DPI products. Therefore, the main 
hypothesis of this work is that lactose carrier particles, when roughened using suitable 
processing methods, can improve the release characteristics of micronized drug during 
aerosolization from an inhaler device. 
Studies with the following objectives were conducted to test the research hypothesis: 
A. To investigate the reliable image processing techniques for particle surface 
roughness using optical profilometry 
B. To investigate the feasibility of preparing roughened carrier particles by surface 
coating and by compaction 
C. To evaluate the in vitro dry powder inhaler performance of carriers with different 
degrees of surface roughness 
D. To investigate the surface distribution of micronized drug particles in carriers of 
different surface roughness using Raman spectroscopy 
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The studies were organized into three parts: 
Part 1. Investigation of the measurement criteria and image processing techniques for 
reliable attributes to quantify surface roughness of particulates by optical 
profilometry 
Part 2. Investigation of two methods to prepare roughened lactose carrier particles 
A. Fluid-bed coating 
B. Dry granulation by roller compaction 
Part 3. Investigation of the use of roughened lactose carriers in dry powder inhaler 
formulations: 
A. Evaluation of the in vitro fine particle fraction and aerodynamic particle 
size distribution in interactive mixtures containing roughened lactose 
carriers 
B. Investigation of the surface distribution of micronized drug particles on 
roughened lactose carriers using Raman spectroscopy 
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3 EXPERIMENTAL 
3.1 Part 1: Investigation of the measurement criteria and image processing 
techniques for reliable attributes to quantify surface roughness of 
particulates by optical profilometry 
3.1.1 Rationale of study 
The literature review suggests that roughness measurements are closely related to: (a) the 
length scale at which measurements were made and (b) the image processing techniques 
performed on the raw surface profiles before determination of roughness parameters. A 
surface can be composed of features at different length scales, ranging from the visible 
surface textures down to the atomic level structures (119). Unless these measurement 
conditions are properly defined, measurements of roughness values and trends observed 
may not be reproducible and the reported measurement values hold little significance to 
other researchers. Two batches of carrier particles (roughened and smoothened) were 
produced by fluid-bed coating and the influences of the following conditions on 
roughness values were examined: filter wavelengths, surface tilt, image size and sample 
size. 
3.1.2 Surface modification of lactose particles by fluid-bed coating 
Surface modification was conducted using a fluid-bed coater, comprising the 
Flexstream™ module, mounted on an air handling system (MP-1, GEA Aeromatic 
Fielder, UK). The photograph of the fluid-bed coater is shown in Figure 5A. The two-
fluid spray nozzle for delivery of the coating liquid is located at the side of the product 
chamber. A non-sifting gill plate (Figure 5B) distributes air from the bottom of the 
chamber in a swirling flow pattern, which contributes to directional mass flow and 
improves the drying efficiency during coating. 
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Figure 5. Photographs showing (A) the fluid-bed coater with the Flexstream™ module 
and the location of the spray nozzle relative to the fluidizing bed, and (B) the 
non-sifting gill plate that distributes air in a swirling flow pattern in the 
product chamber.  
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The powder feed for fluid-bed coating consisted of 2 kg of lactose powder (d50 = 154 µm; 
lactose 100M; SpheroLac® 100, Meggle, Germany). Micronized lactose was produced 
by jet milling (100 AFG, Hosokawa Micron, Germany) lactose 100M at a grinding air 
pressure of 4 bars and classifying wheel speed set at 15000 rpm. The jet mill consisted of 
a milling chamber, also called the grinding zone, integrated with a powder classifying 
system. During jet milling, milled lactose particles from the milling chamber were 
continuously conveyed by air to the vicinity of the classifying wheel rotating at 15000 
rpm. Milled particles smaller than a certain cut-off diameter were removed by the 
classifying wheel with the exiting air flow and conveyed into the product-collecting bin. 
The rotation speed of the classifying wheel determined the cut-off diameter of the milled 
particles collected. The higher the classifying wheel speed, the smaller the cut-off 
diameter and the particle size of the milled lactose collected. Prior milling trials were 
conducted in order to optimize the grinding air pressure and classifying wheel speed so 
that micronized lactose with d50 of 2 µm were obtained for use in fluid-bed coating.  
Liquid suspensions of micronized lactose were prepared immediately before use and 
sprayed onto the powder feed in the fluid-bed chamber. The spray liquids were prepared 
by dispersing 15 %, w/w micronized lactose in the suspension liquid. The suspension 
liquid consisted of a combination of isopropyl alcohol (IPA; Aik Moh Paints and 
Chemicals, Singapore) and water in a 3:2 (v/v) ratio, which was previously saturated 
with lactose. This IPA/water ratio was selected as it has been shown in previous work to 
result in the greatest increase in surface roughness compared other volume ratios (48). 
The saturated solution was first prepared by adding excess fine lactose (lactose 400M; 
Sorbolac® 400, Meggle, Germany) into the IPA/water combination, stirring the mixture 
for at least 24 hours and filtering through a 0.45 µm membrane filter. A 600 g spray 
liquid was prepared and used to spray on the powder feed to produce roughened lactose 
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particles. Smoothened lactose particles were also prepared in the same manner, except 
that the spray liquid used was a saturated lactose solution, without any dispersed 
micronized lactose added.  
During fluid-bed coating, the inlet airflow rate was maintained between 70 – 100 m3/h, 
just sufficient to ensure the complete fluidization of the powders in the fluid-bed 
chamber. The inlet air temperature was maintained at 60 °C throughout fluid-bed coating. 
The spray liquid was delivered using a two-fluid spray nozzle with 0.5 mm diameter at 
an atomizing pressure of 2.5 bars. The spray rate was kept between 10 - 15 g/min to 
achieve the steady state product temperature of about 30 °C throughout the process. 
After all the spray liquid was delivered, the product was further fluidized until the 
product temperature reached 45 ºC. All the powders in the fluid-bed chamber was 
collected and passed through a powder classifying system (50 ATP, Hosokawa Micron 
Ltd, Germany) with the classifying wheel speed set at 7500 rpm. The purpose of this 
step was to rapidly remove the micronized lactose which did not successfully adhere 
onto the feed particles. The rotation speed of the twin screw feeder of the classifying 
system was set at 3 rpm, which corresponded to the material feed rate of approximately 
26 g/min. Similar to the jet milling process, lactose fines were removed by the 
classifying wheel with the exiting air flow. The remaining particles, with the fines 
removed, were conveyed by gravity into a product-collecting bin. 
3.1.3 Air-jet sieving 
The lactose particles produced in Section 3.1.2 were further fractionated using the air-jet 
sieve (Hosokawa Micron, USA). A 30 g powder sample was placed on a 180 µm 
aperture size sieve and the sieving process carried out for 15 min. The powder which 
passed through the sieve apertures was transferred to a 125 µm aperture size sieve and 
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sieving was carried out for another 15 min. The coarse carrier particles retained on the 
125 µm aperture size sieve, which fell within the size range of 125 – 180 µm, were 
collected for further analysis.  
3.1.4 Scanning electron microscopy 
The lactose particles were sprinkled on carbon tape and their surface morphologies were 
examined under the SEM (JSM-6010LV, JEOL, Japan) using an accelerating voltage of 
1.2 kV.  
3.1.5 Surface profiling of coarse lactose carrier particles 
3.1.5.1 Acquisition of surface images 
Particle surfaces were profiled using an optical profiler (Wyko® NT1100 Optical 
Profiling System, Veeco, USA) using the white light vertical scanning interferometry 
mode (Figure 6). An interferometer was present together with the magnification 
objective for the mapping of 3D surface profiles of the particulates. The optical profiler 
was placed on an air table maintained with 3 bars of air pressure to isolate the instrument 
from vibrations arising from the surroundings. Surface images of 109 µm x 144 µm were 
captured using a 2.0x field-of-view lens and 20x objective lens. Each raw surface profile 
was captured and displayed on the Wyko® Vision® 3.0 software without any prior 
processing of the image. All further image processing operations, including the 
roughness calculations, were conducted using the same software and are described in 
detail in the subsequent sections. 
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Figure 6. The optical profiler, which was placed on an air table, was used for surface 
roughness measurements in this study. 
3.1.5.2 Assessment of surface features using power spectral density plots 
The total surface information, including the shape, waviness and roughness, of the 
roughened and smoothened coarse lactose carrier particles were first examined using the  
power spectral density (PSD) plots. A total of five randomly selected particle surface 
images from each batch of carrier particles was analysed. One PSD plot was obtained for 
each surface image by Fourier decomposition of the measured surface profile into 
several sine waves with different spatial frequencies (120). Each sine wave has its 
corresponding amplitude, phase and frequency. The PSD is therefore a plot of the power 
of the signal, which is a square function of the surface heights, per unit spatial frequency 
against the spatial frequency (1/µm). The units of PSD can be simplified from nm2 ∙ µm 
into nm3 but it is not related to actual physical volumes. These plots describe the 
variation of the surface heights with increasing spatial frequency. Surface features of 
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lower spatial frequencies are more widely-spaced while those of higher frequencies are 
more closely-spaced. The PSD plots were used in the data pre-processing stage for 
visually examining the variation of surface heights at different length scales on the 
surface. The lower limit of the spatial frequency that could be analysed was limited by 
the largest size of the image (approximately 100 µm x 100 µm) while the upper limit 
was determined by the lateral resolution of the optical profiler. The lateral optical 
resolution was 0.75 µm when the 20x objective, with a numerical aperture of 0.4, was 
used for surface profiling. By obtaining the reciprocals of these upper and lower limits, 
the useful range of values on the x-axis on the PSD plots for meaningful analysis was 
about 0.01 – 1.5 (1/µm). 
3.1.5.3 Application of digital filters on surface images  
A total of 50 sub-regions of the surface images of various sizes (10 x 10 µm2, 20 x 20 
µm2 and 30 x 30 µm2) were randomly selected from the two carrier batches. Digital 
filtering was applied on all sub-regions before the surface parameters were derived. In 
the digital filtering process, three different types of filters could be used: the high-pass, 
band-pass and low-pass filter. The purpose of applying these filters was to separate the 
surface features of different length scales, which collectively made up the raw surface 
profile. The transmission characteristics of the three different filters are shown in Figure 
7. After the application of a low-pass filter, only the surface features of longer 
wavelengths were retained in (or transmitted to) the filtered profile, indicating the overall 
shape of the surface. Conversely, only the surface features of shorter wavelengths were 
retained in the filtered profile when the high-pass filter was used. The band-pass filter 
was used to suppress the surface features of both longer and shorter wavelengths, so that 
the features that were of intermediate wavelengths were retained. The three different 
filters were defined by the value(s) of the cut-off spatial frequencies being set and were 
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applied individually, where appropriate. The cut-off frequency is the frequency at which 
50 % of the amplitude of the surface height is being transmitted. The cut-off frequency 
was set at below 0.1 µm-1 for the low-pass filter, 0.1 – 1.5 µm-1 for the band-pass filter 
and greater than 1.5 µm-1 for the high-pass filter. The Gaussian filtering window was 
selected for this study and the standard deviation of the filters was set at 2 x 10-4 µm-1. 
Hence, for the band-pass filter, the width of the filter was much smaller than the 
bandwidth of the filtered profile. In terms of physical length scales, the filters were used 
to extract surface features that were of length scales of either smaller than 0.66 µm, 0.66 
– 10 µm or greater than 10 µm along the horizontal plane on the surfaces. These cut-off 
filter values were selected on the basis of the typical size of the micronized drug particles 
in DPI formulations. It was felt that surface features which were most important in drug-
carrier interactions were of a similar length scale corresponding to the size range of the 
drug particles.  
Histogram plots were also constructed to aid in the visualization of changes in the 
surface height distributions after the application of digital filters with different cut-off 
frequencies. Each surface image is a digital image and each pixel on the image has a 
corresponding surface height value assigned to it. The distribution of surface heights in 
each image was presented in the histogram plots. The changes in the distribution of the 
surface heights were analysed after different filters were applied on the raw surface 
profiles. In addition to digital filtering, the effect of the removal of tilt on surface 
topology was also studied. Where the tilt removal function in the software was used, 
linear tilt from the surface image was removed using a least-squares fitting technique. 
This involved the fitting of a plane to the data points on the original surface image and 
the subtraction of the fitted plane from this image, so that the tilt can be removed in the 
processed image. 
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Figure 7. Graphs showing the transmission characteristics for the (A) low-pass, (B) 
high-pass and (C) band-pass filters. 
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3.1.5.4 Calculation of surface roughness parameters 
Particle surface roughness was characterized using two roughness parameters. The 
arithmetic mean roughness, Ra, represents the average height deviation of the surface 
profile from the mean surface. The root-mean-square roughness, Rq, represents the 
standard deviation of the surface heights with reference to the mean surface. The mean 
surface refers to the horizontal plane that divides the surface profile equally above and 
below the plane. Since 3D surface images were obtained using optical interferometry, 
3D roughness parameters were digitally approximated using 2D assessments and they 
were calculated by the following equations: 
Ra =
1
m∙n
∙ ∑ ∑ |Zij|
n
j=1
m
i=1                (1) 
Rq = √
1
m∙n
∙ ∑ ∑ Z2(xi, yj)
n
i=1
m
i=1               (2) 
where m and n are the number of pixels in the image array in the x and y directions, 
respectively. Z is the local value of the surface height, relative to the mean surface, at 
each grid point. 
3.1.5.5 Determination of the sample size for roughness measurements 
A total of 400 surface images of area 20 x 20 µm2 was obtained using the smoothened 
particles. During the surface profiling, the stage was moved in a systematic pattern to 
ensure that no overlapping surface images were collected. The Ra and Rq values were 
then calculated for each surface image, after the application of the band-pass filter as 
described in Section 3.1.5.3. In order to determine a suitable sample size (N) for the 
calculation of roughness parameters, moving averages of Ra and Rq were calculated 
using different values of N. Using N = 20 as an example, the 1st element of the moving 
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average is the average of the first 20 values, while the 2nd element is the average of the 
2nd – 21st value in the series. The process was repeated for the entire series of 400 Ra and 
Rq values. The 400 values were used in the same order that they were collected and the 
series was assumed to be in randomized order since the carrier particles were randomly 
orientated on the measurement stage. The N values investigated were 20, 60, 80, 120, 
150, 200 and 250. 
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3.2 Part 2: Investigation of two methods to prepare roughened lactose carrier 
particles 
3.2.1 Part 2A: Fluid-bed coating 
3.2.1.1 Rationale of study 
The research work conducted in Part 1 of this study has shown that lactose particles were 
successfully roughened after fluid-bed coating. As the carrier particles in a DPI 
formulation have commonly been reported to exist in a wide size range of 40 – 200 µm, 
it was of interest to investigate whether the fluid-bed coater was capable of roughening 
lactose particles in this wide size range. Surface roughening of lactose particles by the 
fluid-bed is a coating process and its efficiency depends on sufficient separation of 
individual particles during fluidization and good powder movement around the spray 
zone. This in turn is largely dependent on the cohesiveness of powder particles, a 
property closely linked to the particle size and size distribution of the powder to be 
coated. 
In order to produce roughened particles in different size ranges, the following 
approaches were considered. The first approach was to coat coarse lactose particles of 
various narrow size ranges with micronized lactose. The second approach was to coat 
coarse lactose particles of a wider size range with micronized lactose, followed by 
fractionation of the coated particles into carriers of different size ranges. Based on 
literature reports, potential segregation of particles based on their size in the fluidization 
chamber can possibly lead to the non-uniform surface roughening effect of different-
sized particles, depending on the location of the spray nozzle relative to the fluidizing 
bed. This is especially true when coating is carried out in the top-spray and bottom-spray 
Wurster fluid-bed coaters. Therefore, this study aimed to investigate whether (a) there 
were differences in the surface roughening effect when feed particles of different sizes 
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were used during fluid-bed coating in the Flexstream™ module, with a size-spray nozzle, 
and (b) the surfaces of particles of different sizes, but within the same processed batch, 
were roughened to different extents.  
3.2.1.2 Preparation of lactose feed particles 
Lactose 100M was used as received (denoted as feed P1) while lactose 140M 
(GranuLac® 140, Meggle Pharma, Germany) was fractionated by classification before 
use in the coating process. Lactose 140M was passed through the classifying system 
using the classifying wheel speed of 7500 rpm and the material feed rate of 26 g/min. 
The coarser particles, with fines removed, in the product-collecting bin were collected 
and denoted as feed P2. The classifying wheel speed of 7500 rpm was determined from 
preliminary studies to remove fines below 5 µm from the classified powder (i.e., d3 = 5 
µm). A portion of feed P2 was further fractionated by passing through the classifying 
system using a classifying wheel speed of 2000 rpm. The classifying wheel speed of 
2000 rpm was determined from preliminary studies to result in the removal of particles 
smaller than 100 µm. The coarser fraction was discarded while the smaller-sized fraction 
(i.e., d97 = 100 µm) was collected and denoted as feed P3. The particle sizes and size 
distributions of the three feed powders are shown in Table 1. All particle size 
measurements were conducted as described in Section 3.2.1.5.1. Micronized lactose with 
d50 of 2 µm was also prepared as described in Section 3.1.2. 
3.2.1.3 Surface modification of lactose particles by fluid-bed coating 
The surface modification process was conducted as described in Section 3.1.2 and the 
powders for coating and spray liquids used are shown in Table 2. Roughened particles 
were produced by delivering the spray liquids containing 15 %, w/w of micronized 
lactose while smoothened particles were produced by delivering only saturated lactose 
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solutions, without any dispersed micronized lactose. For feed P1, a spray liquid with 5 %, 
w/w micronized lactose was also used to produce particles of intermediate roughness. As 
the specific surface areas of feed P2 and P3 were approximately twice (pre-determined, 
Section 3.2.1.5.3) that of feed P1, the masses of spray liquids used had to be doubled to 
1200 g. After fluid-bed coating, the collected powders were passed through the powder 
classifying system with the classifying wheel speed of 7500 rpm and the material feed 
rate of 26 g/min, to remove loose fines. 
3.2.1.4 Air-jet sieving 
The carrier particles produced in Section 3.2.1.3 were fractionated by air-jet sieving as 
described in Section 3.1.3, using sieves of aperture sizes, 180, 125, 63 and 38 µm. The 
duration of sieving was kept at 15 min for each sieve. Particles of three size fractions, 
125 – 180 µm (fraction A), 63 – 125 µm (fraction B) and 38 – 63 µm (fraction C), were 
obtained. Figure 8 summarises the different size fractions of lactose particles obtained 
from the various feed powders after fluid-bed coating. Carrier particles of fractions A 
and B were obtained when feed P1 was used while fractions B and C were obtained 
when feeds P2 and 3 were used. The roughness of the carrier particles (smoother, 
intermediate or rougher) were denoted based on the amount of micronized lactose 
sprayed onto the particles. 
3.2.1.5 Physical characterization of lactose carriers 
3.2.1.5.1 Particle size 
Lactose particles were suspended in IPA and sized in a laser diffraction particle sizer 
(Small Volume Module, LS 230, Beckman Coulter, USA). The dx value corresponded to 
the Xth volume percentile under the cumulative undersize distribution curve. The particle 
size distribution was expressed in terms of span and was calculated as: 
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Span = (d90 – d10) / d50               (3) 
A larger span value indicates a broader particle size distribution.  
3.2.1.5.2 Surface roughness  
Surface images of the lactose particles were captured as described in Section 3.1.5.1. A 
total of 150 surface images of size 20 x 20 μm2 was obtained for each batch of lactose 
carrier. A band-pass filter with cut-off spatial frequencies of 0.1 and 1.5 µm-1 was 
applied to each surface image and the Ra was calculated as described in Section 3.1.5.4. 
The coarse carriers were also viewed under the SEM and the images obtained for 
qualitative surface analysis. 
Table 1. Size characteristics of feed powders used in fluid-bed coating 
Lactose 
grade 
 
Fractionation 
criteria 
 
Particle size (µm)  
Span 
d10  d50  d90  
100M  As receiveda  89 (1)  154 (1)  225 (1)  0.88 
140M  As received  6 (0)  28 (1)  74 (1)  2.43 
 
Classified - 
7500 rpmb 
 
16 (1)  48 (1)  116 (4)  2.08 
Classified - 
7500 rpm 
followed by 
2000 rpmc 
 
19 (2)  47 (4)  86 (0)  1.43 
Micronized  
Air-jet milled 
- 15000 rpm* 
 
1.1 (0.1)  2.2 (0.2)  4.2 (0.2)  1.41 
a,b,cDenote feed P1, P2 and P3, respectively 
*Denotes micronized lactose dispersed in spray liquid  
Values in parentheses represent the respective standard deviation 
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Table 2. Powders for coating and spray liquids used in fluid-bed coating 
Feed 
 Specific 
surface area of 
feed (m2/g) 
 Concentration of micronized 
lactose in spray liquid 
(%, w/w) 
 Total mass of spray 
liquid delivered for 
a 2 kg feed (g) 
P1  0.236  0, 5, 15  600 
P2  0.440  0, 15  1200 
P3  0.447  0, 15  1200 
 
 
Figure 8. Chart showing the various size fractions and surface roughness of carrier 
particles which were obtained, by air-jet sieving, from different feed powders 
after fluid-bed coating. 
  
58 
 
3.2.1.5.3 Specific surface area 
The multi-point BET specific surface area (expressed as m2/g) was obtained using a 
surface area analyser (SA 3100, Beckman Coulter, USA) with nitrogen as the adsorbate 
gas. Vacuum out-gassing was conducted for 15 hours with a furnace temperature of 
70 °C to remove residual moisture from the particles prior to surface area analysis. 
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3.2.2 Part 2B: Dry granulation by roller compaction 
3.2.2.1 Rationale of study 
In previous work, fluid-bed coating of coarse lactose particles resulted in modification of 
the small-scale roughness of the particle surfaces. The coated coarse lactose particles 
retained their general crystal morphologies and were typically tomahawk in shape with 
flat and planar surfaces. Roughened particle surfaces were due to attachment of the 
micronized lactose particles on the coarse lactose particles, creating areas on the particle 
surfaces with micro-scale surface roughness. In order to create particles with a higher 
degree of surface roughness, the application of compaction forces on the particles may 
be useful to disrupt the regular crystal structure of the particles. Tablet formation and 
roller compaction are two common pharmaceutical processes where high compaction 
forces are applied onto powder materials to form compacts. Compared to tableting, roller 
compaction offers greater flexibility in powder processibility in terms of the powder 
flow characteristics. This is because a screw feeder is typically present in a roller 
compactor to aid in feeding of materials into the compaction zone and no high speed die-
filling is required.  
Roller compaction was adopted as an alternative method to increase the Ra values of 
lactose particles by creating macro-scale roughness through compaction of particles. 
This part of the study investigated the influence of lactose powder properties, such as 
particle size and flow, and roller compaction parameters on the degree of surface 
roughening of lactose particles.  
3.2.2.2 Preparation of powder blends 
Prior to use, all powders were manually sieved using a 355 μm aperture size sieve, to 
remove or break up any large agglomerates. Lactose 100M, 200M (GranuLac® 200, 
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Meggle, Germany) and 400M powders were blended in different mass proportions as 
shown in Table 3. All powders were blended in a double cone blender (AR 400, Erweka, 
Germany) rotated at 10 rpm for 15 min. Blending was performed immediately before a 
powder was roller compacted or used for analysis. 
3.2.2.3 Physical characterization of powder blends 
3.2.2.3.1 Particle size 
The particle size of each powder blend was measured as described in Section 3.2.1.5.1.  
3.2.2.3.2 Hausner ratio 
Bulk and tapped densities of each powder blend were determined for the calculation of 
the Hausner ratio. The powder was first passed through a sieve of aperture size 1.7 mm 
into a 100 mL graduated cylinder. The top of the powder was gently levelled with a 
spatula, powder adhering dusted off and the mass of powder in cylinder accurately 
weighed. The powder in the graduated cylinder was then mechanically tapped to a 
constant volume using a tap density tester (Sotax TD2, Switzerland). The final tapped 
volume was noted and used to calculate tapped density. The Hausner ratio was 
calculated as follows: 
Hausner ratio =
Bulk volume (cm3)
Tapped volume(cm3)
                      (4) 
The value of Hausner ratio was always greater than 1 and larger values indicate poorer 
powder flow characteristics. 
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Table 3. Powder blends comprising different mass proportions of lactose 100M, 200M 
and 400M which were used in roller compaction  
Blend code 
  
Percentage by weight (%, w/w) 
Lactose 100M  Lactose 200M  Lactose 400M 
F1 100 - - 
F2 75 25 - 
F3 75 - 25 
F4 50 50 - 
F5 25 75 - 
F6 - 100 - 
F7 50 - 50 
F8 25 - 75 
 
3.2.2.3.3 Basic flowability energy and specific energy 
Flow properties of the lactose powder blends were measured using the FT4 powder 
rheometer (Freeman Technology, UK), equipped with a split vessel with volume of 160 
mL and diameter of 50 mm. Each powder sample was first conditioned by a 48 mm 
helical blade (Figure 9) to achieve a reproducible and low stress packing state. In the 
conditioning cycle, the blade traversed downwards, followed by upwards, through the 
powder bed to create a standardised packing state. This was followed by the test cycle, in 
which the helical blade traversed downward through the powder bed. The axial and 
rotational forces acting on the blade were measured continuously and used to derive the 
total energy consumed in driving the blade downward through the powder bed. The total 
energy was recorded as the basic flowability energy (BFE). The specific energy was 
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derived as the energy expended per unit weight of powder during the upward movement 
of the blade. 
 
Figure 9. Diagram showing the movement of the helical blade during the flowability test 
in the FT4 powder rheometer and the compressive action on the powder 
induced by the blade. 
3.2.2.3.4 Cohesion 
Powder cohesion was measured using the shear cell module of the FT4 powder 
rheometer, equipped with a split vessel with volume of 85 mL and diameter of 50 mm. A 
pre-shear stress of 9 kPa was applied on the powder using a vented piston after the 
powder was conditioned. A shear head consisting of 18 vertical blades was inserted into 
the powder and used to apply a series of normal stresses on the powder. After each 
normal stress was applied, the shear head was rotated slowly and the maximum shear 
stress was recorded when the powder bed began to shear. The shear stresses of the 
powder were determined at normal stress values of 3, 4, 5, 6, and 7 kPa. The yield locus 
was the best-fit line constructed on the plot of shear stress against normal stress. Powder 
cohesion was obtained from the intercept of the yield locus with the y-axis (i.e., at 
normal stress = 0 kPa).  
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3.2.2.3.5 Angle of repose 
The angle of repose was determined in a powder tester (PT-N, Hosokawa Micron, Japan). 
The powder was placed on a vibrating sieve with 1.0 mm apertures and fell gradually 
through the sieve apertures to form a conical heap on a circular base with diameter of 80 
mm. The angle of repose was calculated as the angle between the slope of the conical 
heap relative to the horizontal base. Generally, smaller angles of repose indicate powders 
with better flow characteristics.   
3.2.2.4 Surface modification of lactose particles by roller compaction  
3.2.2.4.1 Roller compaction 
The roller compactor (Pharmapaktor L200/30P, Hosokawa Bepex, Germany) used in this 
study (Figure 10) consisted of 2 fixed rolls with diameters of 200 mm and reduced roll 
widths of 30 mm. The roll width was reduced to customize the regular production 
machine for research use. The surfaces of both rolls contain serrations which were cut 
across the roll width. The maximum depth of the serrations is approximately 0.35 mm 
while the spacing between adjacent serrations is approximately 1.7 mm (121). A powder 
hopper houses a vertical feed screw above the rolls which was used to deliver powder 
material into the compaction zone between the rolls. The roll speed and screw speed 
could be varied from 2.6 – 20 rpm and 8 – 73 rpm, respectively. The normal operating 
range of roll force was 0 – 67 kN/cm, beyond which the protective automated shut-down 
would be activated to stop the compaction process.  
Each powder blend was fed into the roller compactor while it was operating in the 
automatic mode. The roll speed was set at 2.4 rpm. Compacted ribbons were produced at 
3 different roll forces, where possible: 10, 20 and 30 kN/cm. In the automatic mode, the 
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Figure 10. (A) The roller compactor used for the preparation of roughened lactose 
carrier particles in this study, equipped with (B) serrated rolls having 
reduced surface widths of 30 mm.  
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feed screw speed was automatically adjusted by a feedback mechanism to maintain the 
 set roll force. During roller compaction, the roll force, screw speed and roll speed were 
recorded (Labview 6.0, US) at 1 s intervals. The success or failure of the compaction 
experiments conducted using different powder blends at various roll forces are presented 
in Table 4. For certain combinations of powder blend and roll force, the target roll force 
could not be achieved despite using the lowest roll speed and highest screw speed during 
compaction. These were denoted as failed compaction runs. All compacted ribbons were 
collected and manually sieved with a 1.4 mm aperture size sieve to remove any fines 
before they were further processed. 
Table 4. Compaction runs for different powder blends at various roll forces 
Blend code 
 Target roll force used in compaction (kN/cm) 
 10  20  30 
F1  ✓  ✓  ✓ 
F2  ✓  ✓  ✓ 
F3  ✓  ✓  ✓ 
F4  ✓  ✓  - 
F5  ✓  ✓  - 
F6  ✓  ✓  - 
F7  ✓  -  - 
F8  ✓  -  - 
✓indicates successful compaction run; - indicates failed compaction run 
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3.2.2.4.2 Milling and sieving of carrier particles 
All roller compacted ribbons were milled in a conical screen mill (Quadro Comil®, 
Canada). The ribbons were first milled using a grater screen of aperture size 2007 μm, 
followed by a second grater screen of aperture size 457 μm. A teethed round impeller 
was used in the first milling step, followed by a round impeller (without teeth) in the 
second milling step. The impellers were rotated at a speed of 1250 rpm during milling. 
Carrier particles within the size range of 63 – 125 µm were obtained from the milled 
material by air-jet sieving. Two control carriers were also air-jet sieved to allow for 
comparisons with the roller compacted particles. The control carriers consisted of raw 
lactose 100M, which was not processed by roller compaction, and an inhalation-grade 
carrier lactose (InhaLac® 230, Meggle Pharma, Germany), denoted as L100M and INH, 
respectively.  
3.2.2.5 Measurement of surface roughness 
The measurement of particle surface roughness was carried out as described in Section 
3.2.1.5.2. 
3.2.2.6 Statistical analyses 
One-way analysis-of-variance (ANOVA) was carried out using XLSTAT (Addinsoft, 
USA) to determine whether the compaction force resulted in statistically significant 
differences in the mean Ra of the different carrier batches. Post-hoc analysis using the 
Scheffé’s method was then used to identify statistical differences between each pair of 
mean Ra values.  
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3.3 Part 3: Investigation of the use of roughened lactose carriers in dry powder 
inhaler formulations 
3.3.1 Part 3A: Evaluation of the in vitro fine particle fraction and aerodynamic 
particle size distribution in interactive mixtures containing rough carriers 
3.3.1.1 Rationale of study 
In the previous study, two methods of surface roughening, namely fluid-bed coating and 
roller compaction, were explored. The percentage increase in Ra ranged from about 20 – 
60 % after fluid-bed coating and roughness was due to sintering or physical attachment 
of micronized lactose on the coarse carrier surfaces. On the other hand, significantly 
rougher carriers which were granular and irregularly-shaped were successfully prepared 
by roller compaction. The experimental conditions for the preparation of carriers with 
suitably high Ra values were identified in both methods. Based on the results from Part 2 
of the thesis, carrier particles with Ra values spanning a range from about 400 – 1200 nm 
were prepared using appropriate experimental methods and conditions. The in vitro 
performance of the DPI formulations containing these surface-modified carriers, 
including the FPF and aerodynamic particle size of released drug, was evaluated using 
the Next Generation Impactor (NGI).  
3.3.1.2 Preparation of lactose carriers 
Surface modification by fluid-bed coating was conducted as described in Section 3.2.1.3 
using feed P1. Roughened fluid-bed coated carrier particles (denoted as FBR) were 
obtained by spraying of 15 %, w/w micronized lactose dispersion while smoothened 
carrier particles (denoted as FBS) were obtained by spraying of saturated lactose solution 
only.  
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Surface modification by roller compaction was conducted as described in Section 3.2.2.4. 
The powder for compaction was a blend of lactose 100M and 200M in a 1:1 ratio (w/w). 
The powder blend was compacted at 2 different roll forces (16.7 and 23.3 kN/cm). After 
24 hours, the ribbons were comminuted in a pin mill (ZM 200, Retsch, Germany) with a 
12-pin wheel against a sieve with aperture size of 0.5 µm at impactor wheel speed of 
10000 rpm. Lactose carrier particles produced at roll forces of 16.7 kN/cm and 23.3 
kN/cm were denoted as RC50 and RC70, respectively. 
Commercially-available inhalation grade lactose carrier (INH), lactose 100M (control) as 
well as the surface-modified coarse carriers (FBS, FBR, RC50 and RC70) were 
fractionated in the air-jet sieve using the procedure described in Section 3.2.1.4. The size 
range of all carrier particles obtained in this part of the study was 63 – 125 µm. The 
typical specific surface area of INH was reported to be 0.16 m2/g by the manufacturer.  
3.3.1.3 Physical characterization of lactose carriers 
3.3.1.3.1 Particle size 
Coarse carrier particles were sprinkled on a glass slide and viewed under a microscope 
(BX51, Olympus, Japan), connected to a video camera, at 100x magnification. Images of 
the particles were taken and analyzed using image analysis software (Image Pro Plus 6.3, 
Media Cybernetics, USA). A sufficient number of images was taken such that at least 
600 individual particles from each carrier batch were measured. The diameter of each 
particle was determined as the average length of the diameters, measured at 2° intervals, 
joining two outline points and passing through the centroid of the particle. Light 
microscopy was used for sizing, instead of laser diffraction, as it is better able to detect 
small differences in particle size due to differences in shape. 
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3.3.1.3.2 Aspect ratio 
Image capture and analysis was conducted as described in Section 3.3.1.3.1. The aspect 
ratio of each particle was determined as the ratio between the longest and shortest 
diameters of an ellipse with equivalent area, respectively. The aspect ratio of a particle 
indicates the degree of elongation of its shape and the values are always greater than 1.  
3.3.1.3.3 Convexity 
Image capture and analysis was conducted as described in Section 3.3.1.3.1. Convexity 
was determined as the ratio between the convex perimeter and the actual perimeter of the 
particle. The actual perimeter follows the exact contours of the particle outline while the 
convex perimeter can be thought of as the perimeter of an elastic band surrounding the 
particle (Figure 11). Convexity indicates the degree of irregularity of the boundary of the 
particle.  Particles with smooth outlines will have convexity close to 1 whereas those 
with irregular outlines will have lower convexity values.  
 
Figure 11. Diagram showing how the actual and convex perimeters of a particle are 
determined during image analysis. 
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3.3.1.3.4 Surface roughness 
Surface roughness measurements were conducted as described in Section 3.2.1.5.2. 
3.3.1.4 In vitro drug deposition studies 
DPI formulations, prepared with the six types of coarse carriers respectively, comprised 
(a) various concentrations of fine lactose (0, 0.5, 1, 2, 3, 4.5, 6, 8 and 10 %, w/w) with 
micronized drug (2 %, w/w) and (b) various concentrations of drug (0.5, 1, 2, 4 and 6 %, 
w/w) with coarse carriers alone. Fine lactose (d50 = 9 µm) was produced by jet milling 
lactose 100M particles at a grinding air pressure of 4 bars and classifying wheel speed 
set at 5000 rpm. Isoniazid (Taizhou Tianrui Pharmaceutical, China) was used as the 
model drug in all DPI formulations and was produced by jet milling the coarser drug 
particles at a grinding air pressure of 4 bars and classifying wheel speed set at 14500 rpm. 
Appropriate quantities of the drug, coarse carrier and fine lactose (where applicable) 
amounting to a total mass of 1.5 g were carefully weighed out in a glass tube and 
blended in a vortex mixer (WhirliMixer™, Fisons Scientific, UK) for 10 min. The drug 
contents in ten random samples of 30 mg were assayed and the coefficients of variation 
were found to be less than 6 %. Each capsule (Size 3, Qualicaps, Japan), equivalent to 
one dosage unit, was filled with 30 ± 2 mg of the DPI formulation. 
Each collecting stage of the NGI (Copley Scientific Limited, UK) was first coated with a 
thin layer of 1 %, w/w silicone oil in cyclohexane and allowed to dry completely. The 
collecting stages, pre-separator, induction port and mouthpiece adaptor were assembled 
(Figure 12A). The pre-separator was used in all in vitro experiments in order to prevent 
the entry and deposition of the coarse lactose carrier particles in the NGI, particularly on 
Stage 1. After a capsule was loaded into the Rotahaler® (Glaxo, UK), the inhaler was 
71 
 
twisted to break the capsule and the contents released into the mouthpiece adaptor fitted 
with the NGI. The liberated particles were drawn through the NGI at an airflow rate of 
100 L/min for 2.4 s in each test. The total volume of air drawn through the NGI in each 
test was 4 L, equivalent to the typical volume of air inhaled by an adult in one breath. 
The test was repeated for six capsules and the total amount of drug deposited in each part 
assayed.  
3.3.1.4.1 Fine particle fraction 
The drug deposited in the inhaler, mouthpiece adaptor, induction port, pre-separator, and 
stages 1 to 8 of the NGI (Figure 12B) were collected by rinsing each of the parts with a 
suitable volume of deionised water. The UV absorbance at 262 nm of each rinse fraction 
was determined by a UV spectrophotometer (3101PC, Shimadzu, Japan) and used to 
calculate the mass of deposited drug. In the NGI, the drug particles were deposited on 
the 8 collecting stages according to their aerodynamic particle size. Based on the airflow 
rate of 100 L/min, the cut-off aerodynamic diameters for the pre-separator and stages 1 
to 7 were calculated to be 10, 6.12, 3.42, 2.18, 1.31, 0.72, 0.40 and 0.24 μm, respectively. 
Stage 8 is also known as the micro-orifice collector (MOC). The FPF and fraction of 
drug trapped in the pre-separator (Fp) were determined by: 
FPF =
𝑀𝑓
∑ A
× 100 %                (5) 
Fp =
𝑀𝑝
∑ A
                  (6) 
where ∑ A is the total amount of drug deposited in the mouthpiece adaptor, induction 
port, pre-separator and stages 1 - 8, Mf is the amount of drug deposited in stages 2 – 4 
and Mp is the amount of drug deposited in the pre-separator.  
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(A) 
 
 
(B) 
 
 
Figure 12. Photographs with labels showing (A) the complete assembly of the NGI, pre-
separator, induction port and mouthpiece adaptor for the Rotahaler® and (B) 
stages 1 to 8 in the NGI. 
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3.3.1.4.2 Aerodynamic particle size 
The mass median aerodynamic diameters (MMAD) of the deposited drug particles were 
estimated by fitting the actual size distributions, using the method of least squares, to the 
log-normal distribution (MATLAB®, R2010a, MathWorks, USA). Although there is no 
theoretical justification for its use, many inhaled pharmaceutical aerosols have been 
found to be well approximated by the log-normal distribution (122-124). The log-normal 
function is given by Eqn. (7) and satisfies the condition in Eqn. (8): 
m(x) =
1
x∙√2π∙ln 𝜎𝑔
∙ e
(
− (ln x−ln d)2
2 (ln 𝜎𝑔)2
)
              (7) 
∫ m(x)dx
d
0
= 0.5                (8) 
where x  is the particle size (µm), d  is the MMAD (µm) and 𝜎𝑔  is the GSD 
(dimensionless). The size distributions were constructed by using the mass fraction of 
drug within each aerodynamic size range determined from all stages in the NGI in the in 
vitro deposition studies. Each point on the size distribution curve was calculated by 
taking the mass fraction of drug divided by the size interval and this was then plotted 
against the midpoint of the size interval.  
For size distributions which did not fit well to the log-normal distribution (i.e., goodness 
of fit R2 < 0.85), the MMAD values were estimated using the cumulative drug deposition 
data according to the method stipulated in the USP 30 <601>. The second approach was 
found to be necessary only for formulations containing very low proportions of drug (i.e., 
0.5 and 1.0 %, w/w). 
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3.3.1.5 Geometric particle size of drug 
Micronized isoniazid particles were viewed under the SEM using an accelerating voltage 
of 1.2 kV. A sufficient number of images was taken such that at least 600 individual 
drug particles were measured. The diameter of each particle was defined as the longest 
distance between two vertical parallel tangents on the particle. The size distribution of 
the drug particles was constructed using the fraction of particles (by count) in each size 
range. The median geometric particle size and GSD were determined by fitting the size 
distribution to the log-normal distribution as described in Section 3.3.1.4.2.  
3.3.1.6 Powder flow characterization using the shear cell 
Powder flowability was determined using the 1 mL shear cell module of the FT4 powder 
rheometer as described in Section 3.2.2.3.4. Five DPI formulations, with 2 %, w/w 
micronized drug and concentrations of fine lactose ranging from 0 – 10 %, w/w, were 
prepared for each of the six types of carriers. The powder blends were similarly prepared 
as for the in vitro studies. The yield locus (Figure 13) was constructed from the plot of 
shear stress against normal stress and the flow function, ffc, was calculated as follows: 
ffc =
σ1
σ2
                 (9) 
where 𝜎1 is the major principal stress (kPa) and 𝜎2 is the unconfined yield strength (kPa). 
The methods for determination of 𝜎1  and 𝜎2  are in accordance to widely-used shear 
testing analysis procedures (125). 𝜎1 and 𝜎2 were obtained from the construction of the 
small and large Mohr circles, which represent the combinations of shear and normal 
stresses under which the powder would fail. The small Mohr circle is a semi-circle 
whose circumference passes through the origin and is tangential to the yield locus. The 
large Mohr circle is a semi-circle whose circumference passes through the pre-shear data 
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point (at normal stress = 9 kPa) and is tangential to the yield locus. 𝜎1 is the greater of 
the two values at which the large Mohr circle intercepts the x-axis while 𝜎2 is the greater 
of the two values at which the small Mohr circle intercepts the x-axis. Powders with ffc 
between 2 and 4 are considered cohesive powders while those with ffc between 4 and 10 
are free-flowing powders (126, 127). 
3.3.1.7 Statistical analyses 
One-way ANOVA and regression analyses were carried out using XLSTAT (Addinsoft, 
USA). The purpose of the one-way ANOVA was to identify statistical differences in 
carrier physical properties (particle size, aspect ratio, convexity, Ra) among the 6 carrier 
batches. Contour plots were constructed in MATLAB® using linear interpolation 
between the original data points. 
 
Figure 13. A typical plot of the shear stress against the normal stress after shear testing 
of powder samples. The yield locus and the large and small Mohr circles are 
indicated. 
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3.3.2 Part 3B: Investigation of the surface distribution of micronized drug 
particles on rough lactose carriers using Raman spectroscopy 
3.3.2.1 Rationale of study 
In the previous part of the study, the use of rough roller compacted carriers was found to 
increase the FPF of DPI formulations and the MMAD of deposited drug significantly 
compared to the smoother control and fluid-bed coated carriers. Rougher carrier surfaces 
may exert their effects during interactive mixing or during the aerosolization of drug and 
increase the FPF by the following mechanisms: (a) weaker adhesion of drug to carrier 
results in lower energies required for drug detachment or dispersion of drug 
agglomerates or (b) surface asperities on rough carriers increase frictional forces during 
blending and promote the physical deaggregation of cohesive agglomerates. The first 
mechanism has been widely discussed in literature with supporting evidence. However, 
the second mechanism has been relatively less studied due to experimental difficulties in 
determining the agglomerate distribution on carrier particles.  
Raman spectroscopy can be used for the chemical identification of compounds within 
very small areas of interest. The analysis requires minimal sample preparation and does 
not disrupt the organization of particles in the interactive mixtures. It may be used to 
provide chemical information to differentiate between the carrier material and drug, a 
capability lacking in other common imaging methods (such as light microscopy or 
scanning electron microscopy). Hence, this study aimed to investigate the feasibility of 
Raman spectral mapping as a tool to assess the spatial distribution of drug 
particles/agglomerates on carrier surfaces. 
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3.3.2.2 Screening of drug markers for Raman spectral analysis 
There were 3 main criteria adopted for the preliminary selection of drugs for Raman 
spectral analysis: (a) the drug is used clinically for treatment of either local or systemic 
diseases, (b) the drug is delivered through the pulmonary or oral route, and (c) for drug 
delivered through the oral route only, there should be reported scientific interest in 
developing inhalable formulations of the drug. The drugs which were identified for 
preliminary screening were salbutamol sulphate (Fine Drugs and Chemicals, India), 
budesonide (Jayco Chemicals, India), theophylline hydrate (Janson Chemicals Pte. Ltd., 
Singapore), rifampicin and isoniazid (Taizhou Tianrui Pharmaceutical, China). Of these 
drugs, salbutamol sulphate and budesonide are delivered through the inhalation route for 
the treatment of asthma. Theophylline is largely delivered through the oral route in the 
form of tablets or syrups for asthma treatment while rifampicin and isoniazid are mainly 
formulated as oral tablets for the treatment of tuberculosis. The purpose of screening was 
to select a suitable drug marker for use in the interactive mixtures with lactose carriers. 
Ideally, the Raman spectrum of the drug marker should contain features that can be 
clearly distinguished from that of lactose, such as the presence of intense peaks at Raman 
shifts where the scattering intensity of lactose is very weak. 
The Raman spectra of all drugs, together with lactose, were collected using a Raman 
spectrometer (XploRA, Horiba Scientific, France) equipped with a 532 nm He/Ne laser 
source and connected to a microscope system (BX41, Olympus, Japan). The software for 
spectral acquisition was LabSpec (Version 5, Horiba Scientific, France). The powder 
particles of each pure component were sprinkled on a glass slide and the Raman spectra 
was obtained through a 10x objective (numerical aperture = 0.25) at an exposure time of 
2 s. The diffraction grating was set at 1200 mm-1. The theoretical laser spot diameter was 
calculated as follows: 
78 
 
Laser spot diameter (μm) =
1.22 × λexcitation source (μm)
numerical aperture of objective
 
=
1.22 ×
532
1000
0.25
 
= 2.59 
The spectra of all drugs were obtained within the range of 200 – 4000 cm-1. Isoniazid 
was eventually selected as the drug for Raman spectral mapping as it showed high 
scattering intensities and had a distinct non-overlapping peak at the Raman shift of 1604 
cm-1. The presence of the peak at 1604 cm-1 was used to identify the presence of 
isoniazid particle(s) on the lactose carrier particles. 
3.3.2.3 Preparation of interactive mixtures of drug and lactose 
Appropriate quantities of the drug, coarse lactose carrier and fine lactose (where 
applicable) amounting to a total weight of 1.5 g were carefully weighed out in a glass 
tube and blended in a vortex mixer (WhirliMixer™, Fisons Scientific, UK) for 10 min. 
3.3.2.4 Development of method to identify the presence of drug in Raman 
spectra 
3.3.2.4.1 Determination of concentration ratio of drug to lactose 
Powder samples were first poured into a well on an aluminum sample holder and gently 
leveled to ensure that the mapping surfaces were relatively flat. Individual particles were 
randomly located on the surface of the sample and the Raman spectra were obtained over 
a square area with defined length (Figure 14). One spectrum was obtained at each 
position indicated by a black dot on the figure. The total number of spectra within each 
Raman map was dependent on the sampling step size and the scan length. Baseline 
correction was applied to the Raman spectrum from every scan point in the map. 
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Baseline correction was applied by subtracting a polynomial obtained by fitting of each 
individual spectrum in the software.  
 
Figure 14. Diagram showing a typical carrier particle and how the Raman spectra are 
obtained within a square-shaped area of the particle surface. 
A peak at the Raman shift of 1080 cm-1 in the lactose spectrum was identified as it did 
not overlap with any peaks in the isoniazid spectrum. The relative intensity of the Raman 
peaks corresponding to presence of isoniazid (at 1604 cm-1) and lactose (at 1080 cm-1) 
was calculated by: 
Peak1080/1604 =
Peak intensity at 1080 cm−1
Peak intensity at 1604 cm−1
           (10) 
The highest intensity values at the Raman shift of 1604 ± 2 cm-1 and 1080 ± 2 cm-1 were 
first determined in each spectrum prior to the calculation of the peak ratio. The 
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allowance of ± 2 cm-1 was to account for small shifts in the peak position due to 
variation in the instrument detector. 
A total of 2000 point scans each were first conducted on raw lactose and isoniazid 
powders and the peak ratios were calculated. The range of ratio values for lactose was 
5.9 – 28.5 while that of isoniazid was 0.022 – 0.083. When only lactose was present, the 
signal intensity at the Raman shift of 1080 cm-1 was high while the intensity at 1604 cm-1 
was low as it formed part of the background noise. None of the ratio values fell below 
5.9 when only lactose was present in the sample. Conversely, the signal intensity at 1080 
cm-1 was part of the background noise while the intensity at 1604 cm-1 was high in the 
isoniazid sample. None of the ratio values were greater than 0.083 when only isoniazid 
was present in the sample. The ratios calculated from each type of compound (either 
lactose or isoniazid) varied significantly as they were calculated from the background 
signals which were affected by variations in small measurement distances and surface 
curvatures or distortions. From these preliminary scans, the following inferences could 
be reliably drawn: 
(a) Only isoniazid is present in the scan spot when the ratio is smaller than 0.083 
(b) Only lactose is present in the scan spot when the ratio is greater than 5.9 
(c) Both lactose and isoniazid are present when the ratio is between 0.083 – 5.9 
 
3.3.2.4.2 Calculation of spectral scores 
After the Peak1080/1604  ratios were obtained, they were further used to derive the 
spectral scores (SS) for the Raman chemical images. The SS ranged from 0 – 1, where 0 
was taken to represent the absence of isoniazid while 1 was taken to represent the 
presence of isoniazid only. The SS represented the normalized concentration ratio of 
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isoniazid to lactose at each scan spot. A continuous scoring system was necessary as it 
has been reported that the Raman spectra obtained from a mixture of components rarely 
yield the spectra of pure components on individual scan spots. Composite spectra, which 
are equal to the weighted sum of the Raman spectra of the components present in the 
sample collection volume, are usually obtained instead (128). For interactive mixtures 
comprising a low concentration of micronized drug particles (i.e., lower than 5 %, w/w) 
in coarse lactose particles, literature suggests that the micronized particles are sparsely 
located as agglomerates on the carrier surfaces. Therefore, considering that the laser spot 
size was 2.6 µm, majority of the spectra would be expected to be from lactose alone, 
some would be composite spectra of isoniazid and lactose and an even smaller 
proportion would be the spectra of drug alone. 
The SS was determined as follows: 
If Peak1080
1604
< 0.083,     SS = 1 
If Peak1080
1604
 is between 0.083 – 5.9,  SS = 1 −
Peak1080/1604−0.083
5.9−0.083
 
If Peak1080
1604
> 5.9,    SS = 0 
The SS represents only a rough approximation of the concentration ratio of isoniazid in 
lactose in the sampling volume (129) as Raman intensities are generally too noisy for 
precise quantitative applications. Using the SS, Raman maps containing visual 
information were constructed in grayscale to indicate the relative amounts of isoniazid 
present on the carrier surface. The Raman maps were constructed using MATLAB®. The 
distributions of the SS values were also investigated in histogram plots. 
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3.3.2.5 Sampling strategies for construction of chemical images 
Due to the small laser spot size, relative to the total surface area under analysis, the 
sampling step size and scan area determine how the information obtained from the 
Raman spectra can be utilized. Two different scan lengths were investigated: 400 and 
100 µm. Considering that the carrier particles were ~ 100 µm, the purpose of using a 
scan length of 400 µm was to obtain information over larger length scales (i.e., many 
particles) in the samples. On the other hand, the scan length of 100 µm was used in order 
to maximize the information that can be obtained from single particle surfaces. Prior to 
each scan, the position of the particle was adjusted using the stage controls of the 
microscope to ensure that the scan area fell within the entire surface boundary of the 
particle. Scans were conducted using two sampling step sizes: 5 and 20 µm.
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CHAPTER 4 
RESULTS AND DISCUSSION 
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4 RESULTS AND DISCUSSION 
4.1 Part 1: Investigation of the measurement criteria and image processing 
techniques for reliable attributes to quantify surface roughness of 
particulates by optical profilometry 
4.1.1 Qualitative assessment of the surface morphology of carrier particles 
The changes to the surface morphology of particles were qualitatively assessed using the 
SEM. The carrier morphology, namely their shape and size, did not differ between the 
two carrier batches. The carrier particles generally had tomahawk shape with flat and 
distinct surfaces that were characteristic of α-lactose monohydrate crystals. Spraying of 
micronized lactose dispersion during surface modification had resulted in extensive 
surface coverage of micronized lactose on the lactose carrier particles (Figure 15). The 
micronized particles were preferentially deposited in and around large-scale surface 
features and, to a limited extent, on the flat crystal faces. The lactose particles from both 
batches were visually distinguishable under the SEM as the smoothened particles had an 
obvious lack of adhering surface fines. 
4.1.2 Surface roughness measurements using the optical profiler 
4.1.2.1 Preliminary assessments of raw surface profiles 
The following general observations were noted when lactose particle surfaces were 
initially profiled: 
1) Although the scan area measured was 109 x 144 µm, actual particle surfaces that 
were successfully captured in each scan were always occupying smaller areas. 
Hence, the real captured area was the composite of areas from different particles. 
2) Particle surfaces were almost always tilted with respect to the horizontal plane of 
measurement. 
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3) Tilted surfaces which exceeded a certain angle of tilt could not be captured 
completely. 
4) Surface images were rarely of very good quality and often presented with black 
dots/regions on the image, indicating the loss of data at some pixels. 
5) Flat and smooth surfaces resulted in the best quality images while poor quality 
images were more frequent with rough and tilted surfaces. 
6) Particles from the same sample might have surfaces that ranged from being very 
smooth to very rough. 
Although such issues existed for particulate samples and could impact on roughness 
measurement, they are not well acknowledged or discussed in literature reports. 
 
Figure 15. Scanning electron micrographs of (A) smoothened and (B) roughened carrier 
particles, showing their (1) general particle morphologies and (2) typical 
surface appearances. 
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4.1.2.2 Analysis of surface profiles using power spectral density plots 
The PSD plots of 10 randomly selected surface images from the smoothened and 
roughened batches of carrier particles are shown in Figure 16. They provided 
information on the magnitude of surface heights across varying length scales on each 
surface. This type of analysis can be applied to any physical signal that can be 
decomposed into their constituent frequencies, such as a surface profile. The frequencies 
obtained from surface profiles are expressed in 1/µm, analogous to frequencies on the 
time scale which are expressed in terms of Hertz (Hz; 1/s). The PSD plot was useful for 
identifying the overall surface profile because for any given surface, features within a 
spectrum of length scales can exist, ranging from the micron-sized surface protrusions to 
the nano-scale surface asperities. 
 
Figure 16. Power spectral density plots of 10 randomly selected surface images, of 
which 5 images each were taken from the respective batches of roughened 
(dotted lines) and smoothened (solid lines) carrier particles. 
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In general, all PSD profiles exhibited a decreasing trend with increasing spatial 
frequency. This is typical of natural and randomly rough surfaces (130) and indicates 
that the surface asperities tend to become shorter when they are observed over smaller 
length scales (i.e., surface components of higher spatial frequency). The most significant 
decrease in the PSD profile occurred between the frequencies of 0 – 0.1 µm-1, followed 
by a decrease according to the power law up to 1.5 µm-1 (i.e., linear decrease). At 
frequencies greater than 1.5 µm-1, the graph reached a plateau. As the power spectrum is 
calculated from the magnitude of surface heights, the initial sharp decrease seen in the 
graph suggests that surface features of lower spatial frequencies (0 – 0.1 µm-1, 
corresponding to wavelengths greater than 10 µm) were of the greatest heights. 
Considering that the image sizes were 20 × 20 µm, these spatial frequencies were 
understood to constitute the shape of the surface (i.e., tilt or curvature with reference to 
the horizontal plane). This means that if roughness calculations were performed directly 
on the raw surface profiles, the order of magnitude of Ra (i.e., whether it is in the tens, 
hundreds or thousands of nm) will be determined by the shape of the surface. On the 
other hand, the relatively flat power spectrum beyond frequencies of 1.5 µm-1 suggests 
that the lateral resolution of surface features smaller than 0.66 µm (reciprocal of 1.5 µm-1) 
in scale was approaching a limit. This observation was in agreement with the lateral 
resolution value (Page 48; 0.75 µm) provided by the manufacturer of the optical profiler. 
Hence, very limited useful surface information of this length scale could be extracted 
from the surface profiles. Since the PSD plots were presented in the log-scale, the 
absolute differences in surface heights among the roughened and smoothened particle 
surface images were much higher at the lower frequencies. By comparing the power 
spectrum of roughened and smoothened samples, it was found that on average, the 
graphs from the smoothened and roughened particles overlapped when the spatial 
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frequencies were smaller than 0.1 µm-1. Beyond this length scale, the roughened and 
smoothened surfaces were distinguishable. 
Based on the above observations, a band-pass filter with high and low cut-off spatial 
frequencies of 0.1 and 1.5 µm-1, respectively, was selected for subsequent processing of 
surface profiles. The sampling dimensions (20 × 20 µm2) physically limited the accurate 
representation of surface features of a similar or larger length scale and therefore the 
frequencies smaller than 0.1 µm-1 had to be filtered out. On the other hand, the scale of 
roughness associated with spatial frequencies greater than 1.5 µm-1 were considered too 
small to be applicable for this study as the size of micronized drug particles are typically 
larger than 1 µm. Furthermore, the extreme sensitivity of the optical profiler to 
environmental vibrations has been reported and roughness at smaller scales would be 
increasingly being impacted by random noise during the measurements. 
The surface images in Figure 17 were used to illustrate the effect of different modes of 
digital filtering on a raw surface profile. It was also used to visually verify that the 
selected cut-off frequencies obtained from the PSD plots were relevant. It could be seen 
that the shape of the surface (Figure 17B; Ra = 2140 nm) was extracted from the 
unprocessed image (Figure 17A; Ra = 2800 nm) after the low-pass filter was applied. 
The roughness profile contributed by more closely-spaced surface undulations (Fig 17D; 
Ra = 169 nm) was extracted by the high-pass filter. Most of the original surface 
information was still largely preserved by the band-pass filter except that of the two 
extreme regions of spatial frequencies (i.e., smaller than 0.1 and greater than 1.5 µm-1), 
which were suppressed in the filtered image (Figure 17C; Ra = 976 nm).  
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4.1.2.2.1 Effect of surface tilt on the variation of roughness values 
It was observed that almost all the raw profiled surfaces exhibited a certain degree of tilt. 
The degree and direction of surface tilt were random but had always led to a significant 
increase in the Ra value. This was anticipated as lactose particles were irregular in shape 
and their surfaces would rarely be flat with respect to the horizontal plane of 
measurement. Figures 18A and 18B illustrate a surface before and after the removal of 
linear surface tilt and the Ra value was found to decrease significantly from 1450 to 402 
nm after the linear tilt was removed. During the application of the tilt removal, however, 
only linear tilt can be effectively removed. This is because the raw surface is first fitted 
to a linear plane and the linear plane is then subtracted from the raw surface to obtain the 
processed surface image with tilt removed. Any other irregularly-shaped surface could 
not be reliably removed using this method. The band-pass filter, on the other hand, could 
be used to suppress irregular surface shapes. Figure 18C shows that band-pass filtering 
alone resulted in a relatively similar Ra value of 344 nm, suggesting that surface tilt was 
also successfully removed. The slightly lower Ra value could have resulted from both the 
removal of linear surface tilt and any irregularly-shaped surface shape, which was an 
additional benefit of the band-pass filter. Hence, the band-pass filter alone would be used 
subsequently before any Ra value was derived.  
The histogram plot of the number of image pixels with different surface heights is shown 
in Figure 19. The majority of the highest peaks and valleys (i.e., surface heights between 
-3000 to -1000 nm and 1000 to 3000 nm) in the surface were retained when applying a 
low-pass filter, confirming that they were of the lowest spatial frequencies. The surface 
heights obtained after high-pass filtering were normally distributed and much smaller, 
suggesting a high degree of randomness. The measured values were likely to include 
random noise signals as would be typical for any surface profiling instrument sensitive 
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to environmental vibrations. Combining the analyses of the PSD plots, the histogram 
plot and from the visualization of derived surface images, it was concluded that the 
surface tilt (a part of surface shape) constituted the lower spatial frequencies and had 
contributed most significantly to the order of magnitude of Ra (typically between 1000 – 
3000 nm). The removal of surface tilt, which had no bearing on the surface properties, 
was therefore necessary as it was an inevitable consequence of the surface analysis of 
particulates. 
(A) 
 
(B) 
 
(C) 
 
(D) 
 
 
Figure 17. (A) Raw unprocessed surface image and surface profiles after (B) low-pass 
filtering, (C) band-pass filtering and (D) high-pass filtering. The Ra values of 
the extracted profiles in A – D were 2800 nm, 2140 nm, 976 nm and 169 nm, 
respectively. The vertical scales in the four images are not equal.  
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(A) 
 
(B) 
 
(C) 
 
(D) 
 
Figure 18. (A) Raw unprocessed surface image and the same surface after (B) the linear 
tilt was removed, (C) a band-pass filter was applied and (D) both linear tilt 
was removed and a band-pass filter was applied. The Ra values of surfaces in 
A – D were 1450 nm, 402 nm, 344 nm and 347 nm, respectively. The vertical 
scales in the four images are not equal. 
4.1.2.2.2 Effect of sample size on the magnitude of roughness values 
Unlike for the measurement of particle size, no statistically acceptable sample size for 
roughness measurements of particulates has been proposed in the literature. Surface 
profiling is not a bulk measurement method and can be highly variable and very 
dependent on the method of measurement and treatment of measurement data. Thus, the 
accuracy and statistical reliability of the measurements were deemed to be highly critical. 
A statistically appropriate sample size also depends on the inherent variation of 
roughness values in the same sample and the expected real differences in roughness 
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Figure 19. Histogram plot of the number of pixels with different surface heights after 
low-pass, band-pass and high-pass filtering. 
values between different samples. If the variability in a sample was higher and the 
expected differences between samples were smaller, larger samples sizes would be 
required to demonstrate statistical differences with the same level of confidence. The 
variability of roughness measurements within a sample was found to be inherently high, 
with the coefficients of variation typically above 30 %. Figure 20 illustrates the moving 
averages of Ra and Rq calculated using different samples sizes (N). With N values of 20, 
60 and 80, the spread of values were high and individual average values deviated by 100 
– 250 nm from the mean line. The fluctuations were reduced to an approximately 50 nm 
range with samples sizes of 120 and above. Regardless of the N value, the moving 
averages had fluctuated about the same approximate mean of 420 nm. The results in 
Table 5 show that when N was greater than 120, the relative standard errors of both the 
mean Ra and Rq were less than 5 %. This was taken to be the acceptable limit for the 
0
100
200
300
400
500
600
700
-4000 -3000 -2000 -1000 0 1000 2000 3000 4000
N
u
m
b
er
 o
f 
p
ix
el
s
Surface height (nm)
Unprocessed
Low pass
Band-pass
High pass
93 
 
purposes of this thesis. The use of a larger N only ensures that the mean value would be 
reasonably close to the true mean but has no impact on the variability of roughness. 
From the results, N = 150 was selected for subsequent roughness measurements. 
4.1.2.2.3 Effect of image size on the magnitude of roughness values 
Table 6 shows the Ra of both the smoothened and roughened particles when they were 
obtained using three different image sizes. The maximum image size of 30 × 30 µm2 was 
selected based on the feasibility of obtaining statistically acceptable numbers of surface 
images from particles within the range of 125 – 180 µm. The smaller image sizes of 20 × 
20 µm2 and 10 × 10 µm2 were also investigated to make provisions for roughness 
measurements for particles within a smaller size range. When the images were 
unprocessed, larger image sizes always resulted in higher Ra and Rq values. It has often 
been suggested that higher roughness values with larger scan sizes was due to the 
inclusion of more prominent surface features on a larger length scales. At the same time, 
the surface tilt would also be more significant with larger image sizes. The effect of 
image size was greatly reduced by the band-pass filter. It was anticipated that particles of 
different sizes could be measured in subsequent work. Thus, the possibility to use 
different image sizes was established and suitable processing steps ensured comparable 
roughness values were obtained. 
4.1.2.2.4 Relationship between Ra and Rq 
The Ra and Rq values are amplitude parameters commonly used to express the degree of 
surface roughness of particulates. Due to the nature of their calculation methods, Ra and 
Rq values provide slightly different quantitative information about the surface. The Ra 
parameter is less sensitive to atypical surface features (tall surface asperities and deep 
valleys) as they would be averaged out in the final value. The Rq value, on the other hand, 
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is more sensitive to atypical surface features because the surface height values are 
squared in its calculation. For this reason, the Rq values were always higher than the Ra 
values. The Ra and Rq values occur as pairs as they are simultaneously calculated from 
each surface image. In order to investigate if the Rq would provide any additional 
information about the surface, the Ra and Rq values for all surface images were plotted 
against each other in Figure 21. They were found to be linearly related (R2 = 0.99). 
Hence, only the Ra value would be needed and used to represent the surface roughness of 
lactose carrier particles in subsequent studies. 
Table 5. Statistical parameters calculated from the moving averages obtained using 
different values of N 
Sample 
size (N) 
 
No. of 
elements* 
 Roughness parameter 
Ra (nm)  Rq (nm) 
Average 
 
RSE (%) Average 
 
RSE (%) 
20 381 416.9 12.7 723.7 13.9 
60 341 418.3 5.1 711.5 7.5 
80 321 418.7 4.2 707.7 5.3 
120 281 416.7 3.1 705.6 2.9 
150 251 416.2 2.6 704.2 2.8 
200 201 416.0 1.6 702.7 2.2 
250 151 416.2 0.9 704.2 1.4 
*Number of elements in the moving average, calculated from 400 individual values 
RSE refers to the relative standard error 
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(A) 
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(B) 
 
 
Figure 20. Moving averages of (A) Ra and (B) Rq calculated using different sample sizes 
for the smoothened lactose particles. The dotted lines represent the overall 
averages of all elements in the series for each N value used. Each division on 
the y-axis represents 50 nm and 100 nm in the graphs in (A) and (B), 
respectively.  
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Table 6. Roughness parameters obtained from the smoothened and roughened carrier 
particles when different image sizes, with and without band-pass filtering, were used 
Smoothened carrier particles  
Image size 
(µm2) 
 
Unprocessed  After band-pass filtering 
Ra (nm)  Rq (nm)  Ra (nm)  Rq (nm) 
30 x 30  1642 (704)  2050 (866)  484 (256)  750 (398) 
20 x 20  1285 (583)  1634 (724)  437 (215)  657 (332) 
10 x 10  827 (446)  1110 (573)  431 (219)  631 (360) 
 
Roughened carrier particles  
Image size 
(µm2) 
 
Unprocessed 
 
After band-pass filtering 
Ra (nm)  Rq (nm) Ra (nm)  Rq (nm) 
30 x 30  3303 (1850)  4020 (2186)  772 (288)  1125 (403) 
20 x 20  2088 (1173)  2585 (1397)  726 (275)  1013 (376) 
10 x 10  1362 (735)  1703 (862)  683 (291)  924 (375) 
Values in parentheses represent the respective standard deviation 
 
Figure 21. Relationship between Ra and Rq for all analysed surface images from both the 
roughened and smoothened carrier particles. 
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4.1.3 Summary of Part 1 
Measurement and image processing criteria such as the sample size, sample tilt, scan 
area and type of filter applied were shown to influence the magnitude of Ra significantly. 
Due to the particulate nature of the samples, roughness measurements were challenging 
to perform as the general shape and surface tilt were highly variable among different 
image areas. The scale of observation was found to be the most critical factor which 
influenced the magnitude of Ra values. As the surfaces were profiled with increasing 
detail (i.e., over smaller areas), the Ra value showed a corresponding decrease. The band-
pass filter was a useful tool as it had achieved the following objectives: (a) removal of 
any surface tilt, (b) extraction of surface components of impact, (c) elimination of 
inherent noise due to environmental vibrations and (d) allowed the use of different image 
sizes but enable the determination of comparative roughness values to be made.  
The lack of useful and comparable roughness values reported by various researchers 
stemmed from a lack of standardization in conditions for roughness measurement as well 
as data pre-processing. From this study, a set of measurement conditions was defined for 
the determination of Ra: N = 150, band-pass filtering with cut-off spatial frequencies of 
0.1 and 1.5 µm-1 and surface image areas in the range from 10 × 10 µm2 to 30 × 30 µm2. 
These conditions were employed in all subsequent studies. It should be noted that this set 
of criteria was selected for lactose particles with a size range of approximately 40 – 200 
µm and is suitable for studying only this particular length scale of surface information. 
Where there are vast differences in the size of profiled images or the resolution of other 
surface profiling instruments, the criteria for image processing  are likely to differ but 
may be investigated using a similar experimental protocol.  
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4.2 Part 2: Investigation of two methods to prepare roughened lactose carrier 
particles 
4.2.1 Part 2A: Fluid-bed coating 
4.2.1.1 Particle size and size distributions of lactose carriers 
A total of 10 different types of lactose carriers was obtained and they were labeled 
according to their size range and degree of surface roughness as indicated in Figure 8 
(Page 57). The size and size distribution of all lactose carriers are presented in Table 7. 
In general, carrier particles which were fractionated using the same sieve aperture sizes 
exhibited similar d50 even though they were obtained from powders of different particle 
sizes (i.e., feed P1, P2 and P3). The d50 values were approximately 170, 110 and 60 µm 
for Fractions A, B and C respectively. The span values increased as the size fraction 
increased. The preparation of carriers of consistent and narrow size ranges allowed for a 
more accurate study of the surface roughening effect on particles of different sizes 
during fluid-bed coating. 
4.2.1.2 SEM images of lactose carrier particles 
The changes to the surface morphology of the carrier particles were qualitatively 
assessed using SEM images. Representative SEM images of selected lactose carriers are 
shown in Figure 22. Attachment of the micronized lactose to the surfaces of the 
roughened carrier particles (Figure 8; A2, A3, B2, B4, C2, C3) was evident in all the size 
fractions, albeit to different extents. In all cases, the micronized particles were more 
heavily deposited in the large-scale irregular regions on the particle surface. It was also 
observed that more micronized lactose were deposited on the flat planar surfaces of 
roughened particles in fraction A compared to fraction B. Smoothened particles could be 
clearly differentiated by the lack of micronized lactose adhering to the particle surfaces.  
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Table 7. Size and span parameters of fluid-bed coated lactose carrier particles 
Carrier code 
 Particle size (µm)  
Span 
 d10  d50  d90  
A1 135.0 (1.8) 175.8 (1.0) 225.4 (4.1) 0.51 (0.03) 
A2 130.0 (7.0) 170.9 (3.2) 217.8 (4.3) 0.51 (0.03) 
A3 135.9 (0.6) 176.9 (2.1) 226.8 (5.3) 0.51 (0.02) 
B1 82.3 (5.3) 122.6 (2.2) 160.0 (1.4) 0.63 (0.05) 
B2 79.1 (11.3) 123.5 (3.2) 162.1 (3.4) 0.67 (0.08) 
B3 72.4 (0.5) 112.0 (0.8) 152.7 (1.8) 0.72 (0.01) 
B4 71.0 (0.4) 110.7 (0.3) 149.9 (2.3) 0.70 (0.02) 
C1 38.6 (0.4) 63.5 (0.2) 92.7 (0.2) 0.85 (0.01) 
C2 39.2 (0.4) 63.6 (0.2) 92.8 (1.1) 0.84 (0.02) 
C3 41.2 (2.3) 63.3 (0.5) 92.2 (1.7) 0.81 (0.06) 
Values in parentheses represent the respective standard deviation 
 
 
4.2.1.3 Effect of particle size of feed powder on surface roughening effect 
The sizing data for the three powders used for fluid-bed coating used are presented in 
Table 1 (Page 56). Feed P1 had the largest particle size (d50 = 154 µm) and the smallest 
span value (span = 0.88). Feed P2 and P3 had similar d50 values (48 and 47 µm). 
However, feed P3 had smaller span value than feed P2 because particles larger than 100 
µm had mostly been removed from feed P3. The effect of powder classification could be 
clearly seen from the 30 µm decrease in the d90 values of feed P3 compared to feed P2. 
Due to the differences in particle size of the feed powders, the amounts of micronized 
lactose sprayed on the coarse particles were adjusted based on their measured specific 
surface areas (Table 2). This adjustment was taken to ensure that the extent of surface 
roughening would theoretically be similar, assuming that the efficiency of adhesion of 
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micronized lactose was the same for all feed powders. Collectively, the use of these 3 
feed powders allowed the surface roughening effect on particles ranging from 40 – 200 
µm to be studied. 
The Ra values and specific surface areas for all fluid-bed coated carriers are shown in 
Table 8. The standard deviations of Ra were calculated from the Ra of individual surface 
images and were large in magnitude compared to the mean Ra. This observation 
suggested that there was very high intrinsic variability of Ra at the level of individual 
particles in a population. Nevertheless, valid comparisons can still be made using the 
mean Ra when a sufficiently large sample size is used. Comparing the coated carriers A1 
– A3, it can be clearly seen that the increase in Ra was related to the amount of 
micronized lactose sprayed. Carrier A2 was of intermediate roughness (Ra = 522 nm) 
compared to carrier A1 (Ra = 437 nm) and carrier A3 (Ra = 726 nm). It should be 
recalled that the amount of micronized lactose powder sprayed on carrier A2 was one-
third of that sprayed on carrier A3. Hence, the quantitative change in roughness suggests 
that the extent of surface roughening was dependent on the amount of micronized lactose 
sprayed on the coarse particles. 
The extent of surface roughening for different carrier batches from different feed 
powders was evaluated based on the percentage increase in Ra and specific surface area 
in each carrier batch, relative to the smoothest carrier obtained from the same feed 
powder. In general, it was found that the carrier batches (A1 – B2) obtained from feed 
P1 showed greater increase in both the Ra values as well the specific surface areas 
compared to those obtained from feed P2 and P3. In particular, carrier B2 exhibited a 59 % 
increase in the Ra value compared to 37 % in carrier B4 even though the Ra of the 
corresponding smooth particles were similar. Therefore, the surface roughening effect 
was shown to increase when the feed powder had a larger particle size.   
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Figure 22. Scanning electron micrographs of the surfaces of roughened and smoothened 
carrier particles. Images (A) and (B) are representative smoothened and 
roughened surfaces at higher magnification of 2000x and (C) – (H) are the 
smoothened and roughened particles from different size fractions at lower 
magnifications of 700x and 1000x. 
(C) Carrier A1 
(A) Typical smooth 
       surface 
(B) Typical rough 
      surface 
(D) Carrier A3 
       
(E) Carrier B1 
 
(F) Carrier B2 
       
(G) Carrier C1 (H) Carrier C2 
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Table 8. Surface roughness and specific surface area of fluid-bed coated lactose particles 
Carrier 
code* 
 
Mean Ra 
(nm) 
 
Coefficient 
of variation 
(%) 
 
Change 
in Ra 
(%)** 
 
Specific 
surface area 
(m2/g) 
 
Change in 
specific 
surface area 
(%)** 
A1  437 (215)  49  -  
0.230 
(0.023) 
 - 
A2  522 (299)  57  + 19  
0.258 
(0.019) 
 + 12 
A3  726 (275)  38  + 66  
0.282 
(0.014) 
 + 23 
B1  442 (237)  54  -  
0.278 
(0.019) 
 - 
B2  703 (229)  33  +59  
0.322 
(0.059) 
 +16 
B3  478 (258)  54  -  
0.281 
(0.020) 
 - 
B4  653 (288)  44  + 37  
0.310 
(0.005) 
 + 10 
C1  639 (392)  61  -  
0.356 
(0.024) 
 - 
C2  635 (306)  48  - 0  
0.415 
(0.044) 
 + 17 
C3  698 (318)  46  +9  
0.414 
(0.004) 
 + 16 
*Carriers A1 – B2 were obtained when feed P1 was used. Carriers B3 – C2 were obtained 
when feed P2 was used. Carrier C3 was obtained when feed P3 was used.  
**% change in Ra and specific surface area of the roughened lactose carriers were 
calculated with reference to the smoothened carrier, which was obtained from the same 
feed powder and had the same particle size range. The reference lactose carrier was (i) A1 
for carriers A2 and A3, (ii) B1 for carrier B2, (iii) B3 for carrier B4 and (iv) C1 for 
carriers C2 and C3.  
Values in parenthesis represent the respective standard deviation 
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There are several reasons which may account for the lower degree of surface roughening 
when feed powders of smaller particle sizes were used; larger specific surface area, 
segregative flow in the fluid-bed chamber and more agglomeration between the smaller 
particles during fluidization. An attempt was made to reduce the effect of the differences 
in specific surface area of feeds P1, P2 and P3, by adjusting the amount of micronized 
lactose sprayed based on the total surface area of the feed powder. It was more difficult 
to avoid segregative suspension heights of the fluidizing material as particle size and 
span were the primary variables investigated. Segregation was more likely to occur in 
feed P2 due to the larger span value of 2.08 compared to 0.88 in feed P1. Interestingly, it 
has been reported that the addition of fines to a mixture of small and large particles 
further enhances segregation during fluidization (131). Computer simulations in the 
same study suggested that segregation increased when as low as 1 %, w/w fines were 
present. This was because the inter-particle interactions between small and large 
particles were reduced noticeably. In the present study, micronized lactose accumulated 
in the product chamber with the increase in spraying time. Hence, the efficiency of 
surface roughening in small particles would be expected to decrease even further with 
time. Lastly, the degree of particle agglomeration in the fluid-bed chamber was expected 
to increase as the particle size was decreased due to the cohesiveness of smaller particles. 
This would in turn hinder the wetting and deposition of spray droplets around the 
surfaces of the smaller feed particles when compared to the larger particles.   
4.2.1.4 Extent of surface roughening in particles of different sizes within the 
same feed powder 
The results in Table 8 also show that the extent of surface roughening was always greater 
in the larger carrier particles that were fractionated from the same feed powder. This 
suggests non-uniformity in surface roughening of particles within the same feed powder. 
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There was a larger percentage increase in Ra for carrier A3 (+ 66 %) compared to B2 (+ 
59 %) as well as for carrier B4 (+ 37 %) compared to C2 (- 0 %). The differences in Ra 
between different-sized particles were smaller in feed P1 than in feed P2. There could be 
3 possibilities for the above observations: (a) the specific surface area of smaller 
particles are greater and more micronized fines have to be deposited around the particles 
to achieve the same Ra values, (b) the tendency for adhesion of micronized fines to 
particle surfaces is lower for smaller particles and (c) segregation of particles during 
fluidization leads to much lower probability of smaller particles passing through the 
spray zone located at the lower region of the fluid-bed chamber. Of these various 
possibilities, the segregation effect could be studied by repeating the fluid-bed process 
using feed particles of comparable d50 value but with narrower size distribution. 
Feed P3 was used to investigate whether the segregation effect could be reduced when 
the size distribution of the feed powder was narrower. The particle size data in Table 1 
(Page 56) and Table 7 (Page 100) show that carrier C3 was derived from the largest 
particles in feed P3. The size ranges (i.e., d10 – d90) of feed P3 and carrier C3 were 16 – 
86 µm and 41 – 92 µm, respectively. Hence, carrier C3 was expected to be efficiently 
roughened at the spray zone near the bottom of the chamber even when segregation of 
the feed based on particle size was significant during coating. Surprisingly, only a 
marginal increase in the Ra was observed and this suggests that segregation may not be 
the predominant reason for the poor surface roughening effect for smaller particles. It 
has been reported elsewhere that finer particles are fluidized in the form of cohesive 
agglomerates (132). Larger particles, on the other hand, can exist individually in the 
fluidizing bed (133). The agglomeration and subsequent separation of small particles 
would have prevented the spray droplets from wetting of single particles effectively and 
thus, prevented the surface deposition of fines on smaller particles. In addition, there is 
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an increased tendency of wetted particles to form larger aggregates in the fluid-bed. It 
was reported that the capillary liquid bridge forces were generally stronger than the fluid 
drag and particle-particle collision forces and restricted the motion of individual particles 
in wet agglomerates (134). The presence of 60 %, v/v IPA in the suspension media for 
micronized lactose was meant to reduce the agglomerative effects since the solubility of 
lactose in IPA is minimal and the latent heat of vaporization of the mixture was 
decreased significantly (48). Therefore, if agglomeration occurs during fluid-bed coating, 
the liquid and solid bridges formed between the particles would be weak and likely to 
break down during fluidization. Agglomeration is detrimental to the fluid-bed coating 
process as particle surfaces within the agglomerates would be shielded and remain un-
coated. The reduction in particle-particle agglomeration and increased rate of drying may 
be achieved with higher airflow rates. However, it was observed that higher airflow rates 
led to finer particles being rapidly trapped in the filters and decreased the product level 
in the chamber. The minimum airflow rate required for fluidization, just sufficient to 
keep the entire powder bed in motion, was therefore maintained during the processes. 
Lastly, the size of spray droplets is not likely to be a major contributory factor to non-
uniform surface roughening of large and small particles in the same feed batch. 
Researchers have reported that spray droplets produced from a two-fluid spray nozzle, 
with 1 mm nozzle diameter at an atomizing pressure of 2.5 bars, ranged from 
approximately 1 – 15 µm (135). This droplet size range on exiting the spray nozzle was 
still considerably smaller than the particles in the range of 38 – 63 µm. Hence, there 
were limited improvements which could be effected from changes in other experimental 
conditions. The poorer surface roughening action for particles smaller than 80 – 100 µm 
appeared to be a limitation of fluid-bed coating to produce roughened carrier particles. 
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4.2.2 Part 2B: Dry granulation by roller compaction 
4.2.2.1 Particle size distributions of raw lactose powders and powder blends 
used in roller compaction 
The particle size distributions of the raw powders (lactose 100M, 200M and 400M) are 
shown in Figure 23. Lactose 100M had the largest d50 value of 161 µm and the narrowest 
size distribution. Lactose 200M and 400M had d50 values of 34 µm and 10 µm, 
respectively. By blending lactose 100M with either one of the finer lactose grades (Table 
3, Page 61), powder blends with different size distributions and flow characteristics for 
roller compaction were obtained. It can be deduced that the size distributions of these 
blends would not follow the ‘model’ normal or log-normal distributions but would 
generally be bimodal in nature. 
 
Figure 23. Particle size distributions of lactose 100M, 200M and 400M. 
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The particle size distribution of each powder blend is presented in Table 9. The blend 
codes were labeled according to decreasing d50 for the ease of data analysis. The d50 
values had varied predictably according to the proportion and size of fine lactose added 
to the blends. The addition of the finer grades of lactose 200M or 400M to coarser 
particles of lactose 100M always led to the decrease in d50 values but the increase of the 
span values. Compared to blends with lactose 200M (F2, F4, F5), the addition of 
increasing proportions of lactose 400M (F3, F7, F8) resulted in much greater decrease in 
the d10 and to a lesser extent, the d50 and d90 values. Interestingly, blends F7 and F8, 
which consisted of 50 % and 75 %, w/w of lactose 400M respectively, had almost the 
same d10 and d50 values compared to lactose 400M on its own. However, the span value 
of blend F7 was the greatest among all the blends. The above trends were not observed 
with lactose 200M.  
4.2.2.2 Flow properties of powder blends 
Powder flow properties of the blends were evaluated using flow parameters/methods 
described in the USP; angle of repose, Hausner ratio, cohesion (shear cell). The blends 
were also tested in the powder rheometer and 2 other flow parameters, BFE and specific 
energy, were obtained. The bulk densities and Hausner ratios are presented in Figure 24. 
The bulk densities decreased as the particle size decreased. According to the 
classification scale of powder flowability in the USP (136) based on the Hausner ratios, 
the flowability of the powder blends used in this study ranged from ‘passable’ (F1) to 
‘very very poor’ (F8). The Hausner ratio and powder cohesion described very similar 
trends in flow among the blends. In general, a decrease in the particle size increased 
powder cohesion and led to larger Hausner ratios. A wider size distribution in blend F3 
contributed to deviations from the general trends for bulk density, Hausner ratio and 
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Table 9. Particle size distributions of powder blends used in roller compaction 
Powder 
 
Particle size (um) 
 
Span 
d10 
 
d50 
 
d90 
F1 68 (2) 161 (0) 237 (1) 1.0 (0.0) 
F2 25 (1) 140 (1) 229 (0) 1.5 (0.0) 
F3 5 (0) 90 (6) 189 (6) 2.1 (0.1) 
F4 14 (1) 73 (3) 182 (10) 2.3 (0.0) 
F5 11 (0) 45 (3) 143 (20) 2.9 (0.3) 
F6 10 (3) 34 (3) 86 (6) 2.2 (0.4) 
F7 2 (0) 12 (0) 60 (8) 5.0 (0.6) 
F8 2 (0) 11 (0) 23 (1) 1.9 (0.1) 
Lactose 400M  2 (0)  10 (0)  20 (0)  1.9 (0.0) 
F1 and F6 represent lactose 100M and lactose 200M, respectively  
Values in parenthesis represent the respective standard deviation 
 
powder cohesion. The d90 values of F3 and F4 (about 180 µm) were similar. However, 
the d10 of F3 (5 µm) was much smaller that of F4 (14 µm), indicating that F3 has a 
relatively larger proportion of fines below 5 µm. The results suggest that a larger 
proportion of such fines had a significant detrimental effect on the packing density and 
powder flow. 
The large angles of repose in all powder blends (Figure 25) indicate that the powders 
ranged from having poor to very poor flowability. The trends in the angle of repose 
coincided with the trends in powder cohesion for blends F1 – F5 but not for F6 – F8 (i.e., 
typically the greater the powder cohesion, the larger the angle of repose). This was likely 
due to the tendency for the formation of spherical cohesive agglomerates in very 
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cohesive powders (blends F6 – F8) as they passed through 1.0 mm sieve apertures 
during the measurement of angle of repose. These cohesive agglomerates exhibited 
slightly better flow properties than the individual particles in less cohesive powders, 
resulting in a lower angle of repose. Hence, the results suggest that the angle of repose 
may not be a suitable flow parameter for assessing flow of lactose powders when their 
cohesion exceeded 2 kPa, corresponding to the cohesion value of blend F5.  
The BFE and specific energies of each powder blend is shown in Figure 26. The BFE 
decreased with decreasing d50 while the specific energy showed the opposite trend. Both 
these parameters are energy parameters which describe the amount of work required to 
induce powder flow under different stress states of the powder. Due to the helical shape 
of the blade, some compressive action is generated in the region of powder immediately 
below the blade as it traverses downwards into the powder column. Different degrees of 
compressive action may be induced by separately modifying the rate of rotation of the 
blade as well as the rate that it moves vertically downwards into the powder bed. The 
BFE is a measure of the energy required to drive the rheometer blade through the powder 
bed, originally in a loosely packed state, while inducing powder flow when the powder is 
in a slightly compressed state. The specific energy, on the other hand, is the energy 
expended per unit weight of the powder during the upward motion of the blade which 
results in gentle lifting and flow in a low stress state of the powder. 
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Figure 24. Bulk densities (   ) and Hausner ratios (   ) of powder blends used in roller 
compaction. 
 
Figure 25. Angles of repose (   ) and cohesion (   ) of powder blends used in roller 
compaction. 
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Figure 26. Basic flowability energies (BFE;     ) and specific energies (    ) of the powder 
blends used in roller compaction. 
4.2.2.2.1 Correlations among flow parameters 
The Hausner ratio is a much more widely-used and reported flow parameter compared to 
the BFE and specific energy. Therefore, the suitability of the BFE and specific energy in 
the evaluation of powders with ‘passable’ to ‘very very poor’ flow properties (i.e., 
Hausner ratio between 1.25 – 2.0) was established by correlating them to the Hausner 
ratio. The linear correlation coefficients between the Hausner ratio and both the BFE and 
specific energy are shown in Figure 27. The linear correlation coefficients between the 
cohesion and both the BFE and specific energy are shown in Figure 28. Both the BFE 
(R2 = 0.93) and specific energy (R2 = 0.92) were found to exhibit stronger linear 
relationships with Hausner ratio than powder cohesion. 
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Figure 27. Relationships between the different flow parameters of the powder blends: 
Hausner ratio, BFE (basic flowability energy) and specific energy. 
 
Figure 28. Relationships between the different flow parameters of the powder blends: 
cohesion, BFE (basic flowability energy) and specific energy. 
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4.2.2.2.2 Correlations between particle size and flow parameters 
As a result of their bimodal size distributions, the d50 values of the powder blends did not 
always correlate well with powder flow. It was observed previously (Tables 3 and 9) that 
the addition of a small proportion of fine lactose (i.e., 25 %, w/w) to coarse lactose 
100M resulted in the largest degree of change in the d10 compared to the d50 or d90 values. 
When a sufficiently small proportion of lactose fines is present with the coarse particles 
(or vice versa), the flowability of the powder will be altered but the d50 value may be 
unchanged due to the small volume percentage of the fines. It was thought that certain 
flow parameters would be influenced to a greater extent by the presence of fine particles 
than others. In order to investigate the effect of the size distribution on each of the four 
flow parameters used in this study, a series of dx values (d10, d15, d25, d35, d60, d75, d90, d95) 
of each powder blend was calculated (Table 10). Discrete values of dx were employed 
because most of the powder blends were unable to fit to commonly utilized model 
distributions such as the log-normal or Weibull distributions. This can clearly be seen 
from the size distribution graphs of the various powder blends plotted in Figure 29. 
The linear correlation coefficients of every set of dx values with the four flow parameters 
were obtained and are shown in Figure 30. It was observed that the highest correlation 
was obtained for the d50 with the cohesion, Hausner ratio and BFE, while the d15 was 
best correlated with the specific energy. Across the various dx values, however, the 
trends in the correlation coefficients were found to be very different for the different 
flow parameters. For the cohesion and Hausner ratio, the correlation coefficients ranged 
between 0.71 – 0.92 and were lower for d10 – d35 as well as for d60 – d95 as compared to 
the d50 value. For the specific energy, the correlation coefficients were greater than 0.95 
for d10 – d25 and decreased steadily from 0.88 – 0.60 for d35 – d95. An opposite trend was 
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Table 10. Particle sizes at different volume percentages of powder blends used in roller compaction 
 Blend code 
 
Particle size (µm) 
d10 
 
d15 
 
d25 
 
d35 
 
d50 
 
d60 
 
d75 
 
d90 
 
d95 
F1 68.0 83.9 120.5 121.8 161.0 161.2 200.7 236.7 234.1 
F2 25.3 35.2 72.6 101.1 140.3 146.8 187.8 228.9 234.1 
F3 5.1 7.2 12.2 16.7 90.0 121.8 159.2 189.4 194.2 
F4 14.4 18.3 29.6 39.8 73.1 95.1 145.5 181.9 182.6 
F5 11.3 14.3 22.5 28.4 45.1 54.5 96.4 143.1 148.1 
F6 9.8 12.4 19.2 22.9 34.4 37.5 58.8 86.4 92.4 
F7 2.3 3.4 6.4 7.7 11.6 12.6 18.5 59.9 67.9 
F8 2.1 3.2 6.2 7.4 11.0 11.8 16.2 23.1 32.0 
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(A) 
 
 
(B) 
 
 
Figure 29. Particle size distributions of powder blends (A) F1 – F4 and (B) F5 – F8 used 
in roller compaction. 
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Figure 30. Linear correlation coefficients (R2) obtained when different dx values were 
plotted against the 4 flow parameters: cohesion (    ), Hausner ratio (    ), 
basic flowability energy (   ) and specific energy (   ). Each R2 value was 
obtained by plotting the particle sizes corresponding to the xth volume 
percentile (dx) of all powder blends (F1 – F8) against the corresponding 
values of the flow parameter. 
observed for the BFE, where the coefficients were greater than 0.90 for d50 and above 
but decreased to 0.81 – 0.65 for d35 and below. The results suggest that the specific 
energy was much more sensitive to the size of the finer particles in the blend while the 
BFE was more dependent on the composition of the entire blend. The BFE has been 
reported to be partly dependent on the bulk compressibility of the powder (126), since it 
was a measure of the energy required to generate a compressive action by the blade 
during the test. This was also observed from the good linear relationship between BFE 
and bulk density shown in Figure 31. As slightly higher linear correlation coefficients 
could be obtained for the BFE and specific energy (compared to the cohesion/Hausner 
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ratio) when the suitable dx value was selected, these 2 flow parameters could potentially 
be used as better predictors of powder flow. 
 
Figure 31. Graph showing the linear relationship between the BFE and bulk density of 
powder blends. 
4.2.2.3 Variation in roll force during compaction 
The results in Table 11 show the mean roll force and screw speed recorded for each 
powder blend during each successful compaction run. Consistent compaction parameters 
during compaction generally lead to smaller variation in the quality of ribbons produced. 
Reduced variation in the degree of particle fragmentation/bonding during compaction is 
always more desirable as it leads to reduced variation in the resultant surface roughness. 
The compaction parameters set might vary during compaction due to the influence of the 
feed materials. Several observations could be made regarding the size and flow 
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properties of the blends and the roller compaction parameters. It was noted that there was 
greater difficulty in achieving the higher roll forces in powder blends with smaller 
particle size or poorer flow. Blends F7 and F8 could not be successfully compacted at 20 
kN/cm while blends F4 – F8 could not be successfully compacted at 30 kN/cm. Blends 
F1 – F3, on the other hand, could be successfully compacted at all the three roll forces 
used. The variation of roll force recorded was also found to differ significantly among 
the powder blends. It was observed that blend F1, despite having the largest particle size 
and best flowability, resulted in the most significant variation of roll force during 
compaction. This could be inferred from the larger standard deviations of the roll force 
and screw speed recorded. Blends F3 and F6 – F8 were also found to exhibit higher 
variation in roll force when compacted at 10 kN/cm. A similar trend could be observed 
in blends F1, F3 and F6 at the roll force of 20 kN/cm and in blends F1 and F3 at the roll 
force of 30 kN/cm. Hence, it could be seen that certain intrinsic powder properties had 
contributed to the variation in roller compaction parameters regardless of the compaction 
force used.  
Interestingly, the particle size distributions of the blends which resulted in greater 
variation in the compaction parameters (F1, F3 and F6 – F8) could be divided into two 
categories: (a) powders of very coarse particle size and with minimal amount of particles 
smaller than 50 µm (F1) and (b) powders with greater than 15 % (by volume) of fine 
particles smaller than 10 µm. It appeared that an optimal particle size distribution, such 
as that of blend F2, was required to achieve both a wide range of target roll forces (10 – 
30 kN/cm) as well as minimal variation in roll force during compaction. Figure 32 is a 
schematic diagram of the roller compactor showing the counter-rotating rolls and the nip 
region where powder is being densified and compacted into ribbons. For blends with 
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Table 11. Mean roll force and screw speed recorded for different powder blends during 
roll compaction 
Blend 
code 
 
Target roll force (kN/cm) 
10 
 
20 
 
30 
Roll 
force 
(kN/cm) 
 
Screw 
speed 
(rpm) 
Roll 
force 
(kN/cm) 
 
Screw 
speed 
(rpm) 
Roll 
force 
(kN/cm) 
 
Screw 
speed 
(rpm) 
F1 
9.9 
(4) 
21.5 
(5.3) 
19.8 
(1.5) 
50.4 
(3.4) 
29.7 
(1.1) 
56.9 
(2.0) 
F2 
10.0 
(0.4) 
24.4 
(0.2) 
19.8 
(0.6) 
39.3 
(1.1) 
30.0 
(0.8) 
46.5 
(0.4) 
F3 
10.0 
(0.9) 
30.2 
(2.0) 
20.2 
(1.3) 
37.5 
(2.7) 
29.8 
(1.2) 
44.7 
(2.0) 
F4 
10.0 
(0.6) 
28.2 
(0.7) 
19.4 
(0.9) 
43.3 
(4.0) 
- - 
F5 
 
10.0 
(0.6) 
27.8 
(0.3) 
18.1 
(0.8) 
52.9 
(7.7) 
- - 
F6 
9.8 
(1.0) 
31.5 
(2.9) 
19.2 
(2.1) 
49.5 
(6.8) 
- - 
F7 
10.0 
(1.2) 
43.8 
(2.5) 
- - - - 
F8 
8.8 
(1.0) 
46.3 
(6.5) 
- - - - 
Values in parenthesis represent the respective standard deviation 
 
 
poor flow and low bulk densities (F3 and F6 – F8), the roll force fluctuations were likely 
to be due to the intermittent feeding of material into the nip region. The feed remained 
largely static around the slip region immediately after discharge from the hopper until a 
substantial amount of powder had been accumulated and cascaded towards the nip 
region. On the other hand, the most free-flowing powder (F1) caused rapid flooding into 
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the nip region and the excessive built-up powder between the rolls caused the spikes in 
the roll force. Consequently, the feedback controls resulted in drastic decrease in the 
screw speed, which in turn reduced the feed delivery and the roll force significantly. In 
both situations, the automatic adjustments in screw speed by the roller compactor was 
ineffective at maintaining a continuous and consistent feed flow which translated into the 
recorded peaks and troughs instead of a constant roll force.  
 
Figure 32. Schematic diagram of the roller compactor showing the slip, nip and release 
regions. 
4.2.2.3.1 Prediction of roll force variations using flow parameters 
The powder blends were ranked according to their flowability in Figure 33. Powder 
blends which resulted in greater variability in roll force and screw speeds are encircled. 
With the exception of the angle of repose, the ranked order for each flow parameter 
shows that there was greater agreement among the flow parameters when the flow 
properties were at the extreme ranges. More discrepancies among the flow parameters 
were observed for powders exhibiting intermediate flow properties. It should be recalled 
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that F1, F3 and F6 – F8 showed greater variation in compaction parameters during 
compaction. The specific energy appeared to be the only flow parameter which reflects 
this best. The ranked sequences of the other flow parameters were not always related to 
the variation in roll force encountered. Powder blends with specific energy in the range 
of 7.9 – 8.8 mJ/g (blends F2, F4 and F5) were found to result in more consistent 
compaction parameters during compaction. 
 
Figure 33. Powder blends ranked according to their flowability based on the values of 
each flow parameter. The blend codes encircled indicate blends that showed 
higher variability in both the roll force and screw speed during compaction. 
4.2.2.4 Surface roughness of roller compacted carrier particles 
The Ra values of the carriers obtained from all formulations at the three different roll 
forces are presented in Table 12. There were no clear relationships between the type of 
powder blend and the resultant carrier roughness. Most notably, however, carriers 
obtained from powders comprising higher percentages of lactose 400M (i.e., F7 and F8) 
resulted in relatively low Ra values among other carriers. Compared to the composition 
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of the powder blend, the magnitude of compaction forces exerted on the powders had a 
greater influence over the Ra values and thus was investigated using the ANOVA. The 
results in Table 13 show that the Ra of the INH (573 nm) and L100M carriers (562 nm) 
were not significantly different from each other (p = 0.42). The Ra values of the roller 
compacted carriers were significantly higher (p < 0.01) than the INH or L100M carriers, 
regardless of the roll force used. Among the roller compacted carriers, the Ra values of 
those compacted at 20 kN/cm were significantly higher (p < 0.01) than those compacted 
at 10 kN/cm but were not statistically different (p = 0.77) from those compacted at 30 
kN/cm. These results suggest that roller compaction was effective in increasing the Ra 
value from 10 – 20 kN/cm but there was no evidence of further increase from 20 – 30 
kN/cm. 
Table 12. Surface roughness of carrier particles prepared by roller compaction at 
different roll forces 
Blend code 
 Ra (nm) 
 Target roll force (kN/cm) 
 10  20  30 
F1  998 (46)  1055 (63)  1022 (19) 
F2  855 (96)  1086 (30)  1104 (42) 
F3  900 (171)  828 (38)  952 (147) 
F4  739 (177)  1117 (147)  - 
F5  969 (189)  1177 (136)  - 
F6  804 (227)  1006 (26)  - 
F7  702 (146)  -  - 
F8  494 (211)  -  - 
Values in parenthesis represent the respective standard deviation 
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Table 13. Results of the one-way ANOVA on the Ra of different batches of carrier 
particles 
Pair of samples under comparison  
 
 INH  L100M  Carrier10  Carrier20  Carrier30 
INH  -  0.42  < 0.01  < 0.01  < 0.01 
L100M  -  -  < 0.01  < 0.01  < 0.01 
Carrier10*  -  -  -  < 0.01  < 0.01 
Carrier20*  -  -  -  -  0.77 
Carrier30*  -  -  -  -  - 
Values in the table refer to the p-values and p < 0.05 denotes statistical significance 
*Carrier10, Carrier20 and Carrier30 denotes all carrier batches produced by roller 
compaction at roll forces of 10, 20 and 30 kN/cm, respectively 
 
Representative SEM images of carrier particles produced at different compaction forces 
are shown in Figure 34. Gradual morphological changes were observed as the 
compaction force increased. Figure 34A shows the general morphologies of 
uncompacted α-lactose monohydrate crystals. Figure 34B shows that the morphologies 
of the particles were retained after being subjected to a low compaction force of 10 
kN/cm. However, the surfaces were slightly more irregular compared to the crystallized 
particles due to some fusion of finer lactose on coarse particle surfaces. At compaction 
forces of 20 and 30 kN/cm, particle fragmentation was evident and the carrier particles 
were irregularly-shaped aggregates of particle fragments (Figure 34C and D). The results 
suggest that highly irregular rough carrier particles are obtained only when the 
compaction force was high enough to cause extensive particle fragmentation, followed 
by the bonding of particle fragments. 
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Figure 34. SEM images showing the gross morphologies as well as surface roughness of 
the different lactose carriers. The images show (A) the INH carrier and the 
roller compacted carriers obtained by compaction of (B) F8 at 10 kN/cm, (C) 
F5 at 20 kN/cm and (D) F2 at 30 kN/cm. 
4.2.3 Summary of Part 2 
In this study, in-depth investigations into the two carrier surface modification methods 
were carried out. The primary goal in Parts A and B of the study was to identify the 
physical properties of lactose powders and the processing conditions in each method that 
would result in lactose carriers with suitably high Ra. In surface roughening by fluid-bed 
coating, the larger starting particle size of the core was the most important factor leading 
to higher carrier Ra. Surface roughening effects were not very significant when the size 
of core particles were predominantly smaller than 100 µm, even after the amount of 
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sprayed micronized lactose was adjusted for the total surface area of the core particles. 
Surface roughening was not improved significantly even though the segregation 
tendency during fluidization was reduced by processing core particles with a narrower 
size distribution. The most probable cause was identified to be the intrinsic 
agglomeration of smaller cohesive particles during fluidization. This had prevented 
efficient wetting, spreading and drying of the spray droplets for deposition of micronized 
lactose on the coarser particles. Alternative strategies for obtaining carriers with higher 
Ra include: (a) increasing the amount of micronized lactose sprayed (only applicable to 
core particles larger than 100 µm) and (b) obtaining larger particle fractions from the 
processed powders. 
In surface roughening by roller compaction, carriers with significantly higher Ra values 
were produced. For successful compaction of powder blends at the desired roll force, the 
particle size, bulk density and powder flow had to exist within a certain range of values. 
The variation of roll force in different compaction runs was also investigated. Powder 
blends with the largest and smallest particle sizes showed greater variation in 
compaction parameters than those with the intermediate particle size. Significantly lower 
variations in roll force were observed when powders were compacted at higher roll 
forces. The various flow parameters (angle of repose, cohesion, Hausner ratio, BFE, 
specific energy) showed slight differences in the rank order of the powder blends used. 
This was probably because the size distributions of the powder blends were bimodal in 
nature. Each flow parameter assessed powder flow under slightly different stress states 
and packing conditions. The angle of repose was found to be anomalous for very 
cohesive powders (cohesion greater than 2 kPa) as the angles decreased with increasing 
cohesion. The Hausner ratio, cohesion and BFE generally showed better agreement with 
each other. The specific energy was found to be most sensitive to fine particles in the 
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powder blends and could best account for the trends in the variation of roll force. Along 
with the above considerations on the processibility of powders, carrier particles of higher 
Ra could be produced with higher roll forces. 
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4.3 Part 3: Investigation of the use of roughened lactose carriers in dry powder 
inhaler formulations 
4.3.1 Part 3A: Evaluation of the in vitro fine particle fraction and aerodynamic 
particle size distribution in interactive mixtures containing rough carriers 
4.3.1.1 Size and shape of carriers 
It has been reported that the study of the effect of a single physical property of any 
carrier (such as size, shape and surface texture) on DPI performance is virtually 
impossible because of the inter-dependence of the properties on one another and on the 
presence of fine particles (137). By the use of different conditions in fluid-bed coating 
and roller compaction, six coarse carriers were produced. Their mean diameters, aspect 
ratios and convexity values were evaluated (Table 14) to account for possible 
confounding factors on their DPI performance. The aspect ratio and convexity 
determined using optical microscopy (lateral resolution of 1.3 µm) were employed as 
particle shape descriptors in this study even though other researchers have used 
convexity as a roughness parameter (31, 46, 138). The results of the ANOVA conducted 
on all physical properties of the coarse carriers are shown in Table 15. The size and 
shape properties of the fluid-bed coated carriers (FBS and FBR) were not significantly 
different from each other (p > 0.05). The roller compacted carriers (RC50 and RC70) were 
also similar in their shape but RC70 was smaller in size. The size of the INH carrier (106 
µm) was more similar to the RC carriers (RC50, RC70; 101, 97 µm) while the size of the 
control carrier (113 µm) was more similar to the FB carriers (FBS, FBR; 118, 117 µm). 
The differences in size between the FB and RC carriers could be attributed to the slightly 
more elongated shapes of the FB carriers that allowed larger particles to pass through the 
same sieve apertures during air-jet sieving. 
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Table 14. Size, shape and surface roughness of coarse carriers 
Carrier code 
 
Physical property 
Diameter (µm) 
 
Aspect ratio 
 
Convexity 
 
Ra (nm) 
Control 113 (22) 1.42 (0.26) 0.95 (0.02) 562 
INH 106 (15) 1.32 (0.21) 0.97 (0.02) 573 
FBS 118 (19) 1.47 (0.28) 0.97 (0.02) 557 
FBR 117 (20) 1.47 (0.28) 0.97 (0.02) 907 
RC50 101 (20) 1.41 (0.26) 0.96 (0.02) 1175 
RC70 97 (21) 1.42 (0.27) 0.96 (0.01) 1355 
Values in parentheses represent the respective standard deviation 
The small differences in the absolute mean convexity values (range; 0.95 – 0.97) as well 
as the overlapping groups (Table 15; Tukey’s test, p > 0.05) suggest that, with the 
exception of the control carrier, the differences in convexity among the carriers were not 
large. When the convexity and Ra were compared (Tables 14 and 15), it was clear that 
convexity did not reflect differences in surface roughness between the carrier batches 
adequately or reliably. This show that the degree of irregularity of particle outlines, when 
viewed under the microscope, was not a good measure of its surface properties in this 
study. This was probably related to the lower resolution of the optical microscope and its 
ability to measure only the 2D surface outlines of each particle. Ra was evaluated using 
the optical profiler which had higher resolution of 0.75 µm and was able to map out the 
3D surface structures. It is noteworthy from these results that assessment of particle 
surface properties was dependent on the scale at which the particles are viewed under 
(i.e., resolution of the imaging method) (139). 
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Table 15. Statistical analyses (one-way ANOVA) of the size, shape and surface 
roughness of coarse carriers 
Carrier code 
 
Physical property 
Diameter (µm) 
 
Aspect ratio 
 
Convexity 
 
Ra (nm) 
Control A A A A 
INH B B B, C A 
FBS C C B, D A 
FBR C C D B 
RC50 D A C, E C 
RC70 E A E D 
For each physical property, carrier batches which do not share the same letter are 
statistically different (Tukey’s test, p < 0.05) 
4.3.1.2 Surface roughness of coarse carriers 
The distribution of Ra of each type of carrier is presented in Figure 35 and the median Ra 
values are presented in Table 14. The Ra of the control, INH and FBS carriers were 
statistically similar while those of the FBR, RC50 and RC70 carriers increased in the same 
order. Since the variability of Ra is much wider than its magnitude, it is more appropriate 
to present distributions of Ra values rather than a single median/mean Ra value. The Ra 
distribution of the FBS carrier was largely unchanged compared to the control carrier. 
The Ra distribution of the INH carrier was found to be comparable to the control and FBS 
carriers, suggesting that their profiles of the Ra distribution typically describe the macro-
scale roughness of crystallized α-lactose monohydrate particles. By comparing the 
control with the FBR carrier, it was clear that the range of Ra values (100 – 2100 nm) did 
not change after fluid-bed coating. Instead, a significant shift of the modal roughness 
from 400 to 800 nm had occurred mainly as a result of the adhesion of micronized 
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lactose on coarse lactose surfaces. This suggests that there was a limit to the roughening 
effect (up to about 1500 nm) by this method. For the roller compacted carriers, the range 
of Ra values (100 – 3000 nm) increased significantly compared to the control. A 
significant proportion of particles with very rough surfaces (Ra greater than 2000 nm) 
was created. This was accompanied by significant decreases in fractions of smooth 
particles and more uniform distribution of Ra across a wider range. The SEM images of 
the coarse carrier particles are shown in Figure 36. 
 
Figure 35. Distribution of Ra values (N = 150) of the six different types of coarse 
carriers. 
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(A)  Control 
 
(B)  INH 
 
(C)  FBS 
 
(D) FBR 
 
(E) RC50  
 
(F) RC70 
 
Figure 36. SEM images of lactose particles and their typical surfaces (top right corner) 
from the (A) Control, (B) INH, (C) FBS, (D) FBR, (E) RC50, and (F) RC70 
carrier batches. 
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4.3.1.3 Fine particle fractions of dry powder inhaler formulations 
4.3.1.3.1 Formulations containing various concentrations of fine lactose 
A contour plot (Figure 37) was constructed to illustrate the effects of surface roughness 
and concentration of fine lactose on the FPF. The effect of carrier roughness appeared to 
be most significant when the concentration of fine lactose was between 0 – 3 %, w/w. By 
tracing the contour lines, it was clear that the roughest particles (Ra greater than 1100 nm) 
had achieved almost the same FPF values (approximately 35 %) in the absence of fine 
lactose as when 2 %, w/w of fines was added to the smoothest particles (Ra smaller than 
800 nm). The FPF of the RC carriers were relatively unaffected by fine lactose 
concentration as only less than 40 % increase in FPF was observed within the range of 0 
– 10 %, w/w of fine lactose. In comparison, the FPF of the control, INH and FB carriers 
were approximately doubled by the presence of 10 %, w/w of fine lactose. The 
improvement in FPF with addition of fine lactose has been widely discussed in literature 
(140-146). The mechanisms by which fine lactose increases FPF are: (a) the saturation of 
high energy sites (147) and (b) formation of mixed agglomerates of drug and fines (148) 
which require less detachment and dispersion energy. 
Powder cohesion of the DPI formulations with increasing concentrations of fine lactose 
was determined using shear cell tests (Table 16) in order to investigate whether the FPF 
was associated with powder flowability. The tests showed that all the DPI formulations 
containing up to 10 %, w/w of fine lactose could be classified as free-flowing powders 
since their ffc were greater than 4. The addition of fine lactose resulted in the decrease of 
ffc even though the FPF increased. There were no apparent relationships between the 
particle size, shape or roughness of the carriers and their flow properties. Powder 
cohesion did not seem to be directly related to the FPF. This was most apparent in DPI 
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Figure 37. Contour plot showing the relationships among surface roughness, 
concentration of fine lactose and FPF of the micronized drug. The drug 
load was kept constant at 2 %, w/w in all experiments. 
formulations containing no fine lactose as the RC50 carrier showed significantly higher 
FPF despite having similar ffc to the control and FBS carrier. At concentrations of fine 
lactose less than 7 %, w/w, the ffc values of the RC carriers were slightly higher than 
other carriers. As the fine lactose concentration was increased to 10 %, w/w, ffc values 
between the different carriers became more similar as powder flow became more 
dominated by the fine lactose/drug instead of the coarse carriers. 
 
 
135 
 
Table 16. Flow function (ffc) of DPI formulations containing different concentrations of 
fine lactose 
Carrier 
code 
 
ffc 
Concentration of fines added (%, w/w) 
0 
 
2 
 
4 
 
7  10 
Control 7.3 (0.9) 5.6 (0.3) 5.1 (0.0) 4.4 (0.1) 4.2 (0.2) 
INH 6.4 (0.3) 5.9 (0.1) 5.5 (0.1) 4.7 (0.3) 4.3 (0.0) 
FBS 7.5 (0.5) 5.8 (0.1) 5.3 (0.3) 4.5 (0.1) 4.0 (0.2) 
FBR 6.8 (0.4) 6.2 (0.3) 5.5 (0.3) 4.9 (0.3) 4.2 (0.4) 
RC50 7.4 (0.2) 6.8 (0.0) 6.3 (0.1) 5.0 (0.3) 4.1 (0.2) 
RC70 6.4 (0.1) 6.2 (0.3) 5.8 (0.2) 5.1 (0.3) 4.4 (0.2) 
Values in parentheses represent the respective standard deviation 
4.3.1.3.2 Formulations containing various concentrations of drug 
The FPF of formulations containing various concentrations of drug are shown in Table 
17. The effects of surface roughness and drug load on the FPF can be seen from the 
contour plot in Figure 38. Rougher RC carriers performed significantly better than 
smoother carriers. The FPF values of RC carriers containing 1 %, w/w drug was almost 
equivalent to the other smoother carriers containing 3 %, w/w of drug. Differences in the 
FPF values between the different carriers were pronounced when up to 6 %, w/w of drug 
was added. Comparing these results with those of Figure 37, it is clear that addition of 
fine lactose had improved the FPF values more efficiently than the increase of drug load. 
This was because the FPF of all carriers with 6 %, w/w of drug was about 30 – 40 %, 
which was considerably lower than the maximum FPF (45 – 50 %) that could be 
achieved by the addition of 10 %, w/w of fine lactose.  
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Table 17. Fine particle fractions (FPF) of formulations containing various 
concentrations of micronized drug in the absence of fine lactose 
Carrier 
code 
 
FPF (%) 
Concentration of drug (%, w/w) 
0.5 
 
1.0 
 
2.0 
 
4.0  6.0 
Control 13.3 22.5 23.5 33.8 29.2 
INH 10.7 14.9 19.8 27.4 39.2 
FBS 4.5 10.0 15.1 33.5 31.0 
FBR 7.1 12.9 24.9 29.4 32.7 
RC50 35.0 36.4 39.4 41.7 41.6 
RC70 21.9 32.2 36.8 39.9 38.8 
 
 
Figure 38. Contour plot showing the relationships among surface roughness, drug load 
and FPF of the micronized drug. The DPI formulations contained only 
coarse carriers and drug. 
137 
 
4.3.1.4 Aerodynamic size distributions of deposited drug 
The aerodynamic size distribution of a drug, represented by the MMAD and GSD, is 
useful for assessing the size distribution of drug particles detached from the carrier 
particles during aerosolization. Although the MMAD should preferably fall within the 
size range of 1 – 5 µm, it is not always directly related to the FPF since the MMAD is a 
parameter of size distribution, but not the actual amount, of drug deposited in the NGI. 
Therefore, the efficiency (FPF) and pattern (MMAD) of drug deposition have been 
evaluated separately in this discussion. The geometric size distribution of drug particles 
in the DPI formulation (before aerosolization) showed log-normal distribution (R2 = 
0.96), with median geometric diameter of 2.52 µm and GSD of 1.40. The geometric size 
of particles was not equal to their aerodynamic size as the drug particles could not be 
assumed to be perfectly spherical with a density of 1.0 g/cm3 (124). However, it was 
assumed that the aerodynamic size distribution of these drug particles would follow a 
log-normal distribution. After aerosolization of the dose, these drug particles were 
divided into two major fractions: (a) drug particles detached from carrier particles and 
deposited in NGI stages and (b) drug particles which remain adhered to the carrier 
particles and deposited in the pre-separator. The graph in Figure 39 shows that the FPF 
was linearly related with Fp (R
2 = 0.95), the fraction of drug trapped in the pre-separator. 
This was strong indication that drug particles which were not deposited in the NGI were 
likely to remain adhered to carrier particles trapped in the pre-separator. The x-intercept 
of the best-fit line suggests that all drug particles would be recovered from the pre-
separator when the FPF is 0 %. The y-intercept of the same line suggests that even when 
all the drug particles have completely detached from the carrier particles, a minimum of 
30 % of drug would be deposited in the mouthpiece adaptor, induction port and stages 1 
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and 5 – 8 of the NGI. Hence, the probable maximum FPF that can be achieved in the 
entire set of DPI formulations used in this study is about 70 %. 
 
Figure 39. Graph showing linear relationship between FPF and Fp, using data points 
from all in vitro experiments. 
The aerodynamic size distribution of drug particles which remain on the carrier particles 
cannot be directly determined by conventional methods since they cannot be completely 
recovered in the dry state from the carrier particles. However, changes in this size 
distribution may be inferred from corresponding shifts in the MMAD. The shifts in the 
MMAD values were used as indirect measures of the changes in the size distributions of 
the drug particles remaining on the carrier surfaces after aerosolization. Changes in the 
MMAD may be attributed to either one of the two factors; (a) changes in the size of drug 
(or drug-lactose) agglomerates formed in the ordered mixture or (b) preferential adhesion 
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of smaller-sized (or larger-sized) drug particles to carrier surfaces. To date, few research 
papers have provided information on the potential differences in the interaction behavior 
between the carrier surface and drug particles of different sizes. Different-sized drug 
particles are unlikely to behave in the same way; smaller particles are likely to be more 
strongly adhering to carrier surfaces due to the shorter distance of separation, stronger 
van der Waals forces and have higher likelihood of being entrapped in surface crevices 
than the larger particles. When the degree of surface roughness is increased, however, 
larger drug particles can also be entrapped in wider surface crevices. By comparing the 
MMAD values among the carriers with different surface roughness, it was possible to 
identify if there was preferential adhesion of particles based on their particle size to 
carrier surfaces of different roughness. Figure 40 is a graphical representation of the 
concept described above. 
4.3.1.4.1 Formulations containing various concentrations of fine lactose 
The MMAD values of drug deposited in the NGI were calculated for all DPI 
formulations (Figure 41). As the fine lactose concentration increased from 0 – 1 %, w/w, 
there was an initial decrease in the MMAD of deposited drug when the smooth carriers 
(control, INH and FBS) were used. The same was not observed for the FBR and RC 
carriers as the MMAD remained relatively constant regardless of the fine lactose 
concentration. Although the FPF values increased by almost 2 – 3 folds when the fine 
lactose concentration was increased from 1 to 10 %, w/w in the control, INH and FB 
carriers, the MMAD values did not change (Figures 37 and 41). The results suggest that 
the increasing concentration of fine lactose had an effect on the drug deposition patterns 
(i.e., size distributions) only at low fines concentration in the smooth carriers. When the 
concentration of fines was beyond 1 %, w/w for any carrier or as long as rough RC 
carriers were used, fine lactose had little effect on the drug deposition patterns. 
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Interestingly, carrier roughness appeared to exert greater influence on the MMAD as the 
MMAD of drug using the INH carrier were the lowest while that of the RC70 carrier was 
the highest regardless of the fine lactose concentration. Hence, the MMAD values were 
more dependent on the carrier type than the fine lactose concentration or FPF. 
 
Figure 40. Graph depicting three different possible size distributions of drug particles; in 
the DPI formulation before aerosolization, deposited in the NGI and adhered 
on the carrier particles after aerosolization. 
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Figure 41. Relationship between MMAD of micronized drug and the concentration of 
fine lactose added to DPI formulations. The drug load was kept constant at 
2 %, w/w in all experiments. 
The higher MMAD values of drug in formulations containing rougher carriers may be 
attributed to increased entrapment of the finest drug particles. The same trend has been 
observed in another investigation with a similar reasoning being suggested (37). The Ra 
values from the optical profiler suggest that the magnitude of roughness was in the order 
of 500 – 3000 nm in the roller compacted particles. Fine particles in the size range in the 
order of the roughness values would be more easily entrapped on the surface crevices 
compared to larger particles. It has been suggested that fine lactose particles can 
physically displace drug particles adhering to active sites on the carrier surface after they 
have been blended with the carrier and drug particles (137). The fine lactose used in this 
study had a d10 of 2 µm and hence, very low amounts of fine particles were small enough 
(either comparable or smaller than drug particles) to physically displace the entrapped 
drug particles. As a result, the differences in MMAD of drug between the formulations 
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containing different carriers remained relatively constant at all concentrations of fine 
lactose when the drug load was 2 %, w/w (Figure 41). The presence of up to 10 %, w/w 
of fine lactose had little effect on reducing the entrapment of finer drug particles and 
hence, the FPF was not significantly affected. The results suggest a need to reassess the 
current understanding of drug entrapment on carrier surfaces and its consequences on 
DPI performance (9, 60). As shown in this study, increased entrapment of drug particles 
on rougher carrier surfaces was not always detrimental to DPI performance. Rather, 
considerations about the preferential entrapment of drug particles of comparable size to 
the magnitude of surface roughness as well as its effects on both the FPF and MMAD 
also have to be made. 
4.3.1.4.2 Formulations containing various concentrations of drug 
When the MMAD values were plotted against the drug load for all six types of carriers 
(Figure 42), the initial decrease of MMAD was observed most significantly for the FBS, 
followed by the INH, FBR and control carrier. The decrease in MMAD of drug was much 
reduced in the RC50 carrier and not observed in the RC70 carrier. With a simultaneous 
decrease of the MMAD and increase of FPF when the drug load was increased from 0.5 
to 1 %, w/w, two conclusions could be drawn about drug adhesion to the carrier at a 
lower drug load of 0.5 %, w/w (Figures 38 and 42). The lower FPF value could be 
attributed to stronger adhesion of drug particles to the carrier at lower drug loads. More 
specifically, the finer drug particles may have been more strongly adhered to the carrier 
than the larger drug particles since the MMAD was higher when the drug load was 0.5 %, 
w/w. Changes in the MMAD values were no longer observed when drug loads were 
further increased to greater than 2 – 4 %, w/w. As the drug load increased beyond 2 %, 
w/w, the differences in MMAD of drug among all the carriers became much reduced. 
The trend was different from that shown in Figure 41, where differences in MMAD 
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between the carriers could be observed even at the highest concentration of fine lactose. 
This finding suggests that surface roughness of the carrier had decreasing influence on 
the drug deposition patterns when the availability of drug particles was increased relative 
to the available carrier surface. 
 
 
Figure 42. Relationship between MMAD of micronized drug and the drug load in the 
DPI formulations. The DPI formulations contained only coarse carriers and 
drug. 
4.3.1.5 Strategies to improve fine particle fraction 
Favorable spatial conditions of drug particles in the ordered mixture should be 
established in the formulation and/or blending stages in order to improve DPI 
performance. This in turn depends on the surface properties of the carrier. For smoother 
carriers, the formation of lactose-drug agglomerates by incorporation of fine lactose is an 
144 
 
effective strategy. For rougher carriers, limited effect on the FPF was observed with the 
addition of fine lactose. Roughening of carrier lactose can allow a greater degree of 
separation of drug particles on carrier surfaces and smaller/weaker drug agglomerates. It 
was noted in this study that the MMAD of drug from the RC70 carrier formulation were 
greater than 4 µm in most experiments and this is not ideal considering that the 
aerodynamic size range requirement for optimal drug deposition in the lung is 1 – 5 µm. 
The MMAD of drug when smoother carriers were used were generally smaller than 4 
µm and the lowest range of 3.2 – 3.4 µm was achieved with the INH carrier. Hence, it is 
likely that a slight decrease in the particle size of the drug (to decrease its aerodynamic 
diameter) may be required for rougher carriers compared to the smoother ones. 
It has also been reported that only the very small lactose particles that can be co-
deposited with the drug were useful in improving DPI performance (149) and strong 
linear relationships between FPF and fraction of fine lactose less than 10 µm have been 
observed (141). Based on the results of this study, lactose of very small size (preferably 
close to the size of drug particles) should be used with rougher carriers in order for them 
to displace the drug particles entrapped on the surfaces more efficiently. Collectively, 
these strategies are aimed at reducing the energy requirement for dispersion of drug 
agglomerates during aerosolization. Thus, it is likely that the size requirement of both the 
drug and fine lactose for maximal DPI performance may vary with the nature of the 
carrier surfaces among others. 
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4.3.2 Part 3B: Investigation of the surface distribution of micronized drug 
particles on rough lactose carriers using Raman spectroscopy 
4.3.2.1 Raman spectrum of α-lactose monohydrate 
The Raman spectrum of α-lactose monohydrate is shown in Figure 43. Lactose was 
shown to exhibit auto-fluorescence since the baseline of the raw spectrum was elevated 
from around 200 – 1800 cm-1 and increased gradually beyond 1800 cm-1. Intense and 
well-defined peaks occurred at 1080 cm-1 and in the region of 2800 – 3000 cm-1. The 
peak at 1080 cm-1 was reported to be characteristic of bending and stretching vibrations 
of the bridge COC group (150, 151) in the lactose molecule. By applying a baseline 
correction to the raw spectrum, the fluorescence background could be suppressed. 
 
Figure 43. Raw and baseline-corrected spectra of α-lactose monohydrate. 
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4.3.2.2 Raman spectra of drugs 
The raw Raman spectra of all drugs used are shown in Figure 44. Since the intensity of 
the Raman signals were dependent on how well the sample was focused, the spectra 
were all taken at the point of maximum focus of each sample. The intensities of the 
Raman peaks were highest at the point of maximum focus and this was achieved by 
slowly adjusting the stage while observing the real-time spectrum until the strongest 
signals were obtained. Hence, direct comparisons of the Raman signal intensities were 
possible and this helped in the selection of the model drug to use. Drugs with higher 
Raman scattering intensities were more desirable as there is a greater confidence of 
detection of the drug especially when the drug is present in very low concentrations in 
the interactive mixtures. Baseline correction was not applied to the spectra in order to 
compare the fluorescence effect of each drug, relative to the intensities of its Raman 
signals. 
 
Figure 44. Raman spectra of drugs in the spectral range of 200 – 4000 cm-1. 
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It can be clearly seen that the scattering intensities of salbutamol sulphate and rifampicin 
were very weak compared to the other compounds. Therefore, they were not very 
suitable as drug markers for this work. The scattering intensities of theophylline were 
slightly weaker than that of isoniazid or budesonide. Isoniazid showed a stronger 
fluorescent background compared to theophylline and budesonide. The spectral region of 
200 – 2000 cm-1 was found to contain the majority of the useful information needed, in 
the form of intense and sharp peaks, for isoniazid, budesonide and theophylline. 
The spectra of the three selected drugs and that of lactose were compared within the 
range of 200 – 2000 cm-1 and are presented in Figure 45. The purpose of this was to 
determine the feasibility of using univariate analysis to identify the presence of lactose 
and/or drug when given any spectrum obtained from an interactive mixture comprising 
only the lactose carrier and the drug. The most important criterion for univariate analysis 
is the presence of a distinct and non-overlapping peak in the drug spectrum, when 
compared against that of lactose. As the intensity of the Raman signal at each 
wavenumber is directly proportional to the number of molecules in the sample volume, 
the absolute peak intensity/area can theoretically be used to determine the amount of 
sample present. In reality, however, the absolute intensities of Raman signals are seldom 
useful without complex pre-processing of the spectra to separate the signals from noise 
(128). This is because the signal intensities are dependent on a multitude of factors such 
as random fluctuations and instrument noise. The correct setting of focus at each scan 
spot was also found to influence the intensities significantly. Instead of the absolute 
amount of drug at each scan spot, the concentration ratio of drug and lactose provides 
more reflective quantitative information for the purposes of this work. 
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Figure 45. Comparison of the Raman spectra of lactose and three drugs (isoniazid, 
budesonide and theophylline) for assessment of suitability for use in Raman 
spectral mapping. 
From Figure 45, it can be seen that the Raman spectral features of lactose are 
concentrated in the region of 200 – 1450 cm-1. To minimize the effect of overlapping 
peaks, the spectral region beyond 1500 cm-1 was most ideal for selection of comparative 
peaks in the drug spectra. There was at least one intense peak located in this region in 
each drug spectrum: at 1604 cm-1 for isoniazid, 1663 cm-1 for budesonide and 1689 cm-1 
for theophylline. The absolute peak intensity at 1689 cm-1 for theophylline was the 
lowest while the peak intensities in the spectra of isoniazid and budesonide at 1604 cm-1 
and 1663 cm-1, respectively, were of similar magnitude. Hence, either isoniazid or 
budesonide could be used as drug markers for Raman spectral mapping of the DPI 
formulations. Isoniazid was chosen as the drug in subsequent studies since it had slightly 
higher peak intensity at 1604 cm-1 and was used previously in the in vitro NGI studies. 
The peak at Raman shift of 1080 cm-1 in the lactose spectrum did not overlap with any 
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peak in the isoniazid spectrum and was therefore chosen for relative quantification 
purposes.  
4.3.2.3 Ratio of peak intensities in lactose and isoniazid 
The spread of the Peak1080/1604 values (Page 79) for both lactose and isoniazid are shown 
Figure 46. It can be seen that the values were approximately normally distributed over 
2000 spectra. For lactose, the mean Peak1080/1604 value and standard deviation were 13.9 
± 3.3 while that of isoniazid were 0.047 ± 0.008. By assuming normal distribution of 
Peak1080/1604 and calculating for 2 standard deviations on either side of the mean values, 
there was a 98 % chance that Peak1080/1604 would be: (a) greater than 7.21 if lactose alone 
was present and (b) smaller than 0.063 if isoniazid alone was present on the scan spot. 
Therefore, the threshold range of 0.083 – 5.9 (Page 80) meant that the probability of 
falsely detecting isoniazid in any scan spot would be much lower than 2 %. 
4.3.2.4 Effect of mapping parameters and mixture composition on Raman 
images 
The important considerations in the construction of Raman chemical images from 
interactive DPI mixtures are summarized in Figure 47. The variable factors in this study 
include the concentration of drug, step size and scan length. The particle size of drug and 
coarse carrier, blend uniformity and laser spot size were taken to be fixed variables. The 
long duration of time for data acquisition and processing was the major limiting factor 
for Raman spectral mapping. The average time for spectra acquisition in a 20 × 20 grid 
array typically took about 30 – 40 min. The time was inclusive of the exposure time for 
spectra acquisition and stage movement and settling time. This had posed a limit to the 
number of images that could be generated for the study. 
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 (A) 
 
(B) 
 
Figure 46. Histograms showing the spread of ratios of the peak intensity at 1080 cm-1 to 
the peak intensity at 1604 cm-1 when 2000 points scans were conducted on 
(A) lactose and (B) isoniazid. 
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Figure 47. Chart showing the important considerations for obtaining Raman chemical 
images from interactive DPI mixtures containing micronized drug and 
coarse carrier. 
4.3.2.4.1 Sampling step size and scan length 
A total of four different mapping experiments were performed on various sampling step 
sizes, scan lengths and drug concentrations in the interactive mixtures. The purpose of 
this was to determine the type of visual/statistical information that can be provided by 
Raman spectral analysis under these various conditions. This is because the scan spot of 
the laser is extremely small, in the order of a few µm, compared to the typical area for 
analysis (hundreds of µm to the mm range). The Raman maps were constructed using 
either the step size of 5 µm and sampling length of 100 µm or the step size of 20 µm and 
152 
 
sampling length of 400 µm. The Raman maps were constructed using the SS of the scan 
spots and are presented in Figures 48 and 49. A map obtained using a scan length of 100 
µm captured only one particle surface while a scan length of 400 µm captured 
approximately 10 – 20 particles in the scan area. The use of 20 µm step size resulted in 
the loss of more information in between each scan point compared to the 5 µm step size. 
Hence, it can clearly be seen that the maps obtained using the step size of 5 µm provided 
more visual information regarding the distribution of drug on the surface of each carrier 
particle. The step size of 20 µm provided more useful statistical information about the 
distribution of drug particles across different particle surfaces. Based on visual analysis, 
the drug particles appeared to be well distributed over all carrier particles as the location 
of grid points containing isoniazid was random in most areas of the entire map (Figure 
48). In comparison, more non-uniformity in the distribution of particles was observed 
when the scale of observation was reduced to individual particle surfaces (Figure 49). 
The drug particles appeared to be present as agglomerates with widely varying sizes, in 
the order of tens of µm. It is also apparent from Figure 49 that the surface coverage of 
drug on the carrier may be calculated based on the total percentages of grid points 
containing drug. In other studies, surface coverage of micronized drug particles on 
spherical glass beads has been calculated by assuming a monolayer of spherical drug 
particles with the densest packing on the bead surfaces (152). Unlike Raman chemical 
imaging, these calculations do not usually take into consideration the variation of drug 
particle size, the non-homogeneity of the surface as well as formation of drug 
agglomerates. 
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(A) 
 
(B) 
 
Figure 48. Raman maps constructed when the following mapping conditions were used: 
(A) step size = 20 µm and scan length = 400 µm and (B) step size = 5 µm 
and scan length = 100 µm. The sample comprised 1.5 %, w/w of micronized 
isoniazid in lactose carrier particles. White grid points represent the scan 
spots where only lactose was detected while gray/black grid points indicate 
the presence of isoniazid. 
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(A) 
 
(B) 
 
Figure 49. Raman maps constructed when the following mapping conditions were used: 
(A) step size = 20 µm and scan length = 400 µm and (B) step size = 5 µm 
and scan length = 100 µm. The sample comprised 0.75 %, w/w of 
micronized isoniazid in lactose carrier particles. White grid points represent 
the scan spots where only lactose was detected while gray/black grid points 
indicate the presence of isoniazid. 
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4.3.2.4.2 Concentration of micronized drug 
In addition to visual information provided by the Raman maps, the distribution of SS 
was analyzed by the use of histogram plots in Figure 50 and statistical measures were 
also calculated from them (Table 18). For the histogram plots, the grid points in each of 
the five Raman maps were combined and thus there were 2000 scan points in total for 
each combination of step size, sampling length and isoniazid concentration. The greatest 
number of grid points usually occurred when SS was between 0 – 0.1 (i.e., very low 
amount of isoniazid detected). This value decreased as the SS increased (i.e., when more 
isoniazid was detected). An exception, however, was observed in the Raman maps of the 
mixture containing 0.75 %, w/w isoniazid that were obtained using the 5 µm step size. 
The numbers of grid points were relatively similar across the entire range of SS.  
The number of grid points within each range of SS was approximately halved when the 
concentration of isoniazid was also halved. This was observed only when the step size 
was larger (i.e., 20 µm). This observation suggests that the number of grid points 
containing isoniazid could possibly be used as a statistical measure of the concentration 
of isoniazid in these interactive mixtures. In contrast, the same inferences could not be 
drawn from the SS obtained using a smaller step size of 5 µm. One possible reason for 
this is because the relationship between the number of grid points containing isoniazid 
and the concentration of isoniazid were more varied across the different ranges of SS. 
The results in Table 18 show the mean percentages of grid points containing isoniazid of 
five Raman maps in each set of conditions and their coefficients of variation. The results 
suggest that considerable uniformity of distribution of isoniazid particles had occurred 
when the particles are observed at the length scale of 400 µm (i.e., 10 – 20 particles). 
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(A) 
 
(B) 
 
 
Figure 50. Histograms showing the spectral scores (SS) of the Raman maps obtained by 
scanning the samples, containing 1.5 %, w/w (   ) and 0.75 %, w/w (   ) 
isoniazid, using the step size of (A) 20 µm and (B) 5 µm. The sampling 
length was 400 µm in (A) and 100 µm in (B). 
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Table 18. Percentage of grid points containing isoniazid in the Raman maps of lactose 
and isoniazid mixtures 
Concentration of isoniazid 
(%, w/w) 
 No. of grid points containing isoniazid 
 Step size (µm) 
 5  20 
0.75  11.9 (42.8)  19.9 (9.0) 
1.50  36.6 (21.6)  43.4 (3.4) 
Values in parenthesis represent the coefficient of variation (%) of the mean number of 
grid points containing isoniazid (n = 5) 
This was because the coefficients of variation obtained when the step size of 20 µm were 
used were shown to be relatively small (i.e., lower than 10 %) among different Raman 
maps of the same sample. On the other hand, they were much larger when the step size 
of 5 µm was used. This indicates that isoniazid particles were not uniformly distributed 
when carrier particles were observed at the length scale of 100 µm (i.e. about 1 particle). 
For the same step size employed, the coefficients of variation were found to be greater 
when the concentration of isoniazid was lower. This was likely related to the lower 
probability of detecting isoniazid in any one grid point when Raman maps were obtained. 
The smaller the concentration of isoniazid, the larger the number of scans required to 
establish the same degree of statistical confidence from the results. Hence, the choice of 
sampling strategies was shown to influence (a) the distributions of SS and (b) the way 
the Raman maps should be interpreted with respect to the scale of observation and the 
drug concentration. 
4.3.2.5 Qualitative assessments of drug distribution on carrier surfaces  
Visual information about the surface distribution of drug agglomerates/particles on 
carrier surfaces was first assessed from SEM images. Typical images of the INH and 
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RC70 carriers, which were blended with 2 %, w/w drug, are shown in Figure 51. In 
general, drug particles were preferentially packed into the surface crevices rather than on 
the smoother surfaces of the INH carrier particles. For the RC70 carrier, however, surface 
crevices present all around the particles presented as potential sites for drug particles to 
be deposited in. However, the drug particles could not be as easily distinguished from 
the lactose particle fragments or protuberances which were also present on the surfaces 
of the RC70 carrier particles. Thus, the SEM was not a discriminating tool to assess the 
drug distribution on carrier surfaces, especially for the roller compacted carrier particles. 
From the SEM images, it can be seen that the information in a 2D chemical image may 
not be quantitatively accurate in terms of area estimation. This is because the carrier 
surfaces are rarely flat with respect to the horizontal plane for scanning. Furthermore, the 
surface areas covered by the scan spots were much smaller than the total carrier surface 
considered. This led to additional variability in the area parameters calculated from the 
Raman image maps. Thus, visual information from SEM images would also serve as 
complimentary information to the chemical images in terms of the topological landscape 
of the scanned surfaces.  
4.3.2.6 Raman mapping of dry powder inhaler formulations  
4.3.2.6.1 Interactive mixtures containing various concentrations of fine lactose 
In order to investigate the influence of fine lactose content on the distribution of drug 
particles over the carrier surface, Raman maps were obtained from ternary mixtures 
comprising the carrier particles, drug and fine lactose. The results are summarized in 
Table 19. The percentage of isoniazid on the images represented the degree of 
distribution of drug over the carrier surface. As each Raman map is a 2D chemical image 
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Figure 51. SEM images of a carrier particle in DPI interactive mixtures comprising 2 %, 
w/w drug in (A) the INH carrier and in (B) the RC70 carrier. 
of the carrier surface, agglomerated drug particles would be expected to occupy a 
smaller total surface area on the carrier than dispersed drug particles. Surprisingly, the 
mean areas of the Raman maps occupied by isoniazid were generally similar and fell 
within the range of 42 – 46 % (p = 0.92). The increase in the percentage of fine lactose 
in the interactive mixtures did not appear to result in detectable differences in the Raman 
maps. In these three formulations, however, the drug content remained constant (2 %, 
w/w) but the actual content of coarse lactose carrier was decreased as the amount of fine 
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lactose increased. It has been suggested in the literature by other researchers (5) that the 
drug load in a DPI formulation should not only be considered in terms of its mass 
percentage in the formulation but also in terms of the surface area ratio of drug to the 
carrier. Assuming that the available carrier surface area for distribution of drug particles 
is proportional to the mass percentage of coarse carrier, an approximately 8.2 % decrease 
in carrier surface area was incurred when 8 %, w/w fine lactose was introduced into the 
interactive mixture while the drug-lactose ratio was kept constant. The increase in the 
average % isoniazid on the images was only about 4 %, suggesting that a fraction of drug 
particles were not adhering directly to the carrier surfaces. The fine lactose may also 
have shielded the drug particles, causing the reduced presence of drug when the Raman 
maps were constructed. The % isoniazid on the images might have been confounded by 
the formation of mixed agglomerates of drug-fine lactose. As the fine lactose content 
increased, mixed agglomerates may not be strongly adhered to the coarse carrier surfaces. 
Instead, a loose structure comprising mixed agglomerates interspersed between the 
individual coarse carrier particles may be formed.  
4.3.2.6.2 Interactive mixtures containing carriers of different roughness 
The Raman maps were further obtained from binary mixtures of drug and coarse carriers 
only and the results are shown in Table 20. A more significant change in the % isoniazid 
on the images were observed with varying surface roughness of the particles. The 
percentage area of the Raman maps occupied by isoniazid was generally found to be 
slightly higher (54 – 60 %) for the rougher carriers. However, an exception was observed 
in the FBR carrier. Although the FBR carrier had an intermediate roughness of 907 nm, 
the % isoniazid on the Raman image was comparable to the rougher RC carriers. The 
variability of the percentage areas were higher (i.e., greater than 40 %) in the interactive 
mixtures containing the FBS and control carriers. 
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Table 19. Percentage of lactose carrier surfaces occupied by isoniazid particles, 
calculated from the Raman maps of mixtures containing different fine lactose contents  
Interactive mixture used  Map no.  
Total no. of grid 
points with isoniazid 
 
% isoniazid 
on image 
98 %, w/w INH carrier  
2 %, w/w isoniazid 
 1  123  31 
 2  44  11 
 3  232  58 
 4  192  48 
 5  62  16 
 6  321  80 
 7  292  73 
 8  119  30 
 9  98  25 
 10  215  54 
 Average  170  42 
96 %, w/w INH carrier  
 2 %, w/w isoniazid  
2 %, w/w fine lactose 
 1  48  12 
 2  256  64 
 3  74  19 
 4  109  27 
 5  143  36 
 6  258  65 
 7  268  67 
 8  270  68 
 9  163  41 
 10  95  24 
 Average  168  42 
90 %, w/w INH carrier  
 2 %, w/w isoniazid  
8 %, w/w fine lactose 
 1  211  53 
 2  184  46 
 3  78  20 
 4  226  57 
 5  241  60 
 6  96  24 
 7  130  33 
 8  204  51 
 9  265  66 
 10  185  46 
 Average  182  46 
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Table 20. Percentages of lactose carrier surfaces occupied by isoniazid, calculated from 
the Raman maps of mixtures containing carriers of various surface roughness 
Carrier 
code* 
 
Ra 
(nm) 
 
Total no. of grid 
points with 
isoniazid 
 
No. of 
maps** 
 
% isoniazid 
on maps 
 
RSD 
(%) 
FBS  557  779  5  39  62 
Control  562  951  5  48  41 
INH  573  1698  10  42  23 
FBR  907  1199  5  60  20 
RC50  1175  1208  5  60  16 
RC70  1355  1082  5  54  19 
*The interactive mixtures used were binary mixtures of 2 %, w/w isoniazid and 98 %, 
w/w coarse lactose carrier 
**Each Raman map was composed of 400 scan spots 
Figure 52 suggests a positive relationship between the % isoniazid on image and the FPF. 
However, the mixture containing the FBR carrier was also observed to deviate from the 
general trend. The trend of increasing % isoniazid on the image with increasing carrier 
roughness suggests that some differences in the structure of the interactive mixture may 
be present when rougher carrier particles are used. This was likely to be related to the 
more regular distribution of surfaces crevices where drug particles can be distributed to. 
Rougher carrier surfaces might have assisted in the breakdown of drug agglomerates into 
smaller agglomerates/individual particles during the mixing process due to increased 
frictional forces. This might have reduced the energy requirements for dispersion of drug 
agglomerates and increase the FPF. On the other hand, smooth carriers contain relatively 
fewer surface crevices and drug is distributed over a smaller surface area. Some 
researchers have reported that rougher carriers contain more binding sites for drug 
particles since they have greater surface area (152, 153). An alternative explanation for 
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the increase in FPF resulting from the use of rougher carrier particles is the lower 
adhesion strengths of drug particles to rougher carrier surfaces. This could be due to 
sheltering of drug particles from the press-on forces during blending when the drug 
particles were distributed in the surface crevices. Even though no conclusive explanation 
has been given, a high degree of carrier surface roughness has been thought to contribute 
positively to the FPF. 
 
Figure 52. Relationship between the fine particle fraction and % isoniazid on the Raman 
maps. 
4.3.3 Summary of Part 3 
The investigations in Part 3 were conducted to evaluate the impact of surface roughness 
of carrier particles on the in vitro performance and drug distribution on carrier particles 
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of DPI formulations. In Part 3A of this study, DPI formulations with rough roller 
compacted carrier particles exhibited significantly higher FPF than both the inhalation 
grade and fluid-bed coated carriers. While the FPF of formulations containing the 
smoother carriers were significantly improved with the addition of fine lactose, the same 
outcome was not observed for the rougher roller compacted carriers. A direct 
relationship between the FPF and MMAD was not found for the series of formulations 
used in this part of the study. The higher MMAD of drug particles from formulations 
containing the rougher carriers suggested that fine drug particles could have been 
entrapped on rougher carriers. However, surface roughness still had an immensely 
beneficial impact on the FPF of DPI formulations. 
In Part 3B of this study, Raman chemical imaging was explored as a method for 
investigating the spatial distribution of drug particles/agglomerates on carrier surfaces. A 
univariate approach for detecting the presence of isoniazid on the lactose carrier surface 
was successfully adopted. Preliminary work showed that the relatively high probability 
of detecting drug particles of a low concentration was related to the surface distribution 
of small drug particles over the coarse carrier particles in the interactive mixtures. One 
useful parameter that was calculated from the Raman chemical images was the % area of 
the image where the Raman signal of the drug had been detected. By choosing the 
appropriate sampling strategy, this parameter could either be used as (a) an indication of 
the content of drug in the interactive mixture or (b) an indirect method for visualization 
of particle surfaces. The surface coverage of drug was found to be unchanged with 
increasing content of fine lactose in the formulation. However, the surface coverage of 
drug was likely to be confounded by formation of drug-lactose agglomerates when fine 
lactose was added. Differences in surface coverage were much more pronounced when 
carriers of different roughness were used. Rougher carriers showed better drug surface 
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coverage on the carrier particles, suggesting that the spatial distribution of drug particles 
was wider on rougher surfaces. Although the explanations remain elusive, the 
mechanisms by which the spatial distribution of drug affects the FPF warrants more 
future work. This is expected to provide clearer evidence on the positive impact of 
carrier roughness to improve DPI drug delivery performance. 
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CHAPTER 5 
CONCLUSION 
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5 CONCLUSION 
Carrier surface roughness is an important physical characteristic which critically 
influences the aerosolization of micronized drug particles in carrier-based DPI 
formulations. Unlike other carrier particle properties such as size and shape, quantitative 
measurements of surface roughness are challenging to perform. The modification of 
surface roughness of particulates, particularly the process of surface roughening, has not 
been well studied. The research work conducted in this thesis has covered several 
important aspects in the use of rough carrier particles in DPI formulations. They include 
the quantification of surface roughness, preparation of rough carrier particles and the 
evaluation of their performance in DPI formulations.  
Surface topographies of carriers were captured using optical profilometry, which is a 
rapid and non-contact method based on white-light interferometry. Raw surface images 
contained surface information spanning many length scales and the measurements were 
significantly affected by the random orientation of particles with respect to the horizontal 
plane of measurement. The magnitude of surface roughness, Ra, was found to be 
significantly influenced by the image processing techniques utilized in its calculation. By 
applying filters to extract surface information at the desired scale of observation, the 
effects of surface orientation and scan area were minimized. The presentation of 
roughness measurements together with the conditions for their derivation not only allows 
for more valid comparisons of Ra values in subsequent studies, but also ensures that 
measurements can be reproduced by other operators using similar equipment. 
Studies on the preparation of rough carrier particles were conducted using two methods 
which employed very different principles. Surface roughening by fluid-bed coating was 
based on the adhesion of micronized fine lactose on the surfaces of coarse crystallized 
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lactose particles. Surface roughening by roller compaction was based on extensive 
fragmentation and bonding of fragments to create much rougher carriers of granular 
nature. The conditions for the preparation of rough carriers were investigated and 
identified for each method. The particle size of powders used for coating and amount of 
micronized lactose sprayed were found to be important factors contributing to the 
surface roughness of the fluid-bed coated carrier particles. Even for lactose powders with 
a relatively narrow starting size distribution, larger particles in the feed were roughened 
to a greater extent than the smaller particles. For roller compaction, the processibility of 
powder blends were studied in greater detail and the imparted carrier roughness was 
found to be more dependent on the compaction force than the size or composition of the 
powder blends used in roller compaction. The feasibility of compaction at high roll 
forces as well as consistent compaction parameters were identified as the main criteria 
for the selection of powder blends. These desirable characteristics were in turn found to 
be influenced by the particle size distribution and powder flow properties. Of the several 
flow parameters that were evaluated, the specific energy obtained from the powder 
rheometer could best reflect the variability in the compaction parameters during roller 
compaction.  
The effects of rougher carrier particles on the in vitro performance and drug distribution 
of carrier particles of DPI formulations were investigated. The rougher roller compacted 
carriers exhibited significantly higher FPF than both the inhalation grade and fluid-bed 
coated carriers. Addition of fine lactose improved the FPF of formulations containing 
rougher carriers to a much lower extent than those containing smooth carriers. This was 
important since the inclusion of fine lactose particles is a commonly reported strategy for 
improving DPI performance. The higher MMAD of drug particles from formulations 
containing the rougher carriers suggest that fine drug particles could have been 
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entrapped on rougher carriers. Nevertheless, surface roughness was overall shown to 
have an immensely beneficial impact on the FPF of DPI formulations. Following this, 
Raman chemical imaging was explored as a method for investigating the spatial 
distribution of drug particles/agglomerates on carrier surfaces. This method was found to 
be complex and time-consuming but could provide valuable chemical information about 
carrier surfaces which could not be obtained by other imaging equipment, such as the 
SEM. Raman spectral mapping was used for indirect visualization of the drug 
particles/agglomerates on carrier surfaces only after proper considerations of the 
concentration of drug and the sampling plan for construction of the chemical images. 
The surface coverage of drug on the carrier surface had provided useful insights which 
could describe how well drug particles/agglomerates were being dispersed over the 
surface. Rougher carriers were shown to result in greater surface coverage of drug on the 
carrier, suggesting that drug was more efficiently dispersed as smaller agglomerates on 
rough surfaces. 
Finally, two research areas with potential scientific impact are identified for future 
investigation. First, a comprehensive evaluation of carrier surface roughness should also 
include investigations in the macro-, micro- and nano-scale surface features. This may 
require the concurrent usage of multiple surface measurement equipment, such as both 
the optical profilometer and the scanning probe microscope. The most challenging aspect 
will probably be the need to derive common and comparable roughness parameters from 
both line and area profiling methods. Second, the interactive mixing of rough carriers 
with micronized drug is a relatively unexplored area of research. Most researchers have 
instead concentrated their efforts on the process of drug aerosolization. The Raman 
spectral mapping conducted in this thesis has shown that the spatial orientation of drug 
particles was altered by carrier roughness in the interactive mixtures. Hence, it is 
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important to understand the contributions of surface roughness during interactive mixing 
to DPI performance. This could potentially aid formulation scientists in refining the 
selection criteria for carriers in DPI formulations, especially in terms of their surface 
characteristics.  
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